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Abstract
In the last decade, genome-wide association studies have helped to advance our under-
standing of the genetic architecture of many important traits, including diseases. How-
ever, the statistical analysis of genotype-phenotype associations remains challenging
due to multiple factors. First, many traits have polygenic architectures, which means
that they are controlled by a large number of variants with small individual effects.
Second, as increasingly deep phenotype data are being generated there is a need for
multivariate analysis approaches to leverage multiple related phenotypes while retain-
ing computational efficiency. Additionally, genetic analyses are confronted by strong
confounding factors that can create spurious associations when not properly accounted
for in the statistical model. We here derive more flexible methods that allow integrat-
ing genetic effects across variants and multiple quantitative traits. To do so, we build
on the classical linear mixed model (LMM), a widely adopted framework for genetic
studies.
The first contribution of this thesis is mtSet, an efficient mixed-model approach that
enables genome-wide association testing between sets of genetic variants and multiple
traits while accounting for confounding factors. In both simulations and real-data
applications we demonstrate that mtSet effectively combines the advantages of variant-
set and multi-trait analyses.
Next, we present a new model for gene-context interactions that builds on mtSet.
The proposed interaction set test (iSet) yields increased statistical power for detecting
polygenic interactions. Additionally, iSet enables the identification of genetic loci that
are associated with different configurations of causal variants across contexts. After
benchmarking the proposed method using simulated data, we consider two applications
to real datasets, where we investigate genetic effects on gene expression across different
cellular contexts and sex-specific genetic effects on lipid levels.
Finally, we describe LIMIX, a software framework for the flexible implementation of
different LMMs. Most of the models considered in this thesis, including mtSet and iSet,
are implemented and available in LIMIX. A unique aspect of the software is an inference
framework that allows a large class of genetic models to be defined and, in many cases,
to be efficiently fitted by exploiting specific algebraic properties. We demonstrate the
utility of this software suite in two applied collaboration projects.
Taken together, this thesis demonstrates the value of flexible and integrative mod-
elling in genetics and contributes new statistical methods for genetic analysis. These
approaches generalise previous models, yet retain the computational efficiency that is
needed to tackle large genetic datasets.
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The main contributions of this thesis are in the field of statistical genetics. Statistical
genetics is concerned with the development and the application of statistical methods
to study genetic variation and inheritance in living organisms. In this chapter, I give
an overview of this field and the necessary background for the work in this thesis.
After discussing genetic variation and its patterns in human in Section 1.1, I give an
overview of models and methods to study genetic effects on phenotypes in Section 1.2.
In Section 1.3, I discuss some of the statistical challenges in modern genetics. Finally,
Section 1.4 concludes this chapter with an outline of the thesis structure and the main
contributions.
1.1 Genetic variation
In this section I discuss the mechanisms of genetic variation and inheritance.
1.1.1 DNA and genetic variants
All the information needed to build and sustain an organism is encoded in its genome.
The genome is organised into chromosomes, which consist of long molecules of de-
oxyribonucleic acid (DNA) (Brosius, 2009) and other elements. In chromosomes,
DNA is composed of two strands, which are sequences of smaller molecules called
nucleotides (Alberts et al., 2014). Each nucleotide in the sequence contains one of four
distinct bases (adenine - A, thymine - T, guanine - G or cytosine - C). The two strands
are kept together by hydrogen bonds between opposite bases. As these bonds can form
only between specific pairs of bases (G with C and A with T) the two sequences are
complementary. The number, length and shape of chromosomes differ between species.
The human genome consists of 23 pairs of chromosomes: 22 pairs of non-identical
copies of autosomal chromosomes (one inherited from the father and the other from
the mother) and one pair of sex chromosomes. Females have two non-identical copies
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of the X chromosome (one from each of the two parents), while males have only one
copy of the X chromosome (from the mother) and one copy of the Y chromosome (from
the father). The two non-identical copies of a chromosome are called homologous.
The human genome consists of approximately 3 billion base pairs (bp) (Venter et
al., 2001; Lander et al., 2001). Pairs of individuals share on average 99.5% of the
DNA sequence (Levy et al., 2007). A change in the sequence across individuals in a
population is commonly referred to as a genetic variant while the different forms of
the sequence are called alleles. An individual’s collection of alleles at a genetic locus
(i.e., at a location in the genome) is referred to as the genotype of that individual.
An individual is homozygous at a genetic locus on an autosomal chromosome if it has
two copies of the same allele; otherwise it is heterozygous at the locus. Depending on
the length and type of the sequence variation we can distinguish two types of genetic
variants: single nucleotide polymorphisms and structural variants (Frazer et al., 2009).
Single nucleotide polymorphisms (SNPs) are substitutions of a single base pair and
are the most common type of genetic variation. Most SNPs are bi-allelic, meaning
that only two possible alleles are observed in the population (International HapMap
Consortium, 2005). Structural variants are changes that involve more than a single
base pair and include short insertions and deletions (collectively referred to as indels)
as well as larger variants at the chromosome scale, including duplications, deletions,
inversions and insertions.
1.1.2 The biological process underlying inheritance
Meiosis is the process of cell division that leads to the formation of sperm cells in males
and egg cells in females, collectively called gametes. In contrast to somatic cells, which
have two copies of each chromosome (diploid), gametes only have one copy of each
chromosome (haploid). The union of a sperm and an egg cell generates a diploid cell,
the zygote, which is the first cell of a new organism.
Meiosis starts with the pairing of homologous chromosomes in a diploid cell. Each
chromosome is then duplicated giving rise to a pair of chromatids. At the end of
this process each chromosome has four homologous chromatids. Identical and non-
identical copies of homologous chromatids are called respectively sister and non-sister
chromatids. At this stage non-sister chromatids may exchange segments of genetic
material, an event that is known as a crossover. Finally, through two rounds of cell di-
vision the cell gives rise to four gametes. Each gamete randomly receives one of the four
homologous chromatids from each chromosome. This selection occurs independently
for each chromosome, leading to a mixture of maternal and paternal chromosomes in
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each gamete. An important consequence of crossovers is that gametes may contain
chromosomes that are a mixture of the two grandparental chromosomes from the same
parent. During the process of fertilisation a sperm and an egg fuse to generate the
zygote. Each zygote inherits approximately 1/4 of the genetic material from each of
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Figure 1.1: Meiosis and fertilisation. The figure illustrates key stages of the pro-
cesses of meiosis and fertilisation, for simplicity considering a single chromosome.
Crossovers are random events and the rate of their occurrence depends on many
factors, including sex, chromosome location, temperature and age. The occurrence
of a crossover in a region reduces the likelihood of a new crossover in proximity. In
every meiotic event, on average approximately 55 crossovers occur in males and 82
in females (Laird and Lange, 2010). The number of crossovers taking place between
two loci is not an observable quantity. However, if genotype data are available one can
sometimes infer whether a recombination event between two loci has occurred (Morgan,
1915; Laird and Lange, 2010). Note that the occurrence of a recombination only gives
information about whether an odd or an even number of crossovers has taken place
between the two loci. If at least one crossover between two loci has occurred then the
fraction of gametes with a recombination is 50%. The rate of recombination between
two loci can thus be estimated as θ = (1 − P0)/2 (Mather, 1938), where P0 is the
probability of no crossover. For loci that are extremely close on the same chromosome
we have P0 ≈ 1 and θ ≈ 0. These loci tend to be inherited together and are therefore
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in linkage. Conversely, for loci that are far apart on the chromosome we have P0 ≈ 0
and θ = 1. In linkage studies, recombination rates have been used to infer the distance
between loci on chromosomes and thus generate genetic maps (see Section 1.2.2).
1.1.3 Human genetic variation
Allele frequency is an important property of genetic variants. The frequency of an
allele at a genetic variant is the proportion of chromosomes in the population that
carry that allele (Laird and Lange, 2010). For a bi-allelic variant, the frequency of
the less common allele (minor allele) is called the minor allele frequency (MAF). For
multi-allelic variants, the MAF typically indicates the frequency of the second most
common allele.
Based on their MAF, genetic variants are classified as either common or rare, where
commonly a cut-off of 1% is used to define rare variants (MAF<1%) and common vari-
ants (MAF>1%) (Frazer et al., 2009). Comparative analyses of genomic sequences
have provided evidence for over ten millions of common variants (Frazer et al., 2009).
Importantly, allele frequencies of common variants vary widely across groups of indi-
viduals from different geographical regions, with many common variants segregating
across populations. This phenomenon is known as population structure and is the con-
sequence of non-random mating primarily due to geographical distance. In contrast to
common variants, rare variants are unnumbered and include variants that are specific
to close relatives or single individuals (Frazer et al., 2009).
Another central concept in genetic variation is linkage disequilibrium (LD). Two
loci are in LD if some combinations of their alleles tend to occur together more of
less often than expected by chance. There are different factors that determine LD
between variants, including genetic linkage (see above), selection and population struc-
ture (Slatkin, 2008). Different measures of LD have been proposed over the years (for
a review see Devlin and Risch, 1995). A widely used measure of LD is the squared
Pearson correlation between the minor allele counts in the population (Benner et al.,
2016; Pickrell et al., 2016; Yang et al., 2012).
The sequencing of the first human genome (Venter et al., 2001; Lander et al., 2001)
was followed by the start of the HapMap Project (Gibbs et al., 2003) that aimed at
characterising patterns of human genetic variation in different populations with a focus
on common variants. This international effort genotyped more than 10 million SNPs
in 270 individuals from four human populations (Nigerians, Europeans, Chinese and
Japanese). One fundamental result of this study was the haploblock structure of the
human genome: the human genome is characterised by regions in which recombina-
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tion events are limited, resulting in haplotype blocks1 characterised by high LD within
them. Notably, 550,000 haplotype blocks in Europeans and Asians and 1,100,000 hap-
lotype blocks in Africans were sufficient to accurately summarise the genetic variation
described by common SNPs with MAF > 5% (International HapMap Consortium,
2005). An important implication of this finding is that sparse genotype data at tagging
SNPs are sufficient to reconstruct most of the genome-wide genetic variation of com-
mon variants, an insight that is key to the success of genome-wide association studies
(see Section 1.2.3) and genotype imputation (Howie et al., 2009; Marchini and Howie,
2010).
Exploiting the higher coverage at reduced costs offered by next-generation sequenc-
ing (NGS) technologies (Metzker, 2010), the 1000 Genomes Project aimed at studying
high-coverage sequences of at least 1,000 individuals from different world-wide pop-
ulations (1000 Genomes Project Consortium, 2010). In three phases, the consortium
generated reference maps of human genetic variation, first considering 1,092 individuals
form 14 populations (1000 Genomes Project Consortium, 2012) to finally characterise
the genetic variation between 2,504 individuals from 26 human populations. In addition
to characterising SNPs and short indels (up to 500 bp, 1000 Genomes Project Consor-
tium, 2015), the 1000 Genomes project has also progressed the boundaries of detecting
and genotyping structural variants (1000 Genomes Project Consortium, 2015). Col-
lectively, the results from the project provide “the most comprehensive view of global
human variation so far” (Birney and Soranzo, 2015).
1.2 From genetic variation to phenotype
Understanding how genetic variation affects phenotypes is a long standing goal in bi-
ology. In this thesis, I will interchangeably use the terms "phenotype" and "trait" to
indicate any measurable feature of an individual, which can be a disease state as well
as a molecular or cellular feature. Additionally, I will refer to loci that are associated
with a trait as a quantitative trait locus (QTL) for that trait. In this section, I give a
brief historical overview of the approaches that have been used to study genetic effects
on traits.
1.2.1 The first genetic models
Many consider Mendel’s work “Experiments in plant hybridisation” the beginning of sta-
tistical genetics (Mendel, 1866). Studying inheritance of dichotomous traits in plants,
1A haplotype is a set of alleles on the same chromosome.
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Mendel discovered the existence of a dominant and a recessive form of a trait. Anal-
ysis of phenotype data in successive generations led Mendel to formulate the law of
segregation: “One allele of each parent is randomly and independently selected, with
probability 1/2, for transmission to the offspring; the alleles unite randomly to form
the offspring’s genotype” (Laird and Lange, 2010).
In parallel to Mendel’s work, Francis Galton, fascinated by Darwin’s book “On the
Origin of Species” (1859), studied inheritance of height and intelligence in human (Gal-
ton, 1869). The traits considered by Galton seemed to follow completely different
laws of inheritance from those described in Mendel’s work: the parental forms of these
traits appeared somehow to be mixed in the offspring. Such traits that do not follow
Mendelian patterns of inheritance are commonly referred to as complex traits.
This paradox was solved in 1918 by the theoretical work of the statistician Ronald
Fisher (Fisher, 1918). Fisher showed that an additive genetic model with a large num-
ber of small-effect loci results in a continuous normally distributed trait. Moreover,
he proved that the phenotypic correlation between individuals is proportional to the
quantity of genetic material they share. This result demonstrated that heritable com-
plex traits are affected by many genes, each following Mendel’s principle of inheritance.
A few decades later, building on Fisher’s work, Charles Henderson derived the solution
of the mixed model equation (Henderson, 1950). Nowadays linear mixed models con-
stitute the standard tool for many genetic analyses and are the basic building block of
this thesis.
1.2.2 Linkage analysis
Genetic studies were initially performed solely using phenotype data. In the beginning
of the 20th century, the development of the first genotyping technologies introduced the
possibility to identify the genomic position of genetic markers and disease genes, giving
rise to a branch of statistical genetics known as gene mapping. The first statistical
method used for gene mapping was linkage analysis. The core idea underlying this
approach is to use the realised recombination rate between pairs of loci in a short
pedigree to infer relative genomic distances and build linkage maps (see Griffiths, 2005,
chap 5). The same methodology has been successfully applied to locate disease variants
for many Mendelian traits by using genotype and phenotype data on pedigrees over
one/two generations. The strategy employed to map disease loci is to test for linkage
between any of the genotyped markers and the disease variant (whose genotype is
inferred from the phenotype data) by testing whether the recombination rate between
the two loci is significantly different from 1/2 (θ 6= 12). The advantage of considering
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short pedigrees is that only a few recombinations can occur between loci in linkage
so that sparse marker information (up to hundreds of markers per chromosome) are
sufficient to map disease variants, although with limited resolution. Examples for some
of the first linkage analyses include Alzheimer’s disease (Schellenberg et al., 1991), cystic
fibrosis (Lathrop et al., 1988) and Huntington’s disease (Gusella, 1984). However, the
method has been less successful in mapping genes for complex disorders (Altmüller
et al., 2001).
1.2.3 Genome-wide association studies
High-throughput genotyping technologies, including SNP arrays and low-coverage se-
quencing, have enabled genotyping of hundred of thousands to millions of common
SNPs in increasing sample sizes. These technological advances, together with the find-
ings from the Hapmap project on the haploblock structure of the human genome (see
Section 1.1.3) laid the foundation for the success of genome-wide association stud-
ies (GWAS, Frazer et al., 2009), currently the most widely used design for gene map-
ping (McCarthy et al., 2008). GWAS rely on the LD between genotyped and causal
variants, which are potentially not typed, to identify loci implicated in traits and dis-
eases. Contrarily to linkage studies, GWAS are commonly performed in populations of
unrelated individuals (Astle and Balding, 2009), enabling the analysis of larger sample
sizes (typically from 1,000 to 100,000 individuals or even larger2). The basic principle
underlying GWAS is to test for association between individual genotyped variants and
the trait of interest. Given the large number of genome-wide variants to be tested,
stringent criteria of significance are needed to control the number of false discoveries
at the expense of statistical power (see Section 2.2.1).
The first GWAS in human was published in 2005 and revealed two genetic loci
associated with age-related macular degeneration (Klein et al., 2005). Ever since,
GWAS have become increasingly popular, yielding important insights into the genetic
architecture of many complex traits, including type 2 diabetes (Scott et al., 2007),
inflammatory bowel disease (Khor et al., 2011) and major depression (Kohli et al.,
2011; Cai et al., 2015). Today, the GWAS Catalog (Burdett et al., 2015) includes
more than 2,500 published GWA studies and more than 24,000 SNP-trait associations
(August 2016).
Importantly, dense genotype data, such as those from the HapMap, the 1000
Genomes project and, more recently, the UK10K population (Huang et al., 2015) can
2Consortia such as UK Biobank (Sudlow et al., 2015) have currently been producing and studying
cohorts of 500,000 individuals.
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be used as a reference for imputing genotypes at unobserved loci, thereby completing
sparse genotype data (Howie et al., 2009; Marchini and Howie, 2010). Recent GWA
studies in cohorts with NGS genotype data have attempted to identify effects from
rare variants (UK10K Consortium, 2015). However, the robust identification of rare-
variant effects remains challenging, as it requires extremely large sample sizes (Risch
and Merikangas, 1996; Bush and Moore, 2012).
1.2.4 Molecular mechanisms from genotype to phenotype
In the process of gene expression, the genetic information stored in the DNA is used
to produce molecular products. The information on the composition of these products
is contained in restricted portions of the genome known as genes. In the first step
of gene-expression (transcription), genes are transcribed into ribonucleic acid (RNA)
molecules. Although RNA molecules can be the final product of gene expression, many
RNA molecules are translated into proteins in a process known as translation. Proteins
are long chains of smaller molecules called amino acids. Only approximately 1.5% of
the human genome codes for proteins (Lander et al., 2001) while a large fraction of the
remaining portion is likely to play a role in the regulation of gene expression (ENCODE
Project Consortium, 2004). The impact of genetic variation on phenotypes is the
consequence of perturbations to this complex molecular machinery.
An easily interpretable mechanism through which genetic variants may affect phe-
notype is the direct alteration of the structure of the coded protein and thus of its
functionality. For example, sickle cell anaemia is caused by a SNP in the HBB gene,
which causes a substitution of an amino acid in the sequence of the coded protein (Laird
and Lange, 2010). Alternatively, genetic variation may affect the regulation of gene
expression. One way this can occur is through the disruption of a specific sequence
that affects the binding of proteins regulating the expression of a gene. Another possi-
bility is the alteration of the structure of the DNA, thereby affecting the functionality
of regulatory elements and ultimately gene expression (ENCODE Project Consortium,
2004; Kundaje et al., 2015). Importantly, these structural changes are not necessarily
associated with a change in the DNA sequence and are collectively referred to as epi-
genetics, where the prefix epi- is from Greek and means "outside of" (Spector, 2012).
Importantly, such changes can be "inherited" in the process of cellular division and
play a key role in regulation of gene expression. Examples of epigenetic modifications
are DNA methylation and histone modifications. Specifically, DNA methylation is the
process through which a hydrogen atom in adenine or cytosine is replaced by a methyl
group. Methylation of promoters (i.e., the DNA sequences where transcription is initi-
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ated) is associated with the silencing of the corresponding gene (Alberts et al., 2014).
Another important class of epigenetic changes are modifications of structural proteins,
known as histones, which play a key role in the packing of DNA in chromosomes. No-
tably, histone proteins can undergo more than 100 histone modifications (Ernst and
Kellis, 2010), which can be reversibly written and erased by specific enzymes. The com-
bination of the different histone modifications determines “the histone code” (Alberts
et al., 2014). Different combinations have been associated with transcribed regions,
enhancers, promoters, and other functional regions (Ernst and Kellis, 2010). Regula-
tory elements can lie far from the regulated gene (Alberts et al., 2014), hampering the
identification of genes underlying known GWAS loci.









hQTL, mQTL, ... 
mapping
EWAS
Figure 1.2: Overview of genetic analysis of molecular and global traits. Shown
are different molecular layers and association analyses that can be considered to link ge-
netic variation to different molecular and global traits. The grey arrow shows the most
likely causal direction of these effects. Of course there are numerous exceptions to this
simplified scheme. Regulatory elements include DNA methylation, histone modifica-
tion, binding affinity for different proteins, etc. hQTL, mQTL, eQTL, pQTS mapping
stand for histone modification, methylation, expression and protein QTL mapping.
In order to map genes whose regulation is associated with phenotypic changes, many
studies have considered genome-wide association testing between epigenetic features
and complex traits, including disease, mainly focusing on DNA methylation (Paul and
Beck, 2014). These studies are known as epigenome-wide association studies (EWAS).
The decrease in cost of high-throughput profiling of gene expression has made it
possible to measure gene expression levels in large numbers of individuals, thereby
enabling the mapping of quantitative trait loci for gene expression (eQTL mapping,
Schadt et al., 2003). More recently, these studies have been extended to test for genetic
effects on different regulatory elements, including DNA methylation (Gaunt et al.,
2016), histone modifications (Grubert et al., 2015) as well as the activity of known
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proteins and protein complexes that regulate expression and chromatin accessibility,
such as transcription factors (Waszak et al., 2015). An overview of the different genetic
analyses and their relationship to GWAS is given in Fig. 1.2.
As genetic effects on molecular traits may depend on factors such as tissue, en-
vironment and cell type, it is necessary to measure expression and other molecular
traits in disparate cellular contexts. For this reason, the Genotype-Tissue Expression
Project (GTEx Consortium, 2015) has been collecting and analysing gene expression
profiles for more than 50 tissue types from over 900 donors.
Molecular QTL mapping entails QTL mapping for tens of thousands of molecu-
lar measurements. Therefore the “small sample size/high number of tests” problem in
these analyses is even more severe than in GWAS. Moreover, genetic analysis of molec-
ular traits are typically performed in datasets with smaller sample sizes compared to
GWAS3. To circumvent this issue, many studies have focused on mapping proximal
(putatively cis-acting) QTLs by restricting association testing to genetic variants that
are close to the analysed molecular trait as they are more likely to have an effect on
the molecular phenotype compared to distal genetic variants.
1.3 Statistical challenges in genetics
Despite ever increasing sample sizes, the statistical analysis of genetic data remains
challenging. In this section I discuss the limitations of the standard GWAS approach
and recent extensions focusing on aspects that are relevant to the contributions of this
thesis.
Polygenic architectures. A main limitation of the GWAS methodology is that
many complex traits have highly polygenic architectures with numerous weak-effect
variants (Frazer et al., 2009). This is one potential source of “missing heritability” (Ma-
her, 2008), where heritability is defined as the fraction of phenotypic variance explained
by additive genetic effects. This narrow-sense definition of heritability does not include
dominance effects and genetic interactions, which are included in the definition of broad-
sense heritability (Visscher et al., 2008). Heritability was traditionally estimated from
phenotype data on pedigrees (see Falconer and Mackay, 1996), for example by re-
gressing the parental average trait against the trait in the offspring (Laird and Lange,
2010). The phenomenon of “missing heritability” refers to the positive difference be-
tween these heritability estimates and the proportion of phenotypic variance explained
3Typically, molecular QTL mapping is performed considering a few hundreds of individuals.
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by the additive effects of GWAS loci. Performing GWAS in increasingly large cohorts
has helped recover some of this missing heritability, by revealing new associated loci
for traits such as height (Wood et al., 2014), intelligence (Rietveld et al., 2013) and
schizophrenia (Ripke et al., 2014). An alternative approach is to jointly model the
effects from multiple genetic variants. This strategy has been shown to recover large
proportions of the missing heritability for many complex traits (Yang et al., 2010; Lee
et al., 2012b; Gusev et al., 2014; Eichler et al., 2010). A widely used approach to
aggregate genetic effects across multiple variants is to use a random effect within a
linear mixed model (LMM), the same approach initially proposed by Fisher to model
inheritance of complex traits (Fisher, 1918). Prior to applications in human studies
and following Fisher and Henderson’s work, LMMs had been extensively used in the
field of animal breeding (Fisher, 1921; Fisher and Mackenzie, 1923; Henderson, 1984).
Recent studies have shown that genetic effects are not uniformly distributed along
the genome (Gusev et al., 2013) and that genetic loci can harbour multiple causal
variants (Wood et al., 2011; Chiba-Falek et al., 2012; Trynka et al., 2011; Ehret et al.,
2012; Patsopoulos et al., 2013; Corradin et al., 2014). These findings have motivated
the development of set tests, a class of models that allows joint testing of multiple
variants in genetic regions (Wu et al., 2011; Listgarten et al., 2013; Brown et al., 2016).
Set tests have been shown to improve genetic mapping over single-variant approaches,
recovering parts of the unexplained genetic variance (Wu et al., 2010; Listgarten et al.,
2013; Brown et al., 2016).
Correcting for confounding. A second challenge in GWAS is confounding factors,
which can lead to spurious genotype-trait associations (McClellan and King, 2010; Lam-
bert and Black, 2012; Pritchard et al., 2000b; Patterson et al., 2006). A well-studied
confounder in association studies is population structure (Marchini et al., 2004). To
showcase its action, let us suppose we have a population dataset consisting of individ-
uals from different ethnic groups. As alleles at many different loci tend to co-occur
in individuals from the same ethnic group, the genotype data will be characterised by
genome-wide LD between variants. As shown in Fig. 1.3a, if we consider a quantitative
trait that is also influenced by ethnicity (for example because it is affected by an envi-
ronmental factor determined by the geographic region of origin), a GWAS will retrieve
many spurious genetic associations (see Lander and Schork, 1994). In this example,
population structure exhibits a shared influence on both phenotype and genotype data.
As shown in Fig. 1.3b, population structure can also cause genuine genetic signal from
causal variants to be mirrored in numerous non-causal loci in LD (Ewens and Spielman,
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1995). Similar problems affect genetic analyses of related individuals, where genome-
wide genetic similarities are correlated with environmental factors, thereby creating
many spurious genotype-trait associations (Eu-Ahsunthornwattana et al., 2014).
As discussed in further detail in the next chapter, several methods have been pro-
posed to correct for such confounding factors. Among these different strategies, the
linear mixed model has emerged as a particularly robust approach as it can handle
different types of confounding, including complex population structure and related-
ness (Kang et al., 2008b; Kang et al., 2010). However, fitting LMMs can be generally
computationally demanding. Although recent computational advances have enabled
application of specific LMMs to genetic analyses in large cohorts (Kang et al., 2008b;
Zhou and Stephens, 2012; Kang et al., 2010; Lippert et al., 2014a), the application of















Figure 1.3: Two causal networks of confounding. Population structure (P) affects
genome-wide genotypes, creating long-range LD between variants. In (a) P also affects
the trait of interest (y), a scenario that creates spurious associations in GWAS. In (b)
P does not have an effect on the trait, however, because of long-range LD, the effect
of the causal genotype g3 can be mirrored at physically distant loci in an association
test.
Multivariate analysis of related phenotypes. As increasingly deep phenotype
data are becoming available in human cohorts, there has been a growing interest in
multivariate analyses. Multivariate models have several benefits. First, many complex
traits and diseases are affected by shared genetic and environmental influences (Fortune
et al., 2015; Frazer et al., 2009). For example, Pickrell et al. (2016) found that a notable
proportion of the variants affecting age at menarche also affect height (36%), age of
voice drop (30%), BMI (28%), breast size (10%) and male pattern baldness (10%).
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The phenomenon of a variant affecting multiple traits is also known as pleiotropy and
its occurrence in human traits is pervasive (Sivakumaran et al., 2011). Joint genetic
analyses of multiple traits have been shown to increase statistical power by leveraging
trait-to-trait correlations induced by shared genetic and environmental factors (Korte
et al., 2012; Zhou and Stephens, 2014). Second, genetic effects on phenotypes can
depend on environment, sex, age and other contextual variables (Dick, 2011; Winkler
et al., 2015; Sasaki et al., 2015; Kang et al., 2014). By modelling the same trait in
varying contexts, multivariate approaches can help characterising the context-specific
architecture of genetic effects (Korte et al., 2012; Kang et al., 2014). Beyond the
analysis of global phenotypes, these multivariate approaches are also important to
characterise the genetic regulation of molecular traits across tissues (Price et al., 2011;
Sul et al., 2013), environments (Smith and Kruglyak, 2008), development (Francesconi
and Lehner, 2014) and external stimuli (Fairfax et al., 2014). Finally, multivariate
analyses can be used to investigate the molecular mechanism of genetic effects by
enabling joint analyses across multiple phenotypic and molecular layers (Wallace et
al., 2012; Pickrell et al., 2016; Giambartolomei et al., 2014). Despite these benefits,
many multivariate models are hampered by poor computational scalability, hindering
their application to larger cohorts. For example, variant-set tests across multiple traits
were limited to analyses of small cohorts prior to the work presented in this thesis.
Additionally, the number of possible integrative analyses grows dramatically with the
dimensionality of the phenotypic data.
1.4 Thesis overview and individual contributions
The challenges described in Section 1.3 illustrate the limitations of the “one-variant-
to-one-trait” approach of standard GWAS and highlight the need for novel integrative
methods. The linear mixed model has emerged as a flexible framework for many genetic
analyses. Linear mixed models ensure robust control of confounding effects and have
been widely used for association testing for single-variants (Kang et al., 2008b; Zhou
and Stephens, 2012; Sikorska et al., 2013) and variant-sets (Listgarten et al., 2013;
Lippert et al., 2014a). Moreover, recent computational advances have enabled efficient
single-variant association tests across multiple traits (Zhou and Stephens, 2014; Lippert
et al., 2014b; Furlotte and Eskin, 2015). Despite these developments, two main factors
have limited application of a larger class of LMMs to genetic analyses. First, with the
exception of some particular cases, LMMs are generally computationally inefficient.
Second, available software are designed to perform very specific analyses while frame-
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works that enable the flexible design of genetic models are not widely available (an
exception is Gilmour et al., 2009). In this thesis, I present novel and efficient LMMs
that can model relationships between multiple variants and traits, and describe an
inference framework that enables LMMs to be built flexibly.
In Chapter 2, I give an overview of current LMMs for genetic analyses, covering their
use for association testing, heritability estimation, variance decomposition, set tests
and multi-trait modelling.
In Chapter 3 I present an extension of existing LMM inference schemes that enables
association testing between multiple variants and traits in large cohorts (mtSet). After
demonstrating and benchmarking the model in extensive simulations, I discuss two
applications to real data. This work was done in collaboration with Barbara Rakitsch,
Christoph Lippert and Oliver Stegle and resulted in the following publication
• Francesco Paolo Casale?, Barbara Rakitsch?, Christoph Lippert, and Oliver Ste-
gle. “Efficient set tests for the genetic analysis of correlated traits.” Nature
methods 12, no. 8 (2015): 755-758.
? Joint first authorship
Individual contributions:
Francesco Paolo Casale and Barbara Rakitsch developed the method. Francesco
Paolo Casale and Barbara Rakitsch analysed the data. Christoph Lippert pro-
vided analysis tools and contributed to the interpretation of results.
Building on the mtSet framework, in Chapter 4, I derive novel tests for interactions
between variant-sets and categorical contexts (iSet). iSet can be used for interaction
testing either in (i) datasets where trait measurements are available in the same set
of individuals in different contexts or (ii) by stratifying a population into distinct sub-
groups based on an external context variable. In extensive simulations, I demonstrate
that iSet offers power advantages compared to previous interaction tests. Additionally,
the model can identify regions associated with changes in the configuration of causal
variants across the analysed contexts. I discuss results from applications of iSet to a
monocyte stimulus eQTL study (Fairfax et al., 2014) and a gene-by-sex interaction
analysis of blood lipid traits. The work was done in collaboration with Danilo Horta,
Barbara Rakitsch and Oliver Stegle and resulted in the following publication
• Francesco Paolo Casale, Danilo Horta, Barbara Rakitsch, and Oliver Stegle.
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“Joint genetic analysis using variant sets reveals polygenic gene-context inter-
actions.” PLoS genetics 13.4 (2017): e1006693.
Individual contributions:
Francesco Paolo Casale developed the method and analysed the data. Barbara
Rakitsch and Danilo Horta provided analysis tools.
In Chapter 5 I present LIMIX, a mixed-model framework that allows performing dif-
ferent genetic analyses in one tool. LIMIX has been used in several projects to conduct
variance component analyses (Dubin et al., 2015a; Sasaki et al., 2015; Baud et al.,
2017; Chen et al., 2016), single- and multi-trait association test (Kawakatsu et al.,
2016; Horton et al., 2016; Sudmant et al., 2015; Schor et al., 2017; Cannavò et al.,
2016) and genomic predictions (Märtens et al., 2016). The advantage of LIMIX over
other tools is its flexibility, which allows designing customised models to best suit the
scope and data of specific studies. All the models considered in this thesis are im-
plemented within the LIMIX software framework, including both new methods and a
wide range of existing approaches that were used for comparison. Finally, to show-
case the importance of flexible modelling to investigate high dimensional data I present
two applied analyses from collaborative projects. The first analysis is part of a col-
laborative project with Jacob Degner, Ignacio Shor, Oliver Stegle Ewan Birney and
Eileen Furlong’s group at EMBL in Heidelberg, Germany (see Schor et al., 2017). The
aim of this project is to understand the impact of genetic variation on transcription
initiation in Drosophila melanogaster during development. The second analysis is a
component of the BluePrint-WP10 project (Chen et al., 2016) and done in collabo-
ration with Lu Chen, Oliver Stegle, Nicole Soranzo and others. In this analysis, we
leverage high-resolution genetic, epigenetic and transcriptomic data in three human
immune cell types (I will show results only from one cell type in this thesis) to quantify
the contribution of cis-genetic and cis-epigenetic effects to gene expression variability.
• LIMIX framework.
Individual contributions:
Francesco Paolo Casale, Danilo Horta and Barbara Rakitsch wrote the source
code for flexible inference. Francesco Paolo Casale wrote the source code for the
set tests and the variance decomposition module. Christoph Lippert and Oliver
Stegle wrote the source code for fixed effect testing.
• QTL mapping of transcription initiation in Drosophila development.
Individual contributions:
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Francesco Paolo Casale, Jacob Degner and Oliver Stegle designed the statistical
models. Jacob Degner and Francesco Paolo Casale performed the QTL map-
ping. Igacio Shor, Jacob Degner, Eileen Furlong and Oliver Stegle interpreted
the results.
• Dissecting genetics and epigenetics effects in three immune cell types.
Individual contributions:
Francesco Paolo Casale, Oliver Stegle and Nicole Soranzo designed the statistical
models. Francesco Paolo Casale performed the analysis. Nicole Soranzo, Oliver
Stegle and Francesco Paolo Casale interpreted the results.
Finally, in Chapter 6, I give a summary of the work in this thesis and provide an
outlook on future research.
A full list of publications can be found in Section E.
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2 | Linear mixed models for genetic
analyses
The linear mixed model (LMM) has become the standard framework for many genetic
analyses. LMMs provide robust control for confounding factors, allow for aggregating
genetic effects from multiple variants and enable the joint analysis of multiple traits.
While inference in LMMs is in general computationally demanding, efficient implemen-
tations of specific LMMs enable applications to large datasets. In this chapter, I give
an overview of the use of LMMs in genetics and efficient algorithmic implementations.
In Sections 2.1-2.2, I discuss linear models and basic concepts of genome-wide associ-
ation studies (GWAS). In Section 2.3, I introduce the LMM and discuss applications
in genetics. Finally, in Section 2.4, I present the extension of LMMs to the analysis of
multiple traits.
2.1 Linear regression
A linear model describes a continuous output variable as a linear function of one or
more input variables (also referred to as features). Denoting with N the number of
samples, yi the output variable for sample i and {xi1, . . . , xiF } F input variables for









The residual term ψi accounts for the fact that the x-y relationship is not deterministic
because of measurement noise or other unmodelled factors. ψi is here assumed to
follow a normal distribution with mean 0 and variance σ2e and to be independent across
samples, i.e. cov(ψi, ψj) = 0. In equation (2.1), βf denotes the weight of the input
feature f .
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Introducing the output vector y, the input matrix X, the weight vector β and the
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the linear model in (2.1) can be expressed in matrix form as
y = Xβ +ψ, with ψ ∼ N (0 , σ2eIN ) , (2.3)
where IN denotes the N ×N identity matrix.
2.1.1 Maximum likelihood solution





the input variables X and the model parameters β and σ2e . This probability is known
as the likelihood of the model and, for parameter inference, is typically regarded as a
function of the model parameters and denoted as L (β, σ2e). The model in (2.3) can
thus be equivalently specified as
L (β, σ2e) = p (y |X,β, σ2e) = N (y |Xβ , σ2eIN ) , (2.4)
or more directly as
y ∼ N (Xβ , σ2eIN ) . (2.5)
The log marginal likelihood of the model can be explicitly expressed as
logL (β, σ2e) = −N2 log (2pi)− 12N log σ2e − 12σ2e (y −Xβ)> (y −Xβ) . (2.6)
The maximum likelihood estimator (MLE) of the model parameters is defined as the
set of parameter values that maximise the likelihood (or its log). Denoting with βˆ and
σˆ2e the MLE of β and σ2e we can write






The MLE of β and σ2e can be found by equating the gradients of the log likelihood to 0(















































2.1.1.1 Restricted maximum likelihood
The MLE of variance parameters is biased in Gaussian models as consequence of the
fact that the weights are estimated from the data, which entails a reduction of the
effective number of degrees of freedom. Patterson and Thompson (1971) proposed
to estimate variance parameters by maximising the restricted (or residual) maximum
likelihood (REML), which can be obtained by projecting the output vector in a space
that is orthogonal to X. Considering Eq (A.3) for the model in Eq (2.5), we obtain
the following log restricted maximum likelihood (see Section A.1)
logL (σ2e) = −N − F2 log (2pi)− 12 log det(X>X) (2.13)
−1
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Eq (2.15) is identical to Eq (2.12) with the exception that N is replaced by N − F ,
which denotes the loss of F degrees of freedom.
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2.2 Linear models for genome-wide association studies
In genetics, the output variable is typically the trait of interest while input variables
can include genetic variants and known factors, such as age and sex, which can have an
influence on the trait. The linear model that has been widely used in GWAS, models
the phenotype vector as the sum of the contributions of the variant being tested, the







, ψ ∼ N (0, σ2eIN ), (2.16)
where I explicitly separated the terms corresponding to the genetic variant and the co-
variates. In equation (2.16), y ∈ RN×1 denotes the phenotype vector for N individuals,
g ∈ RN×1 denotes the genotype vector of the tested variant, X ∈ RN×K denotes the
input matrix for K covariates, β ∈ R denotes the weight of the variant (also referred
to as the effect size of the variant), and α ∈ RK denotes the weight vector of the
covariates. Note that for a diploid organism, the representation of genotypes as numer-
ical values requires making some assumptions on the genetic model. Let us consider a
bi-allelic variant with major allele a and minor allele A. For the minor allele A, we can
consider either a dominant model (aa = 0, Aa = 1, AA = 1; where only one copy of
the allele is necessary to have a phenotypic effect), a recessive model, (aa = 0, Aa = 0,
AA = 1; where two copies of the minor allele must be present for a phenotypic effect)
or an additive model (aa = 0, Aa = 1, AA = 2; where the effect is proportional to the
minor allele count). In this thesis, I will consider an additive genetic model, which is
widely-used in the analysis of complex traits (Laird and Lange, 2010).
2.2.1 Statistical hypothesis testing
Association testing between a trait and a genetic variant can be assessed by comparing
the hypothesis that the variant has an effect, β 6= 0, on the trait (H1) versus the
hypothesis that the variant has no effect (H0)
H1 : y ∼ N
(
gβ +Xα , σ2eIN
)
, (2.17)





H1 and H0 are referred to as the alternative and the null hypothesis of the statistical
test, respectively. Statistical hypothesis testing consists of three basic steps. First, we
calculate a test statistic, which is a random variable that quantifies the evidence that
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H1 is true. Second, we calculate a probability value (P value) as the probability, under
H0, of sampling a test statistic at least as extreme as the observed one. The P value
is a function of the test statistic and, by definition, it is uniformly distributed under
H0. Finally, if this probability is low H0 is rejected and H1 accepted (positive result),
otherwise, we reject H1 and accept H0 (negative result). In statistical hypothesis
testing, two types of errors can be made. We can either reject H0 when H0 is true,
thus generating a false positive (type-I error), or rejectH1 whenH1 is true, generating a
false negative (type-II error). Other concepts that are central to statistical hypothesis
testing are the significance level, defined as the type-I error rate (i.e. the expected
percentage of false positives), and the statistical power, which is the true positive rate
under H1 (i.e. the ability to recover true associations).
A commonly used test statistic is the log likelihood ratio (LLR), which we will



















the MLE of the
parameters under the null model1. A convenient theorem from Samuel Wilks (Wilks,
1938) guarantees that under asymptotic assumptions (i.e. infinite sample size) and
when null model parameters are not at the bound of the domain of the likelihood of
the alternative model, 2D follows a χ2 distribution with number of degrees of freedom
d equal to the number of tested parameters (2D ∼ χ2(d)). The P value, for a d degree-





χ2 (x; d) dx = 1− Fχ2(2D; d), (2.20)
where Fχ2 is the cumulative density function of the χ2 distribution. A single-variant
test (β 6= 0) has one degree of freedom, d = 1.
2.2.2 Multiple hypothesis testing correction
Hundreds of thousands or millions of variants may be individually tested within a
typical human GWAS.When performing such a large number of tests, controlling single-
test P values results in a high number of false positives (for example, for P < 0.01 and
106 tests we expect 10, 000 false positives under the null hypothesis). This problem
1Note that the log-likelihood function of the null model is logL (β = 0,α, σ2e).
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is known as the multiple hypothesis testing problem. In the following, I give a brief
overview of the methods commonly used in genetic analysis to correct for multiple
hypothesis testing.
Controlling family-wise error rate. One strategy is to control the probability of
having at least one false positive in the experiment, which corresponds to an experiment-
wise P value known as family-wise error rate (FWER)2.
The widely used Bonferroni method follows this strategy assuming independence
between tests. Given a desired family-wise significance level α¯, the method consists
in calculating adjusted P values P¯ = Pn, where n is the number of tests, and setting
P¯ < α¯. This strategy ensures FWER < α¯. The Bonferroni correction strategy is con-
servative, as the consequence of the assumption of independence between test, which
ignores correlations between genotypes due to linkage disequilibrium (LD). An alterna-
tive strategy, which accounts for the dependency of the statistical tests, is to consider
permutations. For example, one way to control the FWER by using permutations is
to perform the experiment M times, each time considering a different permutation of
the genotype data across individuals. The minimum P values from these M additional
experiments are then used to calculate an experiment-wise P value, as the fraction
of the M minimum permutation P values that are lower than the minimum observed
P value. This approach has been used in cis molecular QTL mapping to estimate
gene-level P values (Sudmant et al., 2015; GTEx Consortium, 2015). Although this
strategy accounts for local LD, thereby increasing the statistical power, it entails a
great computational burden and can become unpractical in molecular analyses of large
cohorts.
Recently, several permutation-free methods that allow accounting for local LD have
been proposed (Xu et al., 2014; Sul et al., 2015; Davis et al., 2016). Davis et al. (2016)
proposed to estimate the effective number of independent tests from the genotype data.
Specifically, denoting with R the number of variants in the considered genetic region
and with G the N ×R genotype matrix (encoded as minor allele counts), Davis et al.
(2016) consider a regularised estimator Σˆ of the correlation matrix between the columns
of G. This estimator was initially proposed by Ledoit and Wolf (2004) and has been
shown to produce well-conditioned matrices in cases where R > N . The number of
effective tests is then estimated as the minimum number of eigenvalues of Σˆ needed to
explain a certain fraction C of the total variance (the suggested value for C is 99%).
This method is called eigenMT and I will use it in Chapter 4.
2Denoting with n the number of tests and with α the type I error rate we have FWER = 1−(1−α)n.
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Controlling the false discovery rate. An alternative solution is to control the
false discovery rate (FDR), i.e. the expected percentage of false discoveries.
The most widely used FDR-based correction method is the Benjamini-Hochberg
procedure (Benjamini and Hochberg, 1995), which again assumes independence be-
tween tests3. Let us consider T tests with P values p1, p2, . . . , pT and let ν1, ν2, . . . , νT
be their ranks (the smallest P value has rank 1, the highest has rank T ), defining
adjusted P values as p¯i = Tpiνi and setting p¯i < α ensures FDR < α.
Multiple hypothesis testing correction in molecular cis-QTL mapping. A
typical strategy to correct for multiple hypothesis testing in molecular cis-QTL map-
ping is to use a two-step procedure (Battle et al., 2014; Sudmant et al., 2015; GTEx
Consortium, 2015). First, for each gene an experiment-wise P value is obtained by
correcting for multiple testing across variants using a FWER-based method. These
gene-level P values are probability values for the hypothesis of a gene having at least
one QTL in the analysed region. Second, the gene-level P values are corrected to control
the FDR, typically using the Benjamini-Hochberg procedure.
2.2.3 Distribution of P values and QQ plot
Under the assumption that the vast majority of the tested variants are not associated
with the analysed trait, a GWAS is expected to produce approximately uniform P val-
ues. A representation that is typically used to compare the observed and the expected
distributions of P values is the quantile-quantile plot (QQ plot). In a QQ plot the
observed −log10P is plotted against the expected −log10P , where the expected value
is obtained from the uniform distribution4. Fig. 2.1 shows a close-to-ideal P value
distribution and the corresponding QQ plot from a GWAS of simulated data. In this
example, only a few variants are significantly associated with the trait and deviate
from the uniform distribution. A quantitative measure of the discrepancy between
the observed and the expected distributions is the genomic control λGC (Devlin and
Roeder, 1999), also known as genomic inflation factor. A definition of genomic con-
trol is λGC = median (log10(P )) / log10 (0.5), i.e. it is the the ratio of the median
of the expected and the observed distributions of the log P values. Inflated QQ plots
(anti-conservative P values) are associate to λGC > 1 while deflated QQ plots (conser-
vative P values) correspond to λGC < 1. As confounding factors such as population
3However, the Benjamini-Hochberg procedure is still valid under different dependence assump-
tions (Sun and Tony Cai, 2009).
4Let p1 ≤ · · · ≤ pT be the P values from T tests the expected P values for pi is p(exp)i = iT+1 if all
tests are under the null hypothesis.
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structure and relatedness create spurious genome-wide associations, inflated QQ plots
are typically associated with the presence of confounding (Voight and Pritchard, 2005;
Lin and Sullivan, 2009). However, in analyses of highly polygenic traits, inflation can
arise from genuine genetic signal (Yang et al., 2011c). Bulik-Sullivan et al. (2015) have
recently proposed a method to quantify the inflation that can be attributed to con-
founding only. The discrimination between polygenicity and confounding is based on
the intuition that only polygenicity is associated with high-LD regions.
Figure 2.1: Example of P value distribution and QQ plot for a simulated
GWAS. I simulated genotype data for N = 500 individuals and S = 100, 000 variants
as xij ∼ Bernoulli (nt, r) with number of trials nt = 2 and rate r = 0.2, randomly
selected Sc = 4 variants as causal and generated the phenotype as y =
∑Sc
j=1 xjβj +ψ
where xj is the standardised genotype vector of causal variant j, βj = ±
√
0.1 and ψ ∼
N (0 , σ2eIN ), with σ2e = 0.6. The left panel shows the distribution of the association
P values obtained for the S variants while the right panel shows the corresponding QQ
plot (the 4 causal variants are highlighted in red). The shaded area indicates the 99%
confidence interval around the diagonal (dark grey line).
2.2.4 Accounting for confounding in the linear model
The first two methods to account for population structure were genomic control (De-
vlin and Roeder, 1999) and structured association (Pritchard et al., 2000a). Genomic
control correction adjusts for inflation by dividing the test statistic of each marker by
the genomic control parameter. However, as different markers have different abilities to
differentiate across populations, this uniform adjustment is far from optimal. Indeed,
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the test statistic of markers that strongly segregate across populations may only be
partially corrected, while the test statistic of markers that do not segregate may be
over-corrected (Marchini et al., 2004; Price et al., 2006). The structured association
method splits individuals into different subpopulations, performs association testing
within these subgroups, and then merges the evidence for association. A major limita-
tion of this methodology is that only discrete subgroups can be considered. Moreover,
its results can vary depending on the selected number of clusters (Price et al., 2006).
Analyses of genotype data in larger cohorts, made possible by the advances in
genotyping technology, showed that genome-scale genetic variation could be used to
accurately infer population structure (Bauchet et al., 2007; Jakobsson et al., 2008; Li
et al., 2008; Tian et al., 2008; Price et al., 2008). In particular, the first principal
components (PCs) of the genotype data were shown to correlate with orthogonal geo-
graphic axes (Lao et al., 2008; Novembre and Stephens, 2008) and to better distinguish
between closely-spaced populations compared to geographic information (Novembre et
al., 2008). Price et al. (2006) suggested accounting for population structure by re-
gressing the top (ten) principal components from both genotype and phenotype data
prior to performing association testing. An equivalent strategy is to include the leading
principle components as covariates within the linear model. The optimal number of
PCs can either be selected to minimise inflation (Tian et al., 2008) or be based on
the correlation of single PCs with the phenotype (Lee et al., 2011). In analysis of
unrelated individuals, twenty principal components are typically sufficient to correct
for population structure (Astle and Balding, 2009). However, as the effects of popula-
tion structure are more severe in analyses of larger cohorts (Marchini et al., 2004), the
optimal number of PCs will also depend on the sample size of the considered cohort.
2.3 Genetic analysis with the linear mixed model
A linear mixed model (LMM) describes the outcome variable as a sum of unknown
deterministic effects (fixed effects) and unknown random effects. A random effect is
the realisation of a random variable of which we model the distribution. Denoting with
N , K and Q the number of samples, fixed effects and random effects respectively, a









where y ∈ RN is the outcome vector,X ∈ RN×K and Z ∈ RN×Q are the design matrix
of fixed and random effects respectively, β ∈ RK are the fixed effects, b ∼ N (0 , σ2bΣ )
are the random effects, Σ is a known covariance, ψ ∼ N (0 , σ2eIN ) is the residual
vector and σ2b and σ
2
e are the variance parameters of the random effect and noise
distributions.
Mixed model equations The joint density of y and b is
p
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= N (y , Xβ +Zb, σ2eIN )N ( b , 0, σ2bΣ ) (2.23)
The values β and b that maximise the joint distribution can be obtained by equating
the gradients of f (β, b) = log p
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Solving the equation system gives the mixed model equations (Henderson, 1950; Hen-
derson et al., 1959)[
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Marginal likelihood As σ2b and σ
2
e are unknown, one can estimate these variance
parameters together with the fixed effects β by maximising the marginal likelihood
p
(
y |β, σ2e , σ2b
)
(Dempster et al., 1981). The marginal likelihood can be obtained by
marginalising out the random effect b as follows
p
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This model is equivalent to Bayesian linear regression. The marginal likelihood is
regarded as a function of β, σ2e and σ2b and it is denoted as L
(




. As MLE of
the variance components are biased, parameter inference in LMMs is usually performed
maximising the restricted marginal likelihood (see Section A.1).
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Contrary to the case of linear regression discussed in Section 2.1.1, there is no
close-form solution for the (restricted) MLE of the model parameters. As shown in
Section 2.3.3, an efficient derivative-free inference scheme can be used for association
testing in univariate models (Lippert et al., 2011). However, the number of variance pa-
rameters in variance component analyses and multi-trait models is typically too large
for the efficient use of derivative-fee methods. Multiple optimisation schemes have
been proposed to optimise the restricted marginal likelihood in these cases, includ-
ing first-derivative methods, such as expectation maximisation (EM, Dempster et al.,
1977) and its improved version PX-EM (Liu et al., 1998; Foulley and Van Dyk, 2000),
and second-derivative methods, such as the Newton-Ralphson algorithm (Zhou and
Stephens, 2014), the average information REML algorithm (Gilmour et al., 1995) and
the Broyden’s method (Groeneveld, 1994). In this thesis, we follow (Groeneveld, 1994)
and consider the Broyden’s method for parameters inference. For a discussion on the
different optimisation algorithms for inference in LMMs, I refer to the supplementary
information of Loh et al. (2015a).
In the following I give an overview of the different applications of LMMs in genetics.
2.3.1 Accounting for confounding using the linear mixed model
While PC-based approaches can correct for population stratification in human studies
of unrelated individuals, such a methodology is less successful to account for more
subtle types of confounding. Conversely, linear mixed models have been proven to
yield calibrated P values in analyses of model organisms with complex population
structure (Yu et al., 2006; Zhao et al., 2007; Kang et al., 2008b) and human GWAS with
cryptic related individuals (Kang et al., 2010; Price et al., 2010; Zhou and Stephens,
2012). Fig. 2.2 shows the QQ plots obtained considering alternative strategies to
correct for population structure in a GWAS of flowering time in Arabidopsis thaliana
(A. thaliana). Only the LMM yielded calibrated P values.










where the effects from the genetic variant being tested and the covariates are modelled
as fixed effects, while the effect from confounding is modelled as a random vector
u ∼ N (0 , σ2gR ) . (2.30)
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Figure 2.2: QQ plots obtained from a GWAS of a flowering trait in A. thaliana
using different correction strategies. Compared are a linear model (LM) without
correction, a linear model with 30 genetic PCs and a linear mixed model (LMM).
The shaded area indicates the 99% confidence interval around the diagonal (dark grey
line). In particular, I tested for association between of 39,921 SNPs (MAF > 5%) and
flowering time at 22 degree Celsious in 192 individuals. Phenotypes have been quantile-
normalised to a normal distribution prior to QTL mapping. Data are from Atwell et al.
(2010).
Here, R denotes the genetic relatedness matrix, which accounts for the pairwise genetic
similarity between individuals. As discussed in the next section, such pair-wise genetic
similarities between individuals capture correlations due to both population structure
and family relatedness. Marginalising out u, the model in (2.29) can be equivalently
expressed as
y ∼ N ( gβ +Xα , σ2gR+ σ2eIN ) . (2.31)
This equation suggests an interpretation of the influence of confounding on the pheno-
type values: confounding induces a "covariance structure" between trait observations.
Such a structure is estimated as the genetic relatedness matrix R. As we will see in
the next section, there are different ways of defining R.
2.3.2 Genetic relatedness matrix
Fisher’s work (Fisher, 1919) shows that under an additive model with an infinite number
of infinitesimal genetic effects, the phenotype is normally distributed and the pheno-
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typic correlation between individuals is proportional to the fraction of genetic material
that is identical-by-descent (IBD)5. Therefore, a natural way of defining the genetic
relatedness between two individuals is to use the predicted proportion of the genome
that is IBD in the considered pair. Traditionally, these IBD relatedness matrices were
estimated from known pedigrees (LANGE et al., 1976). Note that the definition of
IBD requires the specification of a base population (i.e. the population of the ances-
tors, whose average relationship is zero), which in the case of pedigree designs is the
population of the founders (Powell et al., 2010).
An alternative that is becoming increasingly common is to estimate relatedness
matrices from genome-wide SNPs. SNP-based relatedness matrices have been shown
to improve narrow-sense heritability estimates (Visscher et al., 2006; Visscher et al.,
2007; Hayes et al., 2009) and to better account for population structure (Kang et
al., 2008b; Lee et al., 2010) compared to pedigree-based matrices. Different ways of
estimating relatedness matrices from genotype data have been proposed (Oliehoek et
al., 2006; Purcell et al., 2007; VanRaden, 2008). A widely-used estimate of the genetic






where G is the N ×S genotype matrix with standardised genotypes across individuals
and S denotes the number of genome-wide variants. Interestingly, the RRM can be
obtained from the polygenic model
y ∼ N (Xα+Gb , σ2eIN ) (2.33)






are random effects of the genome-wide variants. Note that each genetic marker ex-
plains on average variance σ
2
g
S , so that genome-wide variants jointly explain variance
σ2g . Marginalising out the random effect we obtain the RRM in one of the terms of the
covariance
y ∼ N




The RRM can also be interpreted as an IBD relatedness matrix where the base popu-
lation is the current population (Powell et al., 2010).
5A locus is IBD in two individuals if it has been inherited by a common ancestor.
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Relationship to PC-based methods Principal components of the genotype data
G can be calculated as the eigenvectors of the relatedness matrix R = 1SGG
> (Price et
al., 2006). Denoting with USU> the eigenvalue decomposition6 ofR, the marginalised





 , with b ∼ N (0 , σ2gS ) , (2.35)
by integrating out the random effects b. In summary, while a PC-based linear model
only accounts for the first principal components of the genotype data using fixed effects,
linear mixed models consider all the principal components using random effects. This
explains why LMMs can account for more subtle (i.e. high-rank) confounding compared
to PC-based linear models. For further details on the relationship between PC-based
models and random effect models I refer to Hoffman (2013).
Examples of RRMs Fig. 2.3 shows RRMs for 4 different cohorts: the Northern Fin-
land Birth Cohort (Sabatti et al., 2009), the Phase 1 1,000 Genomes Project (Goncalo
R Abecasis et al., 2012), a cohort of inbred lines of A. thaliana (Atwell et al., 2010) and
an outbred rat population (Baud et al., 2014). With the exception of the A. thaliana
dataset, which I considered to generate Fig. 2.2, these datasets will be considered in
the next chapters.
Modelling relationships with MAF, LD tagging and other properties. The
polygenic model considered above builds on the prior assumption that every variant
equally contributes to the phenotypic variance. However, the same framework can
be employed to model relationships of these contributions with variant-specific prop-
erties, such as minor allele frequency, LD tagging and genotype imputation quality
scores (Speed et al., 2016). This can be derived from the generative linear model in





the variance σ2s is a function of such properties. For example, following Speed et al.





6The columns of U are the eigenvectors while the diagonal entries of S are the corresponding
eigenvalues. Eigenvectors and eigenvalues are ordered in decreasing order of variance explained.
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where fs is the minor allele frequency of variant s and α defines the relationship between
the expected variance and the minor allele frequency. Specifically, α < 0 corresponds to
the assumption that low-frequency variants have stronger contributions in comparison
to common variants while α > 0 corresponds to the converse assumption. The uniform
model can be recovered setting α = 0. Note that different assumptions on per-variant
contributions correspond to different strategies of rescaling the columns of G prior to
building the RRM (see Eq (2.32)). Unless stated otherwise, I will make the assumption
of uniform contributions, which corresponds to taking G with standardised columns in
Eq (2.32).














0.1 0.0 0.2 0.4 0.6
0.04 0.03 0.02 0.01 0.00 0.01 0.02 0.03 0.04





































0.1 0.0 0.2 0.4 0.6
0.06 0.04 0.02 0.00 0.02




































(b) 1,000 Genomes Project
(c) A. thaliana dataset















0.1 0.0 0.2 0.4 0.6
0.06 0.04 0.02 0.00 0.02 0.04 0.06




















Figure 2.3: Realised relatedness matrices for four different cohorts. Shown
are the realised relatedness matrices and the scatter plots of the first two princi-
pal components for four different cohorts. (a) 5,402 unrelated individuals from the
Northern Finland Birth Cohort (NFBC, phs000276.v1.p1) (Sabatti et al., 2009). (b)
1,092 individuals from the 14 populations that are part of the Phase 1 1,000 Genomes
Project (Goncalo R Abecasis et al., 2012). (c) 192 inbred Arabidopsis lines from Atwell
et al. (2010) used in Fig. 2.2. (d) 1,334 rats from the outbred population in Baud
et al. (2014).
2.3.3 Efficient linear mixed models for GWAS
Computations associated with inference in linear mixed models scale cubically with
the number of individuals in the dataset. For example, the evaluation of the restricted
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marginal likelihood in Eq (A.3) entails the computation of operations with O(N3)
complexity, such the matrix inverse and of the log determinant of the total covariance.
However, for the model in (2.29) it is possible to speed up computations (Kang et al.,
2008b; Kang et al., 2010; Lippert et al., 2011; Zhou et al., 2012) enabling applications
to large cohorts. These strategies reduce the computational complexity from O(N3)
per-variant to a single O(N3) cost up-front and a per-variant complexity of O(N2).
The complexity can be further reduced to O(N2) for the up-front computation and a
per-test complexity of O(N), provided the genetic relatedness matrix is low-rank. In
practice, this can be achieved through a feature selection approach, selecting a small
proportion of all genome-wide variants to estimate R (Listgarten et al., 2012) or by
randomly selecting a subset of the genome-wide variants. In the following I will briefly
describe the efficient FaST-LMM algorithm proposed by Lippert et al. (2011).
The objective is to optimise the log marginal likelihood
y ∼ N ( gβ +Xα , σ2gR+ σ2eIN ) (2.37)
iteratively for different tested variants (i.e.,for different genotypes vectors g). The
strategy can be summarised in three steps, (1) eigenvalue decomposition of the genetic
similarity matrix, (2) transformation of the data in a space where they are uncorrelated
and (3) single-variant testing in the new space.
1. Eigenvalue decomposition ofR = USU> needs to be computed only once upfront
and has complexity O(N3).





= σ2gU (S + δIN )U
>. (2.38)
The log marginal likelihood of the model is
logL (β,α, σ2g , δ) = −N2 log (2pi)− 12 log detK + (2.39)
−1
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log detK = N log σ2g + log det (S + δIN ) (2.42)
where we introduced Dδ = (S + δIN )−1, we have






























y˜ − g˜β − X˜α
)
. (2.43)
Here, y˜, g˜ and X˜ denote the "rotated" phenotype vector, genotype matrix and
covariate matrix, respectively. This rotation needs to be performed for each geno-
type g to be tested, which is equivalent to rotating the full genotype matrix. The
rotation of the phenotype vector, the genotype data and the matrix of covariates
requires O(N2 + N2S + N2K) operations, where K and S denote the numbers
of covariates and variants respectively.
3. Fixing delta and regarding the likelihood in Eq (2.44) as a function of only β, α
and σ2g we have


























































which can be computed in closed-form. Optimisation can thus proceed by con-
7the two likelihood functions differ by a constant.
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sidering a 1D Brent search optimisation routine in δ (Brent, 1971) while using
close-form computations for β, α and σ2g . Note that all operations at this step
are linear in N .
The same strategy can be used to calculate the REML of the model (see Eq (A.3))
logLREML
(






log detK − log detA (2.45)
−1
2
(y − gβ −Xα)>K−1 (y − gβ −Xα) (2.46)
where A = X>K−1X. Note that as we are interested in testing for β the genotype
vector g is not considered in the regularisation term log detA (Lippert et al., 2011;
Zhou et al., 2012).
2.3.4 Variance component models
We have seen how genetic relatedness matrices can be used in linear mixed models
to account for confounding effects in GWAS. The central idea of this approach is to
estimate the structure of confounding from genetic relatedness between individuals.
However, in analyses of datasets where environmental factors are controlled for, the
same models can be used to estimate narrow-sense heritability. Traditionally, LMMs
have been considered for heritability estimation in genetic analysis of animal mod-
els using either pedigree-based or SNP-based relatedness matrices (Lynch and Walsh,
1998; Valdar et al., 2006; The Rat Genome Sequencing and Mapping Consortium,
2013). More recently, this approach has been applied to human cohorts of unrelated
samples (Yang et al., 2010; Lee et al., 2012b; Gusev et al., 2014), where population
structure can be accounted for by using the top genetic principal components (Yang
et al., 2011a). In this section, I briefly review the concepts and models for heritability
estimation and variance decomposition. The standard software tool for these analyses
is GCTA (Genome-wide Complex Trait Analysis, Yang et al. (2011a)). GCTA employs
gradient-based parameter inference using the PX-AI algorithm (Meyer, 2006), which
combines EM and average information REML.
Estimating narrow-sense heritability In absence of confounding, if genotype data
at causal variants were known, one could estimate narrow sense heritability using the
LMM
y = 1Nµ+G







, ψ ∼ N (0, σ2eIN) , (2.47)
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where 1Nµ is a mean term, Sc is the number of causal variants, G(c) is the standardised
genotype matrix at causal variants and σ2g is the variance explained jointly by all causal







where R(c) = 1ScG
(c)G(c)
> is the RRM at causal variants. Using this model, the







where σˆ2g and σˆ2e are the restricted MLE of σ2g and σ2e respectively. If covariates X are










var (Xαˆ) + σˆ2g + σˆ2e
(2.51)
where αˆ, σˆ2g and σˆ2e are the MLE of α, σ2g and σ2e respectively.
As causal variants are generally not known, one can use the model with an RRM
estimated from all genotyped variants (R) to estimate narrow-sense heritability
y ∼ N (Xα, σ2gR+ σ2eIN) (2.52)
However, as a consequence of the incomplete and uneven tagging of causal variants
from the observed SNPs, this model will give lower heritability estimates compared
to the ideal model. Yang et al. (2010) studied the effect of the incomplete tagging of
causal variants when observed and causal variants have different MAF distributions. To
alleviate this bias, they proposed a shrunk version of the RRM obtained by regressing
R towards the identity matrix (Powell et al., 2010). Speed et al. (2012) studied the
effect of uneven tagging of causal variants caused by the different extent of LD along
the genome and found that it can lead to biased heritability estimates. Therefore they
proposed an adjusted RRM where SNPs are weighted according to local LD.





Variance decomposition The approach presented above can be extended to par-
tition the phenotypic variance across different sets of SNPs, for example SNPs from
different genetic regions (Yang et al., 2011b; Lee et al., 2013) or SNPs with distinct
functional categories (Gusev et al., 2014). Formally, let {G1, . . . ,GM} denote the stan-
dardised genotype values corresponding to M disjunct sets of variants. Additionally,
let Sm denote the number of variants in set m and Rm = 1SmGmG
>
m denote the RRM
estimated from the variants in set m. The variance explained by the different sets can






















where αˆ, σˆ2m and σˆ2e are the MLE of α, σ2m and σ2e respectively.
Alternatively, in order to estimate the variance explained by a specific set of genetic
variants, Kostem and Eskin (2013) proposed the two-variance-component model
y ∼ N (Xα, σ2pRp + σ2gRg + σ2eIN) , (2.55)
where Rp is the partial RRM based on the variants in the set while Rg is the global
RRM built from genome-wide variants. This model estimates the variance explained
by the SNP-set while accounting for polygenic effects from genome-wide variants and,
in case of confounding, for population structure and cryptic relatedness.
Standard errors on variance component estimates can be calculated using the Fisher
information matrix as discussed in Section D.3.
2.3.5 Set tests
Set tests are a class of statistical models that enable testing for association between a
set of genetic variants and the trait of interest. Set tests can help reduce the multiple
hypothesis testing burden and detect loci harbouring multiple causal alleles (Listgarten
et al., 2013).
Depending on the strategy employed to aggregate effects from multiple variants,
set tests can be broadly classified in three categories (Schifano et al., 2012): methods
that combine results from single-variant association testing (Conneely and Boehnke,
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2007; Gao et al., 2008; Liu et al., 2010; Moskvina and Schmidt, 2008), methods that
consider association testing with a weighted sum of the set genotypes (Li et al., 2009;
Gauderman et al., 2007) and methods that use genetic similarity matrices (Tzeng et al.,
2003; Schaid et al., 2005; Wessel and Schork, 2006; Tzeng et al., 2009; Mukhopadhyay
et al., 2010; Wu et al., 2010; Schifano et al., 2012; Listgarten et al., 2013; Chen et
al., 2013; Lippert et al., 2014a). The methods in the last category can be formulated
within the LMM framework, where the effects of the variants in the set are modelled
as random.
The first set tests have considered linear mixed models with an only variance com-
ponent to jointly model the effects of the variants in the set (Wu et al., 2011; Wu et al.,
2010). More recent implementations have introduced a second variance component in
the model to account for relatedness (Listgarten et al., 2013; Lippert et al., 2014a;
Schifano et al., 2012; Chen et al., 2013). These set tests with two variance components
consider the model in Eq (2.55) and test for σ2p 6= 0. As discussed in Section 3.1.2,
for variance component tests the assumptions underlying Wilk’s theorem do not hold
and as a consequence, the asymptotic distribution of the LLR test statistic is generally
not known (Molenberghs and Verbeke, 2007; Self and Liang, 1987; Dominicus et al.,
2006). For this reason, a large class of set tests employ score-based test statistics, whose
asymptotic distribution is known. Score-based set tests have been used for testing for
associations with rare and common variants (Wu et al., 2011; Wu et al., 2010). As an
alternative to score-based set tests, Listgarten et al. (2013) have proposed an efficient
procedure based on permutations to compute P values from the likelihood ratio test
statistic. LLR-based tests have been shown to be more powered than score-based tests
in analyses of real data (Lippert et al., 2014a). Importantly, as we will see in detail in
the next chapters, the computational efficiency of both score-based and LLR-based set
tests strongly depends on the number of variants in the considered genomic region. In
particular, for regions for which the number of variants is greater than the number of
individuals, computations scale cubically with the number of individuals.
2.3.6 Genomic predictions
Suppose we have observed phenotype data and K covariates for N individuals (in-
sample individuals) and the genetic relatedness matrix for a larger set of N + N?
individuals. The phenotypes of the non-phenotyped N? individuals (out-of-sample
individuals) can be predicted using the genetic relatedness matrix. Let y ∈ RN denote
the phenotype vector of the in-sample individuals and R(all) ∈ R(N+N?)×(N+N?) denote









where R ∈ RN×N is the relatedness matrix for in-sample individuals, R?? = 1SG?G>? ∈
RN?×N? is the relatedness matrix for out-of-sample individuals and R? ∈ RN?×N is the
cross covariance between out-of-sample and in-sample individuals. Denoting with u?
the genomic prediction vector for the out-of-sample individuals, we can model the joint

























where X ∈ RN×K is the design matrix of the K covariates for in-sample individuals.
Using the rule for conditioning Gaussians, we have
























The genetic parameters can be estimated by maximising the marginal likelihood of
y. Subsequently, Eq (2.59) can be used for predicting phenotypes for out-of-sample
individuals. The predictor in Eq (2.59) is known as Best Linear Unbiased Predictor
(BLUP) and has been extensively used in livestock breeding (Henderson, 1984; Lee
et al., 2008; Clark and Werf, 2013).
If covariates are observed also for out-of-sample individuals, they can also be used
for predicting out-of-sample. Denoting with X? ∈ RN?×K the design matrix of the
covariates for out-of-sample individuals, the predictions from genetic relatedness and
covariates follows the conditional distribution
u
(cov)
















(y −Xα) . (2.62)
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2.4 Extension to the analysis of multiple traits
Models for the joint analysis of multiple traits can be broadly classified in four groups:
methods based on principal components (Aschard et al., 2014), canonical correlation
analysis (Ferreira and Purcell, 2009), multivariate linear regression (Bottolo et al.,
2013), and meta analysis (Bolormaa et al., 2014). Multi-trait LMMs are a class of
multivariate linear regression models and have been used to estimate genetic and en-
vironmental correlations as well as for association testing, first in the field of animal
breeding (Henderson, 1984; Jiang and Zeng, 1995), and more recently in human genet-
ics (Lee et al., 2012a; Korte et al., 2012). In association testing, the multi-trait LMM
has been shown to improve statistical power by leveraging genetic and environmental
correlations between traits (Korte et al., 2012; Zhou and Stephens, 2014). Addition-
ally, these class of models can also enhance the interpretation of genetic associations by
testing for effects that are either shared across all of the considered traits or specific to
some (Korte et al., 2012). Recently, computational advances have enabled application
of these models to cohorts of thousands of individuals and multiple traits (Rakitsch
et al., 2013; Zhou and Stephens, 2014; Lippert et al., 2014c; Furlotte and Eskin, 2015).
In Section 2.4.1, I define some basic operators and distributions that are central to
multivariate modelling. In Section 2.4.2, I introduce the matrix-variate mixed model
that is used for multi-trait analysis. In Section 2.4.3, I discuss joint statistical testing
across multiple traits while, in Section 2.4.4, I give an overview of the algebraic speed-
ups that enable applications to larger cohorts.
2.4.1 Mathematical background
In this section, I introduce some basic notation and concepts for multivariate modelling.
Definition. Let A and B be two matrices having dimensions M × N and Q × R
respectively, the Kronecker product of the two matricesA⊗B has dimensionsMQ×NR
and is defined as
A⊗B =





AM1B . . . AMNB
 . (2.63)




• (A⊗B) (C ⊗D) = AC ⊗BD (2.64)





Definition. A N × P matrix X follows a matrix-variate normal distribution
X ∼ MVN (M , C, R) (2.66)
if and only if
vec (X) ∼ N (vec (M) , C ⊗R) . (2.67)
2.4.2 The matrix-variate linear mixed model
Let us consider a population dataset consisting of N individuals and P traits. Further,
let yp ∈ RN denote the phenotype vector of trait p and X ∈ RN×K the design matrix









where bp ∈ RK denotes the effects of the covariates, ψp ∈ RN is the residual vector
for trait p, R is the N ×N genetic relatedness matrix and σ2gp and σ2ep are the genetic
and residual variance components for trait p. Multi-trait LMMs model the covariance







= ρgpp′σgpσgp′R+ ρnpp′σepσep′IN . (2.69)
where ρgpp′ and ρnpp′ denote the genetic and environmental correlations between traits




y1 · · · yP
]
∈ RN×P , (2.70)
B =
[
b1 · · · bP
]
∈ RN×K , (2.71)
Ψ =
[
ψ1 · · · ψP
]
∈ RN×P , (2.72)
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and defining the genetic and environmental covariances as
Cg =

σ2g1 ρgσg1σg2 · · · ρgσg1σgP
ρgσg1σg2 σ
2









σ2n1 ρnσn1σn2 · · · ρnσn1σnP
ρnσn1σn2 σ
2





ρnσn1σnP ρnσn2σnP · · · σ2nP
 , (2.74)
the model can be specified as the matrix-variate mixed model
Y = FB +U + Ψ, (2.75)
where U and Ψ follow matrix-variate normal distributions
U ∼ MVN (0,R,Cg) (2.76)
Ψ ∼ MVN (0, IN ,Cn) . (2.77)
Using the definition of matrix-variate normal and the properties of the Kronecker prod-
uct and the vec operator, the marginal likelihood of the model can be equivalently
expressed as
L (B,Cg,Cn) = N (vec (Y ) |vec (FB) , Cg ⊗R+Cn ⊗ IN ) , (2.78)
which we want to maximise with respect to B, Cg and Cn. As a general P ×P covari-
ance matrix is described by 12P (P+1) parameters (see Section D.2), the model in (2.91)
has P (P + 1 + K) parameters. Given the large number of parameters, derivative-free
methods (as the approach discussed in Section 2.3.3) are highly inefficient. Conse-
quently, the likelihood of multi-trait LMMs is commonly optimised using a gradient-
based optimisation algorithm. For example, Korte et al. (2012) considered average
information REML (Gilmour et al., 1995) while Zhou and Stephens (2014) proposed
Newton-Raphson (Thompson, 1973) in combination with the PX-EM (Liu et al., 1998;
Foulley and Van Dyk, 2000). An exception is the work from Furlotte and Eskin (2015),
where the authors proposed to first estimate the marginal variances using a single-trait




Denoting with g ∈ RN the genotype of the variant being tested and b ∈ RP its effects











where F ∈ RN×K and B ∈ RK×P the design matrix of K covariates and their effect
sizes respectively, and U and Ψ are respectively the effect from confounding and the
residual and follow matrix-variate normal distributions:
U ∼ MVN (0,R,Cg) , Ψ ∼ MVN (0, IN ,Cn) (2.80)
In (4.2) R ∈ RN×N denotes the RRM, Cg is a P × P covariance matrix describing
covariances between traits due to confounding/polygenic effects while Cn is the residual
P ×P trait covariance. While R is estimated from genotype data, Cg and Cn need to
be estimated by (restricted) maximum likelihood.
Korte et al. (2012) proposed using the model in (2.79) to test for different hypothesis
on the design of the genetic effect across traits. Introducing a common effect model,
where the variant has the same effect size across all traits (b = 1P b), and a no-effect
model, where b = 0P , we can define the following tests:
• Any effect test : P degree-of-freedom (dof) test where the model in (2.79) is tested
against the no-association model (i.e. b 6= 0P );
• Common effect test : 1 dof test where the common effect model is tested against
the no-association model (i.e. b = 1b and b 6= 0);
• Specific effect test : this is a 1 dof test where a model that contains both a common
effect across all traits and a specific effect for trait p is tested against the common
effect model (i.e. b = 1P bc + Ipbs with (Ip)i = δip, and bs 6= 0).
Similarly to univariate testing P values can be obtained using a LLR test. In Section
5.2.2, we will generalise this testing framework to consider more complex designs.
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2.4.4 Efficient implementation
Fitting the no-association model
Let us start considering the no-association model, Eq (2.78) with β = 0. As discussed
above, model parameters are typically optimised using a gradient-based optimisation
algorithm, which requires multiple evaluations of the (restricted) marginal likelihood
and its gradients. A naive approach to compute these quantities scales with the cube of
the number of individuals and traits, hindering application to bigger cohorts. However,
efficient algebraic implementations can reduce computational complexity to an up-
front O(N3) operation, after which gradient-based optimisation proceeds linearly in
N (Rakitsch et al., 2013; Zhou and Stephens, 2014; Lippert et al., 2014c; Furlotte and
Eskin, 2015). These speedups are possible because of the particular structure of the
total covariance matrix A, which is the sum of two Kronecker products
A = Cg ⊗Rg +Cn ⊗ IN . (2.81)
Following Rakitsch et al. (2013) and using the notation M = UMSMU>M to indicate
the eigenvalue decomposition of matrix M , the inverse of A can be rewritten as
A−1 =
(UCnS1/2Cn ⊗ IN)


























































L = Lc ⊗Lr (2.86)
D =
(
SC?g ⊗ SRg + INP
)−1
. (2.87)
. Writing explicitly the log-marginal likelihood of the model and using (2.82)





vec (Y − FB)>A−1vec (Y − FB) (2.89)
= −NP log (2pi) + 1
2















log detA = − log detD +N log detCn, (2.92)













F˜ = LrF (2.94)
B˜ = BL>c . (2.95)
Note that, similarly to Section 2.3.3, we have introduced "transformed" phenotypes,
which are linearly independent across all individuals and traits. This transformation is
the Kronecker product between an across-individual (row) transformation Lr and an
across-traits (column) transformation Lc. The insight that Lr does not change during
optimisation allows the derivation of an efficient algorithm, as row transformations
needs be computed only once upfront. The full algorithm can be summarised in three
steps:
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1. Compute Lr. This requires computation of the eigenvalue decomposition of the
genetic relatedness matrix R = USU>, which has complexity O(N3).
2. Compute LrY and LrF , which has computational complexity O(N2P +N2K).
3. Perform gradient based optimisation with the row-transformed quantities. This
can be done in time complexity O(N).
Section A.2 gives a full description of all computations for a more general version of
this model.
In the next Chapter, we will generalise this efficient inference scheme to a multi-trait
LMMs with two variance components.
Genome-wide testing
Genome-wide association testing requires maximum likelihood optimisation considering
each of the genome-wide variants in turn. A strategy to reduce computation is to
estimate variance components under the no-association model and then fix the structure
of the total covariance in the genome-wide tests (Korte et al., 2012; Lippert et al., 2014c;
Furlotte and Eskin, 2015). Briefly, introducing Aˆ = Cˆg ⊗R+ Cˆn⊗ IN , where Cˆg and
Cˆn are the (restricted) MLE of Cg and Cn under the no-association model (Eq (2.79)
with b = 0), one can consider
vec (Y ) ∼ N
(
(IP ⊗ g) b+ (IP ⊗ F ) vec (B) , σ2t Aˆ
)
. (2.96)
Similarly to the univariate approach discussed in Section 2.3.3, the MLE for the σ2t ,
B and b can be computed using close-form solutions. Overall, this strategy has a per-
variant computational complexity of O(N2), which correspond to the transformation
of the tested genotype vector, while other operations are linear in N .
We have here focused on studying how the model scales with the number of in-
dividuals. However, this approach does not not scale as well with the number of
phenotypes (Zhou and Stephens, 2014), hindering applications to joint analysis across
more than twenty traits. This is mainly due to the fact that the trait covariances are
estimated by restricted maximum likelihood, which implies that (i) the number of pa-
rameters of the model increases quadratically with the number of traits and (ii) trait
(column) computations cannot be cached as trait covariances change during optimisa-
tion. These concepts will be discussed in more detail in the next chapter, where I will
discuss a generalization of the model considered here, enabling joint association testing
of multiple variants and traits.
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3 | Efficient set tests for joint anal-
ysis of correlated traits
As discussed in Section 2.3.5, set tests are statistical models that enable association
testing between sets of genetic variants and a quantitative trait. Set tests can help re-
duce the number of genome-wide tests and have been shown to be more effective than
single-variant approaches to detect effects due to either untyped variants (Wu et al.,
2010) or multiple causal variants in linkage (Listgarten et al., 2013). Consequently, sev-
eral set tests have been proposed for association testing with common (Wu et al., 2010;
Listgarten et al., 2013) and rare variants (Wu et al., 2011; Lee et al., 2012c; Klaudia
Walter et al., 2015). Within the linear mixed model (LMM) framework, the additive
effects of the variants in a set can be aggregated using a variance component. However,
LMMs that consider set tests for multiple traits are computationally demanding, and
hence these methods have been limited to single-trait analysis.
The main hurdle for deriving an efficient multi-trait set test is that the speedups for
single-variant testing rely on the fact that these LMMs only have one variance compo-
nent (see Section 2.4.4). This is sufficient for single-variant association testing as the
genetic tests are implemented using fixed effects. Conversely, LMM-based set tests re-
quire two variance components, one for modelling the joint effect of the variants in the
set (set component) and a second component to account for genetic relatedness (relat-
edness component). In this chapter, I will present mtSet, a mixed-model approach that
enables association testing between multiple variants and traits in a scalable manner
while accounting for arbitrary confounding. mtSet builds on a matrix-variate LMM
with two variance components, yet is computationally efficient and permits genetic
analysis in large cohorts. An open-source software implementation of mtSet is avail-
able as part of the LIMIX software suite (http://github.com/PMBio/limix), which I
discuss in Chapter 5.
In Section 3.1, I describe the mtSet model. In Sections 3.2, I discuss results from
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experiments using simulated datasets, which were used to validate the model. Finally,
in Section 3.3, I present results from two case studies from applying mtSet to real data.
The material presented in this chapter is joint work with Barbara Rakitsch, Christoph
Lippert and Oliver Stegle, and it was published in Nature Methods in June 2015 (Casale
et al., 2015).
3.1 A multi-trait set test
In this section, I introduce the mtSet model, discuss the strategy used to obtain P
values and provide implementation details of the efficient algorithm. I also introduce
faster versions of mtSet for analyses of cohorts with unrelated individuals and, finally,
discuss the relationship of mtSet to existing methods.
3.1.1 The model
mtSet model is closely related to the matrix-variate mixed model introduced in Sec-
tion 2.79. However, instead of a single variance component that accounts for genetic
relatedness, we consider a second random effect that models the effect of the variants
in the set. The matrix-variate phenotype Y ∈ RN×P for N individuals and P traits
is modelled as the sum of the contribution from fixed effect covariates, the variants in
the genetic region (set component), a random genetic background effect (relatedness










Here F is the N × K design matrix for K covariates, B the corresponding K × P
weight matrix, Ur and Ug denote effects from the set and the relatedness components




Ψ ∼MVN(0.IN ,Cn), (3.2)
where Rr ∈ RN×N and Rg ∈ RN×N are the local and global realised relatedness
matrices (RRMs), respectively. Specifically, denoting withG ∈ RN×R the standardised
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genotype matrix for the R variants in the set and with S ∈ RN×S the standardised
genotype matrix for S genome-wide variants, we defineRr = 1RGG
> andRg = 1SSS
>.
Cr ∈ RP×P and Cg ∈ RP×P are the trait-to-trait covariance matrices of the set and
the relatedness component, while Cn is the residual trait-to-trait covariance matrix.




∣∣∣∣∣∣∣vec(FB), Cr ⊗Rr︸ ︷︷ ︸set component + Cg ⊗Rg︸ ︷︷ ︸relatedness component +Cn ⊗ IN︸ ︷︷ ︸noise
(3.3)
where we used the Kronecker product and vec(·) operator (see Section 2.4.1). The case
P = 1 corresponds to
Y ∈ RN×P → y ∈ RN ,
B ∈ RK×P → b ∈ RK ,
Cr ∈ RP×P → σ2r ∈ R,
Cg ∈ RP×P → σ2g ∈ R,
Cn ∈ RP×P → σ2n ∈ R
and mtSet reduces to a single-trait set test
L(b, σ2r , σ2g , σ2n) = N
y







which we will denote with stSet. This special case of mtSet is equivalent to the model
proposed in Lippert et al. (2014a).
Rank of the set component. As described in Section 3.1.3, a key insight to achieve
computational efficiency is that the typical number of variants in the set is lower than
the number of individuals (R < N), and thus the local RRM Rr = 1RGG
> is low rank.
Denoting the rank of the trait-to-trait covariance matrix Cr with C, the total rank
of the set component is
rank (Cr ⊗Rr) = CR. (3.5)
Although mtSet allows considering any rank C of the trait covariance, we consider C =
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1 in the experiments. Set trait covariances with higher ranks can also be considered,
however at the cost of increased computational burden. As we will see in the next
Chapter, considering higher-rank models allows for decomposition the local genetic
effect into distinct genetic signals, where the rank C corresponds to the number of such
signals.
Parametrisation of trait-to-trait covariances. In contrast to the individual-to-
individual covariances, the three trait-to-trait covariance matrices Cr, Cg and Cn are
estimated by maximising the restricted marginal likelihood.
To explicitly model the dependency of Cr on its rank C, we set Cr (E) = EET
where E ∈ RP×C and consider the PC entries of E as model parameters. Conversely,
for the relatedness and the noise trait-to-trait covariance matrices we consider general
positive-definite matrices, which we parametrize in the Cholesky space. Specifically,
we set Cg = LgLTg and Cn = LnLTn where Lg and Ln are lower triangular matrices
and consider the non-zero entries of Lg and Ln as model parameters. In this way, both
Cg and Cn are parametrized by 12P (P + 1), i.e. the number of non-zeros entries of a
lower diagonal matrix.
Maximisation of the marginal likelihood. To fit the model, we optimise the log
restricted maximum likelihood with respect to the weight matrix B and the three trait-
to-trait covariances Cr, Cg and Cn, using a gradient-based parameter optimiser. In
our implementation, we use a low-memory BFGS (Liu and Nocedal, 1989; Zhu et al.,
1997) as implemented in the fmin_l_bfgs_b optimisation method in the SciPy python
library (Jones et al., 2001). To improve convergence for datasets with smaller sample
sizes (N < 5, 000) and large windows we increase accuracy of the optimisation proce-
dure by setting the SciPy default parameter factr to 103 (the SciPy default value is
107). As shown in Section 3.1.3, a combination of low-rank covariance updates, eigen-
value decomposition-based speedups and Kronecker product properties allows achieving
efficient evaluations of the likelihood function and its gradients. Prior to model fitting,
Cg and Cn are initialised to their maximum likelihood estimator (MLE) for Cr = 0
(i.e., from the model in Eq (2.78)). This strategy exploits that (i) learning Cg and Cn
is very efficient (see Section 2.4.4) and (ii) in many settings variant-sets do not explain
a high proportion of the phenotypic variance so that the MLE of the full model is very
close to this starting point.
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Choice of variant sets. Different strategies can be adopted to define the variant-sets
to be tested. Common choices include gene-set analyses (Wu et al., 2010; Listgarten
et al., 2013) and sliding window approaches (Wu et al., 2011). In the experiments
presented here we opted for the latter, as depending on the window size a gene-based
approach can result in an uneven representation of the genome, with high gene-density
regions corresponding to a large number of overlapping sets and low gene-density regions
corresponding to a few or no sets. However, gene-based analyses can be implemented
in the same vein and are supported by the mtSet implementation. Another important
parameter to choose is the size of the variant sets. In Section 3.2.5 we use simulated
data to study how the choice of the window size affects the statistical power and the
computational efficiency of the method.
3.1.2 Statistical testing
In mtSet, we test for association between the considered set of variants and any of the
modelled traits by assessing whether the set component is significantly different from
zero. More formally, we compare the null model without the set component
M0 : vec (Y ) ∼ N
vec(Y )
∣∣∣∣∣∣∣vec(FB), Cg ⊗Rg︸ ︷︷ ︸relatedness component +Cn ⊗ IN×N︸ ︷︷ ︸noise
 (3.6)
with the alternative model
M1 : vec (Y ) ∼ N
vec(Y )
∣∣∣∣∣∣∣vec(FB), Cr ⊗Rr︸ ︷︷ ︸set component + Cg ⊗Rg︸ ︷︷ ︸relatedness component +Cn ⊗ IN×N︸ ︷︷ ︸noise
(3.7)
using the log likelihood ratio (LLR) test statistics (see Section 2.2.1). As for variance
component tests the parameter space is constrained and the null hypothesis lies on the
boundaries of the parameter space (Molenberghs and Verbeke, 2007; Self and Liang,
1987; Dominicus et al., 2006) Wilk’s theorem does not apply, meaning that the asymp-
totic distribution of the LLR test statistics is generally not known. Indeed, the trait-to-
trait covariance matrices are constrained to be positive-semidefinite (Cr,Cg,Cn  0)
and the null hypothesis is Cr = 0.
For single-trait set tests (P = 1), the constraint corresponds to the non-negativity
condition of the set variance component (σ2r ≥ 0 in Eq (3.4)) while the null model
corresponds to σ2r = 0. Self and Liang (1987) showed that, under certain regulatory
conditions, the asymptotic distribution of the LLR statistics is a 50-50 mixture of two
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χ2 components, the first with 0 degrees of freedom (dof) and the second with one dof
2LLR ∼ 0.5χ20 + 0.5χ21. (3.8)
Intuitively the first χ20 component (which is equivalent to a Dirac function δ(x)) cap-
tures the cases where the constrained MLE σˆ2r of σ2r is at the bound (σˆ2r = 0) while
the second term describes cases where σˆ2r > 0. As suggested by the coefficients of
the mixture, the two scenarios are expected to occur with probability 50%. However,
one of the necessary conditions for this asymptotic form is that multiple sub-vectors
of the output variable are identically distributed, which is unlikely to hold in genetic
analyses. In practice this results in conservative P values as the realised mixing weight
of the χ20 component is higher than 0.5 (Greven et al., 2012; Listgarten et al., 2013).
To overcome this Listgarten et al. (2013) proposed relaxing the distributions to
1
a
LLR ∼ piχ20 + (1− pi)χ2d, (3.9)
where a, pi and d are fit to match the empirical distribution of null tests obtained from
permutations. We have adopted this strategy within mtSet and empirically validated
this approach for multi-trait set tests.
Obtaining P values in mtSet. Let us assume we have performed a set-based GWAS
consisting of T genome-wide set tests. Following Listgarten et al. (2013), we employ
the following three-step procedure to compute P values:
1. Obtain the empirical distribution using permutations. We consider J
permutations of individuals in the set components and for each permutation we
perform a genome-wide scan (consisting of T set tests). The empirical distribution
of the LLR under H0 is then obtained by pooling the JT test statistics across
all tests and permutations1. Note that this permutation strategy i) keeps intact
the LD structure and MAF distribution of real genotypes and ii) retains the
dependency between the relatedness component, the fixed effect covariates and
the phenotypes.
2. Fit the parametric form to the empirical distribution. We consider the
parametric form in Eq. (3.9). The P value corresponding to a LLR test statistics
1By pooling across all tests, we assume that the distribution of the LLRs under the null model is
the same across all sets.
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D can be obtained as









where F (·, d) is the cumulative density function of χ2d(·). The parameters pi, a
and d are empirically determined by fitting the parametric form to the obtained
distribution in a two-step procedure. First, we estimate pˆi as the fraction of LLRs
that are lower than a tolerance value (which we set to 3 · 10−4). Second, we
determine a and d by minimising the squared error between log P(D; pˆi, a, d) and
the log of the corresponding theoretical values under H0 (P values are uniformly
distributed H0). To prioritise accuracy for low P values, we only consider the
lowest 10% of the P values to determine a and d. Sorting the T LLRs from the
largest to the smallest, i.e., D1 ≥ D2 ≥ · · · ≥ DT , and indicating with I the














The MSE is minimised by grid search with a ∈ [0.1, 5.0], d ∈ [0.1, 5.0] and
considering 100 equally spaced values for both parameters. Although only the top
10% of the null test statistics are used in the fit of the parametric distribution, we
find empirically a good fit for the complete range of the test statistics. Fig. B.1
shows five examples of fits from the calibration experiment using genotypes from
the 1000 Genome Project (see Section 3.2.4). The estimated parameters for the
two real-data analyses described in Section 3.3 are reported in Table B.1.
3. Pv estimation. Once the optimal parameter values pˆi, aˆ and dˆ are determined,
the P value can be calculated from the test statistics as P(D; pˆi, aˆ, dˆ).
Given the large number of genome-wide tests, we found that approximately 30 genome-
wide permutations are sufficient to estimate the null distribution and obtain calibrated
P values in our experiments.
3.1.3 Efficient parameter inference
In this section, I outline the efficient algebraic computation of the log marginal likeli-
hood (LML) implemented in mtSet. Derivations for efficient computation of the gra-
dients of mtSet are given in Section A.3.
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Log-marginal likelihood. The log likelihood of the model in Eq (3.3) is given by
L = −NP log 2pi − 1
2
log detK − 1
2
vec (Y )T K−1vec (Y ) , (3.12)
where


















+Cg ⊗Rg +Cn ⊗ IN︸ ︷︷ ︸
A
(3.15)
= XX> +A. (3.16)
In Eq (3.16) we have made the low rank structure of the set component explicit, by
writing Cr = EET and Rr = 1RGG





A = Cg ⊗Rg +Cn ⊗ IN . (3.18)
Note that A is the total covariance matrix of the model in Eq (2.78) that is used for
single-variant association testing across multiple traits.
The bottleneck operations in the computation of the likelihood in Eq (3.12) are
K−1vec (Y ) and the log determinant of K. However, in the following we will see how
these calculations can be performed efficiently by exploiting the low-rank nature of
XX>.
Rewriting the inverse. Using the Woodbury identity (Woodbury, 1950) we can










Using Eq (2.82), which shows that





SC?g ⊗ SRg + I
)−1
(3.21)







































= Wc ⊗Wr (3.28)




LrG ∈ RN×R. (3.30)
Computation of the column matrix Wc has O(P 2C) complexity, while computation of
the row covariance matrix Wr has O(N2R) computational complexity. Note that Wr
is constant during optimisation and thus it needs to be computed only once per region.
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The matrix Λ can also be computed efficiently by rewriting it as
Λ = I +W TDW (3.31)
= I +
(
W Tc ⊗W Tr
) [











. . . (3.33)







Indeed, computingW explicitly and computingDW takes O(CNPR) time, multiply-
ing DW by W from left has complexity O(CR(NPC + RNC)), while the inversion
of Λ has complexity O(C3R3). In practice, we use the Cholesky factorization to com-
pute the inverse of Λ having the advantage that we can re-use the decomposition for
computing the log determinant later on.
Evaluating the log-determinant. The log-determinant can be computed by using
the matrix determinant lemma (Harville, 1998)





= log detA+ log det(I +W TDW︸ ︷︷ ︸
Λ
). (3.36)
Provided that we have already computed Lc,Lr,D and the Cholesky decomposition of
Λ, evaluating log detA takes O(NT ) using Eq (2.92) while evaluating log det Λ takes
O(CR).
Evaluating the squared form. The squared form can be evaluated as follows
vec (Y )T K−1vec (Y ) = vec (Y )T LTDLvec (Y )










− vec (Y¯ )T Λ−1vec (Y¯ ) ,
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Rotating and scaling the data Eqs (3.37 - 3.38) takes O(N2P +NP 2 +NP +NPC +
RNC) time, where again the O(N2P ) operation is done only once prior to the analysis.








takes O(C2R2) time after having
inverted Λ.
The efficient derivation of gradients is described in Section A.3. Overall, combining
eigenvalue decomposition and low-rank updates with Kronecker product algebra the
O(N3P 3) computational cost can be reduced to a O(N3) operation upfront and O(N2+
NR2P 2+NRP 4) per set. Note that the quadratic operation inN needs to be performed
only once for each set while gradient-based optimisation is linear in N (see Table B.2).
3.1.4 Analyses of cohorts with unrelated individuals
As any exact LMM, mtSet is bound to the upfront eigenvalue decomposition of the
genetic relatedness matrix, which has complexity O(N3), limiting the scalability of
LMMs to very large cohorts (N ≥ 20, 000). To overcome this, we considered two
different strategies that can be employed for analysis of unrelated individuals: mtSet-
PC and mtSet-LowRankBg. Both models scale linearly with the number of samples,
enabling analysis of cohorts with up to 500,000 unrelated individuals (Fig. 3.1). In
mtSet-PC, the relatedness component is dropped and population structure is accounted
for by modelling the top principal components of the RRM as fixed effect covariates.
In mtSet-LowRankBg, we instead consider a low-rank approximation of the RRM. The
two methods build on the same modelling assumption, i.e., they both use a low-rank
representation of the RRM, and gave similar results in simulated data (see Fig. B.2).
For this reason we considered only mtSet-PC in simulations and real-data experiments.
Full details on the algebraic implementation of the two methods are provided in Sections
A.4-A.5.
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3.1.5 Relationship to existing methods
mtSet is related to the single-variant LMM for multiple traits (Section 2.4) and to
single-trait set tests (Section 2.3.5). In the following, I briefly review the computational
complexity of related LMM implementations.
LMMs with fixed effect testing. As discussed in detail in Section 2.3.3, single-
variant LMMs with fixed effect testing require a single O(N3) operation up-front and a
per-test complexity of O(N2). Considering a RRM with low-rank structure (for exam-
ple using feature selection, see Listgarten et al. (2012)), the computational complexity
of these approaches can be further reduced to O(N2) for the up-front computation and
a per-test complexity of O(N). The multi-trait extension of this model (see Section
2.4.4) requires a singleO(N3) operation up-front andO(N2+NP x) per variant, where x
depends on the optimisation algorithm. In particular, the efficient implementation pro-
posed by Zhou and Stephens (mvLMM 2014) combines Newton-Raphson (Thompson,
1973) and the the PX-EM (Liu et al., 1998; Foulley and Van Dyk, 2000) algorithms.
LMMs for set tests. In the same way mvLMM extends a standard single-variant
LMM to multi-trait analysis, mtSet can be regarded as the multivariate generalisation
of the full-rank fast LMM-set proposed in Lippert et al. (2014a). The computational
cost of mtSet consists in O(N3) operations upfront and O(N2 + NR2P 2 + NRP 4)
per set, where R denotes the number of variants in the set. We also considered two
alternative low-rank approximations of the full mtSet model: mtSet-PC, where the
relatedness component is omitted and population structure is modelled as a fixed effect,
and mtSet-LowRankBg, which assumes a low-rank RRM. mtSet-LowRankBg can be
regarded as the multi-trait extension of FaST-LMM-Set (Listgarten et al., 2013), which
uses the same strategy to achieve fast computations in single-trait analyses.
Table B.3 provides a tabular listing of the per-test computational complexity for
alternative LMM methods and implementations. Note that the listed complexities do
not take into account the upfront O(N3) operation2 for the eigen decomposition of the
relatedness covariance matrix that.
2Or O(N2) if a low rank relatedness covariance is used
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3.2 Simulation study
First, we validated mtSet and assessed its scalability, calibration and statistical power
using simulations. Genetic effects were simulated based on genotype data from the 1000
Genomes project (Phase 1, 1000 Genomes Project Consortium (2012)). In Sections
3.2.1-3.2.2 I describe the simulation strategy, in Sections 3.2.3-3.2.5 I discuss the results.
3.2.1 Genotype simulation strategy
To study scalability and calibration of mtSet, we generated cohorts with different sam-
ple sizes and types of confounding based on genotype data from 1000 Genomes Project
(Phase 1), consisting of 1,092 individuals and 9,034,769 genome-wide variants with a
minor allele frequency of at least 2%. To do so, we followed the two-step procedure
proposed in Loh et al. (2015b):
1. for each newly synthesised individual we randomly select A ancestors;
2. the new genotype is built as a mosaic of blocks of 1,000 variants, where each
block is copied from the corresponding block in one of the A ancestors (selected
at random).
As discussed in Loh et al. (2015b), the amount of genetic relatedness in the cohort
depends on the number of ancestors A. For example, A = 10 gives rise to a cohort
with approximately unrelated individuals while A = 2 gives a cohort with some highly
related individuals, thereby simulating family relatedness. Moreover, by sampling all
the ancestors of an individual either from the same sub-population or randomly from
the whole cohort, one can generate genotype data with or without population structure,
respectively.
Genotype data for runtime experiments. For runtime experiments, we generated
cohorts with 500, 1K, 2K, 5K, 10K, 20K, 50K, 100K, 200K and 500K individuals. We
first assigned each individual to one of the 14 populations in the 1000 Genomes Project
and then we sampled A = 10 ancestors from that population, generating cohorts of
unrelated individuals and preserving the population structure in the original data.
Genotype data for calibration experiments. For calibration experiments, we
generated three cohorts with 1,000 individuals and different genetic structures, consid-
ering only European populations (CEU, FIN, GBR, IBS and TSI).
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• Population Structure (simPopStructure). We simulated population structure
by (i) assigning each newly synthesised individual to one of the five European
populations (CEU, FIN, GBR, IBS and TSI) and (ii) considering A = 10 ances-
tors from that population;
• Unrelated individuals (simUnrelated). For each synthesised individual, we
considered A = 10 ancestors, which were randomly sampled from the whole set
of Europeans;
• Related Individuals (simRelated). For each synthesised individual, we consid-
ered A = 2 ancestors, again sampled from the whole set of Europeans.
The RRM for the original 1000 Genomes project data and the three synthetic cohorts
is shown in Fig. B.3.
3.2.2 Phenotype simulation strategy
Quantitative traits were simulated assuming a linear-additive model, considering the
contributions from a randomly selected causal genetic region for the set component,
polygenic background effects from all remaining genome-wide variants, a contribution
from unobserved covariates and iid observational noise. When assessing calibration of
significance levels, phenotypes were generated from the null model, omitting the effect
from the set component. To study the performance of the proposed set tests under
different genetic architectures, we varied the variance explained by the selected region
(h2r), the number of causal variants in the region (Sr), the percentage of shared causal
variants (pir), the variance explained by relatedness effects (h2g), the fraction of residual
variance that is not iid across samples (λ), and the fraction of relatedness and residual
signal that is shared across traits (α). Unless specified otherwise, we consider a region
of 30 kb and use default values of the simulation parameters in Table B.4, which were
chosen to mimic trait architectures observed in the rat data and the NFBC study (see
Sections 3.3.1-3.3.2). In the following I provide details on the simulation pipeline and
give a precise definition of the simulation parameters.
1. Set contribution.
Sr = average number of causal variants from the region across traits,
h2r = average fraction of variance explained by causal variants across traits,
pir = fraction of causal variants that have shared signal across traits
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• Set shared signal
We first select S(s) = pirSr variants. Then we sample a binary vector
b
(s)
snps ∈ {−1, 1}S(s) that defines the relative directionality of the effects across
variants and a binary vector b(s)traits ∈ {−1, 1}P that defines the relative direc-





and indicating with X(s) ∈ RN×S(s) the standardised
genotypes of the S(s) variants, the shared signalR(s) from the set component
is defined as
R(s) = X(s)B(s) (3.39)
• Set independent signal
For each trait we select Sr−S(s) variants on average across traits and gener-
ate their effect sizes as iid from {−1, 1}. Indicating with X(i)p ∈ RN×S
(i)
p the
standardised genotype matrix for the S(i)p causal variants selected for trait
p and with b(i)p ∈ {−1, 1}S
(i)
p their effect sizes on trait p, the independent







1 · · · X(i)P b(i)P
]
(3.40)
R = Rcomm +Rind is then scaled such that the average variance of its columns
is h2r .
2. Relatedness contribution.
h2g = average fraction of variance explained by relatedness across traits,
αg = fraction of signal from the relatedness contribution that is shared across traits
• Relatedness shared signal
The shared signal from relatedness is generated as
G(s) ∼ MVN (0, Rg, aaT ) , with a ∼ N (0, IP ) (3.41)
and rescaled such that the average variance of its columns is αh2g.
• Relatedness independent signal
The independent signal from relatedness is generated as
G(i) ∼ MVN (0, Rg, diag (c2)) , with c ∼ N (0, IP ) (3.42)
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and rescaled such that the average variance of its columns is (1− α)h2g.
3. Residuals.
λ = fraction of structured noise,
αH = fraction of structured noise that is shared across traits
• Structured noise
We generate the input matrix for K = 10 unobserved covariates Γ ∈ RN×K
as iid from N (0, 1).
– Structured-noise shared signal





, with aH ∼ N (0, IP ) (3.43)
and rescaled such that the average variance of its columns is αHλ(1 −
h2r − h2g).
– Structured-noise independent signal







, with cH ∼ N (0, IP ) (3.44)
and rescaled such that the average variance of its columns is (1 −
αH)λ(1− h2r − h2g).
• IID noise
We generate iid Gaussian noise E ∼ ∏N (0, 1) that we rescale so that the
average variance of its columns is (1− λ)(1− h2r − h2g).
We considered αg = αH = α in all simulation experiments. Overall, the phenotype can
be expressed as
Y = R(s) +R(i) +G(s) +G(i) +H(s) +H(i) +E, (3.45)
where the average variance across traits of each term can be written as a function of
the simulation parameters introduced as shown in Table B.5.
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3.2.3 Empirical complexity and scalability
To assess the scalability of mtSet, we considered synthetic cohorts with increasing
sample sizes (up to 500,000 individuals), which were generated as described in Section
3.2.1. Phenotype data were generated as described in Section 3.2.2. However, to
avoid computation of the RRM and its Cholesky decomposition for big cohorts (N >
20, 000) we used a low-rank approximation of the RRM based on population labels
when simulating phenotypes. Specifically, denoting with Π the number of populations
and J ∈ RN×Π an indicator matrix such that Jij is 1 if individual i is from population
j and 0 otherwise, we considered 1ΠJJ
> as relatedness matrix. We then assessed
empirical runtime to complete a sliding-window experiment with a window size of 30kb
and a step of 15kb on chromosome 20 (which resulted in 3,975 analysed regions) for
the following set test implementations:
1. A naive implementation of the full mtSet model (without efficient algebra imple-
mentation, mtSet-naive);
2. The full mtSet model, which uses a random effect to model genetic relatedness
(mtSet);
3. mtSet-PC, including the population labels J as fixed effect covariates to account
for population structure;
4. mtSet-LowRankBg, considering a low-rank relatedness matrix 1ΠJJ
>.
Empirical runtimes were assessed as the CPU time on a single core of an Intel Xeon
CPU E5-2670 2.60 GHz processor. The reported runtime includes the cost for fitting
the null model (only once) and the alternative models (for each test).
The results of the analyses are showed in Fig. 3.1. While a naive implementation of
the algorithm becomes impractical already for analysis of cohorts with 1,000 samples,
the full mtSet model can be used for genetic analyses in structured populations of
moderate size (20,000 individuals). For analyses of unrelated individuals, mtSet-PC
and mtSet-LowRankBg can be applied to even larger cohorts, enabling multi-trait set
test analyses in cohorts with up to 500,000 individuals. Note that the decrease in CPU
time for the mtSet-PC method in the range of 500-10,000 individuals is due to the
decreasing number of the iterations needed by the optimisation algorithm (BFGS) to
achieve convergence. This is the consequence of the fact that the log marginal likelihood
is more informative (peaked) when considering bigger sample sizes.
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We also assessed scalability of the considered methods when considering larger
numbers of traits. Runtimes for a cohort with 1,000 individuals when varying the
number of traits are reported in Fig. B.4.
3.2.4 Calibration of P values
To assess calibration of type I error, we tested that the P values estimated by mtSet were
uniformly distributed under the null hypothesis when considering cohorts with different
types of confounding. To do so, we considered synthetic genotype data for independent
individuals, population structure with European subpopulations and family relatedness
(Section 3.2.1 and Fig. B.3). For each of the four datasets (the original data and
the three synthetic cohorts), we considered five independent simulations. Phenotype
values for four traits were generated from an empirical null model, without contribution
from the set component. In each experiment, we considered a genome-wide sliding-
window scan with a window size of 30kb and a step size of 15kb, which resulted in
178,695 set tests. P values were obtained from LLRs using a mixture of two chi-squared
distributions (see Section 3.1.2), using five genome-wide permutations to estimated
the parameters. For comparison, we also estimated P-values from the LLRs from an
additional genome-wide permutation, which was not used to estimate the parameters
of the test statistic distribution. Moreover, in addition to mtSet and mtSet-PC we also
considered a single-trait set test (stSet) and single-variant LMMs, either considering
individual traits (stLMM-SV) or performing joint tests across traits (mtLMM-SV).
For mtSet-PC, we used the first 30 principal components of the RRM as fixed effects.
stLMM-SV corresponds to an implementation of the fastLMM algorithm (Lippert et al.,
2011) in LIMIX (Lippert et al., 2014c). mtLMM-SV is based on the equivalent version
of the MTMM model (Korte et al., 2012), again implemented in LIMIX. Single-trait set
tests are a special case of mtSet, which is equivalent to fastLMM-set model in Lippert
et al. (2014a). Results for all scenarios and method are reported in Table B.6 while
QQ plots are shown in Fig. B.5.
Both mtSet and mtSet-PC were sufficiently calibrated when considering genotype
data of unrelated 1000 Genomes Project individuals (Fig. 3.2a) or simulated cohorts
either with no structure or with population structure (Fig. B.5). In contrast, the
relatedness component of mtSet was important to ensure statistical calibration in the
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(b) Number of iterations
Figure 3.1: Computational runtime of mtSet and alternative methods as a
function of the cohort size. Panel (a) shows the CPU time (h) to test associations
on chromosome 20 (3,975 windows/tests) on a simulated cohort with increasing number
of individuals and for four traits. Compared are the full mtSet, the PC approximation
(mtSet-PC) and the low-rank approximation (mtSet-LowRank). Naive denotes the
runtime for a standard LMM package, which scales cubically with the number of traits
and samples. Runtime estimates were obtained on a single core of an Intel Xeon CPU
E5-2670 2.60 GHz processor. Panel (b) shows the number of iterations of the BFGS
algorithm for the different methods and cohort sizes.
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3.2.5 Power comparison
To assess statistical power, we considered real genotypes from the 1000 Genomes
Project, for which both mtSet and mtSet-PC yielded calibrated P values (see Fig. 3.2a).
We considered the same set of models used in the calibration experiments. To simu-
late a representative range of genetic scenarios, we varied the variance explained by
the causal region, the number of signal variants in the causal region, the percent-
age of shared variants across traits, the proportion of variance explained by genetic
background, the percentage of residual variance explained by unobserved covariates,
the percentage of background signal that is shared across traits and the window size
(see Section 3.2.2, Table B.4). For each parameter setting, we simulated a total of
1,000 datasets with four phenotypes each, resulting in 44,000 experiments in total.
In order to reduce the computational burden, we restricted each simulated dataset to
randomised regions drawn from chromosome 20, each containing 100 windows (corre-
sponding to genomic regions of approximately 2Mb). For set tests, we considered a
sliding-window approach (30kb window size, 15kb step size). To compare alternative
methods, we counted the top-associated window as a true positive if it overlapped with
the simulated causal region (+/- 50kb) and was significantly associated at a family-wise
error rate (FWER) of 10%. For single-variant methods the top-associated window was
(a) 1000 Genomes Project (b) Related individuals
Figure 3.2: QQ-plots for the P-values obtained by mtSet and mtSet-PC con-
sidering datasets with different sample structure. (a) QQ-plots for the P-values
obtained by mtSet and mtSet-PC when simulating four phenotypes with only back-
ground effects (no set term) using genotypes from 1000 Genotype Project individuals.
Shown are results from 5 (independent) simulations. (b) Identical analysis as in (a),
considering simulated phenotype data based on synthetic genotypes with related indi-
viduals.
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defined as the window centred on the lead variant with the same size as the testing
window used for set tests. Single-trait methods were applied to individual traits in
turn, scoring each window/variant based on the maximum test statistics across traits.
The family-wise error rate was controlled for using a two-step permutation approach.
For each simulated phenotype, we first repeated the experiment with permuted geno-
types and recorded the maximal test statistic. In a second step, we pooled the maximal
test statistics over datasets with identical simulation parameter settings. We used this
distribution to define an empirical FWER as the fraction of maximal test statistics
under permutations that is larger than the observed one (Westfall et al., 1993). This
approach accounts for LD and the effective number of tests performed, thereby enabling
an objective comparison between single-variant method and set tests.
Varying the number of causal loci. Initially, we assessed the sensitivity of different
models with respect to the number of causal loci. When increasing the numbers of
causal loci within the simulated region, the performance of single-locus models (stLMM-
SV, mtLMM-SV) deteriorated markedly (Fig. 3.3a), since each locus on its own could
only explain parts of the phenotypic variance explained by the region. As expected set
tests were able to aggregate over multiple effects and were generally well powered when
two or more causal loci were simulated.
Varying the proportion of shared background signal. As expected, when we
altered the proportion of shared background effects (i.e., the parameter α introduced
in Section 3.2.2), single-trait methods were not able to leverage correlated background
(Fig. 3.3b). In contrast, multi-trait models account for trait-trait correlations and
hence were substantially more powerful than the corresponding single-trait alternatives
when the traits were correlated (Fig. 3.3b).
Varying the size of the testing region. We also studied the power and compu-
tational efficiency of set tests when considering different testing-region sizes (Fig. 3.4,
Fig. B.6). Varying the size of the testing region from 1 kb to 200 kb, the power results
were generally robust (Fig. 3.4). However, as expected mtSet was best powered when
the size of the region term matched the simulated size of the true causal regions (30
kb). Fig. 3.4 and Fig. B.6 suggest that when selecting the size of the testing window
both the local linkage disequilibrium and number of SNPs within regions should be
considered. Testing regions that are too small will lead to high LD among the variants
in the set component, which results in limited advantages of set tests compared to
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single-variant LMMs. Conversely, large regions may lead to reduced power, as a con-
sequence of including many non-causal variants in the set component, and increased
computational burden, as the computational efficiency of mtSet depends on the number
of variants in the set.
Varying other simulation parameters. Fig. B.7 shows results across all simu-
lated scenarios. We note that the exact mtSet model was in general slightly better
powered than the PC-based approximation (mtSet-PC), confirming the expected ben-
efits of including a relatedness component (Kang et al., 2010). In sum, these results
show that mtSet is a robust method for association mapping across a wide range of
simulated genetic architectures.
3.3 Applications to real data
To illustrate the advantages of mtSet we considered two real data application: a human
GWAS of four lipid traits from the Northern Finland Birth cohort (Sabatti et al.,
Number of causal SNPs Fraction of correlated polygenic signal
(a)
Number of causal SNPs Fraction of correlated polygenic signal
(b)
Figure 3.3: Power comparison of alternative methods on simulated data from
1000 Genomes Project genotypes. Power comparison of alternative methods on
simulated data based on 1000 Genome Project data with four phenotypes, varying
the complexity of true causal effects (number of causal variants) (a) and the extent
of correlated genetic background (b). The stars denote the default values that are
kept constant when varying the respective other parameter. Shown is the average
power for different methods and simulation settings across 1,000 repeated experiments
where the error bars denote standard errors. Compared are the full-rank multi-trait
set test (mtSet), the PC approximation (mtSet-PC), the single-trait set test (stSet),
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(c) Number of SNPs
Figure 3.4: Power comparison when varying the size of the set component
on simulated data from 1000 genomes project genotypes. (a) Shown is power
at 10% family-wise error rate for mtSet, stSet, mtSet-PC, mtLMM-SV and stLMM-SV
when varying the window size for set test approaches. While the methods are overall
robust, the set test methods were most powerful when the testing size matched the
size of the simulated causal region. (b) Shown is the averaged squared correlation
coefficient within a window as a function of the window size. Larger windows tend to
contain fewer tightly correlated SNPs within windows. (c) Shown is the number of
SNPs within windows as a function of the window size. When selecting the size of the
testing window both linkage disequilibrium and number of SNPs within regions should
be taken into account.
2009) and a GWAS of six haematology traits in a population of outbred rats (Baud
et al., 2014). While the first is a medium-sized cohort of unrelated individuals (5,256
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individuals), the second is a smaller cohort (1,334 individuals) characterised by strong
genetic relatedness. The RRM of both datasets is shown in Fig. 2.3. Fig. B.8 shows
the distribution of the number of variants and the squared average correlation coefficient
between variants in genetic regions, both as a function of the considered window size.
As these figures show, the rat genotypes have a slower LD decay, which is consequence
of the large haplotype blocks that characterise this dataset.
3.3.1 Genetic analysis of lipid traits in human
We applied mtSet to data from four lipid-related traits (C-reactive protein (CRP),
triglycerides (TRIGL) and LDL and HDL cholesterol levels) measured in 5,256 unre-
lated individuals from the Northern Finland Birth cohort (Sabatti et al., 2009), which
were previously considered for multi-trait analysis using single-variant LMMs (Korte
et al., 2012; Zhou and Stephens, 2014). Following the approach taken in Zhou and
Stephens (2014), we regressed out sex, usage of contraceptive pill (Pills31) and oral
contraception (ZP4202U) and then quantile-normalised each trait to follow a unit vari-
ance normal distribution (see also Fusi et al. (2014a) for a comparison of alternative
pre-processing methods in the context of LMMs). For set tests we employed a sliding-
window approach, considering a window size of 100 kb and a step size of 50 kb (for
a total of 328,517 variants with an MAF of at least 1%). Regions with fewer than
4 SNPs were discarded (1,802 SNPs, corresponding to <0.5%), resulting in a total
of 51,658 sets for analysis. Heritability estimates and correlation coefficients on the
null models of mtSet were in line with those previously reported in Korte et al. (2012)
(Table B.7 - the procedure for calculating standard errors is described in Section D.3),
where small deviations are likely due to small differences in the phenotype normalisa-
tion. Following the strategy described in Section 3.1.2, we estimated P-values using 10
genome-wide permutations per window to fit an empirical null distribution. A genome-
wide run required 49h for mtSet (null model: 2.58 min, average window: 5.18s), and
5h for mtSet-PC (null model: 44.89s, average window: 1.78 s). We again compared
mtSet and mtSet-PC to a single-trait set test, and single-trait and multi-trait LMMs
for single-variant testing. All methods yielded well-calibrated P values (Fig. B.9-
B.10). Significance of QTLs was assessed at the Bonferroni adjusted significance level
α < 0.01. For single-trait methods, we considered the minimum P-values across traits,
again adjusting for the additional tests using Bonferroni.
Manhattan plots for all methods are shown in Fig. B.11 and a tabular summary
of the QTLs is provided in Table B.8. Notably, mtSet identified 14 genome-wide
significant quantitative trait loci (QTL) (alpha<0.01, Bonferroni adjusted), 13 of which
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have previously been identified in a larger meta-analysis (Teslovich et al., 2010) and
the remaining one has been reported when applying single-variant multi-trait LMMs
to the same dataset (Zhou and Stephens, 2014). Single-variant LMMs missed four
associations and single-trait set tests failed to detect three of the associations detected
by mtSet. In contrast, mtSet identified all but one association found when considering
the union of associations detected by previous methods and retrieved one additional
association close to the ANGPTL3 (Anglopoletin-like 3) gene, a known regulator of
lipid metabolism in mice (Koishi et al., 2002). Notably, mtSet-PC was even slightly
better powered than mtSet (identifying 16 QTLs). The model retrieved all associations
found by mtSet or any other method and found an additional association close to
the LCAT (lecithin cholesterol acyltransferase) gene, which is known to contribute
with multiple rare alleles to low plasma levels (Cohen et al., 2004). Finally, in order
to assess robustness of the results to the choice of the window size we repeated the
analysis considering either a smaller window size of 60kb or a larger window size of
300kb. Table B.9 shows that results are overall robust when considering different
window sizes.
3.3.2 Genetic analysis of haematology traits in rat
To evaluate mtSet in a setting with strong relatedness, we considered a QTL study of
1,334 outbred rats (The Rat Genome Sequencing and Mapping Consortium, 2013) and
applied mtSet to six traits related to basal haematology (concentrations of basophils
(basos), eosinophils (eos), large unstained cells (luc), lymphocytes (lymphs), monocytes
(monos) and neutrophils (neuts)). We regressed out sex and batch covariates and
quantile normalised each trait to a unit variance normal distribution. Variants were
filtered to have a minor allele frequency (MAF) of at least 5% resulting in 4,138,000
variants for the analysis. Because of the large haplotype blocks in this particular study
(multi-parent cross genetic design), we considered larger regions (1Mb size) and a step
size of 500kb, resulting in a total of 5,220 sets. Heritability estimates from a single-
trait LMM were consistent with the marginal heritability estimates of the mtSet null
model (Table B.10). To estimate P-values, we used 30 genome-wide permutations per
window to fit an empirical null distribution.
First, to study calibration of P values using different correction strategies we com-
pared mtSet to mtSet-PC and a single-variance component model without correction for
population structure (mtSet-NoBg). All three models were calibrated when permuting
the SNPs within the set (using genome-wide permutations to retain the LD structure,
see Section 3.1.2), which corresponds to empirical data from the null without asso-
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ciation signal (Fig. 3.5a). However, for the observed data (Fig. 3.5b, Fig. B.13),
only mtSet yielded calibrated results, confirming the expected benefits of the second
variance component term to control for relatedness (Kang et al., 2010; Schifano et al.,
2012). The QQ-plots in Fig. 3.5c were obtained after removing duplicate SNPs, i.e.
only considering unique variants.
We then compared mtSet to different LMMs, including single-trait set test, single-
trait LMM for single variants and multi-trait-LMM for single variants. Again, signif-
icance was assessed at FWER < 0.01 significance level, adjusting for multiple testing
using Bonferroni (considering only unique variants in the dataset). For single-trait
methods we corrected Bonferroni both across variants and traits. Fig. 3.5c shows the
Manhattan plots for the four methods (for single-trait methods we report the minimum
P value across traits; Manhattan plots for single-traits tests are reported in Fig. B.13).
A tabular summary of the results is given in Table B.11. mtSet identified one ad-
ditional QTL (alpha < 0.01, Bonferroni adjusted, see Fig. 3.5c). This QTL points
to NFKB2, a gene that is involved in immune response in humans (Wit et al., 1998),
making it also a plausible candidate gene for haematological traits in rat.
3.4 Summary and discussion
In this chapter, I have shown how set tests can be extended to enable joint analy-
sis of multiple traits. Through applications to both simulated and real data, I have
shown that the mtSet model increases power compared to existing LMMs for associ-
ation testing, while retaining computationally efficiency and controlling for arbitrary
confounding structure. mtSet builds on an efficient inference scheme for multi-trait
LMMs with two variance components, by exploiting the low rank structure of genetic
region terms. The proposed algebraic implementation extends the efficient inference
schemes of existing LMMs for genome-wide association studies.
Although mtSet can be used to fit variance component models in general, it is not
free of limitations. First, it builds on the assumption that the number of variants in the
analysed region is lower than the number of samples. Although this assumption holds
for many use cases, analysis of high-density genotype markers or genome sequencing
data will entail a trade-off between the size of the genetic region that can be tested and
computational efficiency. Notably, as the marker density increases, one will typically
test smaller regions to improve the resolution of the mapping, which may help mitigate
this concern.
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Figure 3.5: Application of mtSet to six basal haematology traits in the rat
data. (a,b) Comparison of the calibration of alternative methods, considering both
permuted (null) data (a) and the real rat dataset (b). The null data is obtained from a
single permutation applied to SNPs used to estimate the set component. Compared are
mtSet run with relatedness component (mtSet), without relatedness component, prin-
cipal components to adjust for structure (mtSet-PC) and a variant of mtSet without
relatedness component and no PCs (mtSet-NoBg). (c) From top to bottom, Man-
hattan plots for mtSet, the single-trait set test (stSet), a multi-trait single-variant
LMM (mtLMM-SV) and a standard single-trait single-variant LMM (stLMM-SV). For
single-trait models (stLMM-SV, stSet), minimal P-values across traits are shown. The
horizontal line indicates the FWER = 0.01 significance threshold (Bonferroni adjusted).
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served phenotype data. This assumption is shared with the majority of alternative
inference schemes to efficiently fit LMMs (Zhou and Stephens, 2014; Furlotte and Es-
kin, 2015). If phenotype data are partially observed, phenotype imputation methods,
e.g. the one proposed by Dahl et al. (2016), can be reused.
Although I here exclusively considered tests for shared effects across multiple traits
(i.e., we used a rank-one parametrisation of the set trait covariance), the mtSet model
can describe more complex genetic architectures as I discuss in the next chapter.
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4 | Testing for polygenic interac-
tions using set tests
Genotype-context (GxC) interactions are genetic effects that depend on external con-
texts, including environment. Studies that explicitly test for differences in genetic
effects have revealed that GxC interactions are common and occur for a large number
of complex traits, including whole-body phenotypes, disease susceptibilities and psychi-
atric disorders (Warren et al., 2012; Modinos et al., 2013; Winkler et al., 2015; Young
et al., 2016). While for global phenotypes typical contexts under study are environ-
mental factors, genetic effects on molecular traits have been surveyed across multiple
tissues, cell types and stimuli (see also Section 1.2.4).
There are two canonical designs for the analysis of genotype-context interactions.
If the system permits the study of the same genotype in different conditions, the same
individuals can be phenotyped repeatedly in different contexts. However, in general this
design is not always feasible, for example, when studying variation of global phenotypes
in human. In this case a typical approach is to stratify the population into distinct
subgroups using a context variable. In the following, I will refer to these two alternative
study designs as complete and stratified designs.
Building on the mtSet model from the previous chapter, I here derive interaction
tests between sets of genetic variants and categorical contexts (iSet). This approach
generalises previous single-variant and set-based interaction tests and can be applied
to analyse datasets with either complete or stratified designs. iSet offers two major
advantages compared to the classical single-variant GxC test that uses a fixed effect to
test for differential effect sizes between contexts. First, by accounting for effects due
to multiple causal variants the method offers increased statistical power for detecting
polygenic interactions, analogous to set tests for persistent genetic effects (Listgarten
et al., 2013; Casale et al., 2015; Brown et al., 2016). Second, as described in more detail
in the following, this approach enables the characterisation of changes in the genetic
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architecture at specific loci across the analysed contexts.
Let us consider a categorical context and a quantitative trait locus harbouring
multiple causal variants. The baseline setting is that the effects of the causal variants
at the locus do not depend on the analysed context (Fig. 4.1a). In other words there is
no GxC; we denote such genetic effects persistent effects. A simple model of interaction
at the locus assumes that the local genetic effects in one context are proportional to
the effects in all other contexts; a criterion that has also been considered to assess
co-localisation of genetic effects across multiple traits (Wallace, 2013) (Fig. 4.1b).
We denote this class of interactions rescaling-GxC. In the most general case, however,
there may also be changes in the configuration of causal variants between contexts
(Fig. 4.1c). We denote this class of interactions heterogeneity-GxC. The proposed iSet

















































Figure 4.1: Schematic representation of different architectures of polygenic
effects. Alternative genetic architectures that are modelled in iSet: (a) persistent
effects, where causal variants have identical effects in the two contexts, (b) rescaling-
GxC effects, where the effects of causal variants in the two contexts are proportional,
(c) and heterogeneity-GxC effects, where the effect sizes in the two contexts are not
simply proportional, indicating a change in the configuration of causal variants.
In Section 4.1, I introduce the iSet model. In Sections 4.2-4.3, I describe results from
simulation experiments and an application to a stimulus eQTL study. In Section 4.4, I
present the extension of iSet to enable analyses of stratified designs and I illustrate this
approach in both simulations and a genotype-sex interaction analysis from real data.
Finally, in Section 4.5, I present a summary and a discussion of the limitations and
possible extensions of iSet.
76
4.1 The interaction set test
In this section, I derive the different models considered by iSet from a generative linear
model perspective. I then discuss the proposed statistical tests, the strategy to obtain
P values and an interpretation of the estimated variance parameters. Initially, we will
study the case of complete designs. The generalisation of the model to stratified designs
will be given in Section 4.4.
4.1.1 Model derivation
The N × C phenotype matrix Y for N individuals and two or more contexts C is
modelled as the sum of the contribution from K fixed effect covariates, the contribu-
tion from R variants in the region of interest (set component), a term accounting for
population structure or relatedness (relatedness component) and residual noise
Y = FB︸︷︷︸
fixed effects







Here, G ∈ RN×R denotes the standardised genotype matrix of the R genetic variants in
the set, W ∈ RR×C the matrix of their effect sizes across the C contexts, F ∈ RN×K
the design matrix of the K covariates, B ∈ RK×C the matrix of their effect sizes,
and Ug and Ψ are random effects that account for relatedness and noise and follow
matrix-variate normal distributions:
Ug ∼ MVN (0,Cg,R) and Ψ ∼ MVN (0,Cn, IN ) , (4.2)
where R ∈ RN×N denotes the RRM and Cg and Cn are C × C covariance matrices
accounting for co-variation of trait measurements across contexts due respectively to
the contributions from relatedness and noise.








, ∀s ∈ {1, . . . , S}, (4.3)
where Cr is the C × C covariance matrix of the effect sizes of the set variants across
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traits. Marginalizing out W , we obtain the mtSet model in Eq. (3.3)
vec (Y ) ∼ N
 vec (FB)︸ ︷︷ ︸
fixed effect covariates
, Cr ⊗Rr︸ ︷︷ ︸
set component
+ Cg ⊗Rg︸ ︷︷ ︸
relatedness component
+Cn ⊗ IN︸ ︷︷ ︸
noise
 (4.4)
where Rr = 1RGG
> ∈ RN×N is the a local RRM, estimated solely from the R variants
in the region.
A key insight derived here is that different local architectures (Fig. 4.1) correspond
to alternative assumptions on the structure of the trait-context covariance Cr (see also
Fig. 4.2a-b). To simplify the notation, we focus on the case of two contexts (C = 2).
The generalisation to the analysis of multiple contexts is discussed at the end of this
section.
Persistent effect model. In the scenario of local persistent effects, the matrix of
the variant effect sizes can be written as
W = [aγ, aγ] = γa1>2 , (4.5)
where the effect size profile γ ∈ RR of the genetic variants has same scale a in the both
contexts (Fig. 4.1a). Considering the prior γ ∼ N (0, 1RIR) and marginalising out γ
out, we obtain the model in Eq (4.4) with Cr = a212×2 (block covariance). One way




= a (12 ⊗G)γ. As
γ ∼ N (0, 1RIR) it follows
r ∼ N







Rescaling-GxC model. In the scenario of rescaling-GxC effects, we consider
W = [a1γ, a2γ] = γa
>, (4.7)
where the effect size profile γ ∈ RR of the genetic variants has scales a = [a1, a2] in the
two contexts (Fig. 4.1b). Considering the prior γ ∼ N (0, 1RIR) and marginalising γ
out we obtain Cr = aa> (rank-one covariance).
This model can capture three different biological settings:
• a1a2 > 0, the signal from the set has same direction;
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• a1a2 < 0, the signal from the set has opposite direction;
• a1 ≈ 0 and a2 6= 0 (or vice versa), the signal from the set is specific to one of the
two contexts.
Moreover, note that for a1 = a2 the model reduces to the case of persistent effect.
General-GxC model. For the most general case in Fig. 4.1c, we introduce effect



















is a rescaling matrix (aij is the scale of variant effect profile
γj in context i). Introducing the prior γ1,γ2 ∼ N (0, 1RIR) and marginalising γ1 and
γ2 out, we obtain the model in Eq (4.4) with Cr = AA> (full-rank covariance). Note
that the model includes the cases of both rescaling-GxC and persistent effects as special
cases.
Analyses across more than two contexts. For analyses of C > 2 contexts we
can consider a model with L ≤ C distinct genetic signals {γ(1), . . . ,γ(L)}. Introducing
ΓL =
[
γ(1), . . . ,γ(L)
] ∈ RR×L and the rescaling matrix AL ∈ RL×C , we can write
W = ΓLAL. (4.9)
Setting ΓL
iid∼ ∏N (0, 1) we obtain Cr = ALA>L , which has rank L. This result also
clarifies the aforementioned interpretation of the rank of the genetic trait-correlation
matrix Cr (Section 3.1.1). The rank of Cr is the number of distinct local genetic signals
across the different contexts. Note that each signal may be polygenic, resulting from
the joint effect of multiple variants in the set.
4.1.2 Statistical testing
Model comparisons of the LMM in Eq (4.4) considering alternative covariance struc-
tures for the set trait covariance enables us to test for different hypothesis on the local
genetic architecture (Fig. 4.2). Specifically, we consider the following tests:























































Figure 4.2: Illustration of the iSet model. (a) shows the multivariate mixed-model
underlying iSet. (b) illustrates the different covariance models of the set trait covariance
Cr considered in iSet and the corresponding changes in the local genetic architecture
associated to these models. (c) shows the null and the alternative hypotheses that define
the tests for association (mtSet), interaction (iSet) and heterogeneity-GxC (iSet-het).
Interpreting the variance parameters estimated by iSet, we can quantify the proportion
of local variance explainable by persistent, rescaling-GxC and heterogeneity-GxC effects
(d).
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null covariance model (no association):
H1 : Cr = AA> vs H0 : Cr = 0 (4.10)
• Interaction test (iSet). The full-rank covariance model is tested against a
block covariance model (which only captures persistent effects):
H1 : Cr = AA> vs H0 : Cr = a212×2 (4.11)
• Heterogeneity-GxC test (iSet-het). The full-rank covariance model is tested
against a rank-one covariance model (which captures both persistent and rescaling-
GxC effects):
H1 : Cr = AA> vs H0 : Cr = aa> (4.12)
Note that the covariance models introduced in the previous section are nested and
thus statistical tests are well defined. A summary of the different covariance structures
considered by the model and their use to derive specific tests is shown in Fig. 4.2.
P values. For the proposed tests, we consider the log-likelihood ratio (LLR) test
statistics. While for the standard association test (mtSet) P values can be obtained
using the permutation-based approach described in Section 4.1.2, permutation schemes
are not defined for interaction tests (Bůžková et al., 2011). Following Bůžková et al.
(2011), we consider a parametric bootstrap procedure to estimate P values for the
iSet and the iSet-het tests. To generate test statistics from an empirical null, this
procedure consists in drawing phenotypes from the null model with parameter values
that maximise the likelihood on real data. Similar to the strategy employed for mtSet,
we consider a small number of parametric bootstraps for each region (typically 10-100
bootstraps) and pool the obtained null LLRs across all tested regions. We then use the
estimated distribution of null LLRs to obtain empirical P values.
In an analysis of T genomic regions, the procedure to obtain P values for the the
three tests can be summarised as follows:
• For each of the T sets
– fit the no-association model (Hna), the block covariance model (Hblock),
the rank-one covariance model (Hrank1) and the full-rank covariance model
(Hfull) and estimate LLRs for mtSet (Hfull vs Hna), iSet (Hfull vs Hblock)
and iSet-het (Hfull vs Hrank1);
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– sample J LLRs from the null hypothesis for each of the three tests
∗ for mtSet, null LLRs are sampled as the LLRs from the mtSet test
considering J permutations the individuals in the set component;
∗ for iSet, null LLRs are sampled as the LLRs from the iSet test consid-
ering J parametric bootstraps from Hblock;
∗ for iSet-het, null LLRs are sampled as the LLRs from the iSet-het test
considering J parametric bootstraps from Hrank1;
• for each of the three tests, pool the JT null LLRs across regions to obtain an
empirical null. Empirical P values are obtained as the fraction of null LLRs that
are at least as extreme as the observed one.
4.1.3 Interpretation of the variance parameters
The expected sample variance of a random vector u following a multivariate normal
distribution with mean 0 and covariance K, u ∼ N (0,K), is (Searle, 1982, p 67)
E [var (u)] =
tr (PnK)
n− 1 , (4.13)
where n is the total number of samples and Pn = In − 1n1n×n is the centring matrix.
Using Eq (4.13), iSet allows for estimating (i) the fraction of variance explained by
the genetic region (as in Kostem and Eskin, 2013) and (ii) the relative proportions of
local variance that is explainable by persistent, rescaling-GxC and heterogeneity-GxC
effects (Fig. 4.2d).
Fraction of variance explained by the region. Considering the model in Eq (4.4),
the variance explained by the set component (vset), the relatedness (vrel) and the noise




























Here Cˆr, Cˆg and Cˆn denote the maximum-likelihood estimator (MLE) of Cr, Cg
and Cn considering a full-rank covariance model for Cr. The expected proportion of
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variance explained by the genetic region can be estimated as
h2set =
vset
var(vec (FB)) + vset + vrel + vnoise
. (4.17)
Note that vset, vrel and vnoise can be computed efficiently as
PNC = INC − 1
NC
1NC×NC = IC ⊗ IN − 1
NC
(1C×C ⊗ 1N×N ) . (4.18)
Decomposing the local variance. To estimate the relative proportions of local
variance that is explainable by persistent, rescaling-GxC and heterogeneity-GxC effects
we use the following strategy:
• consider the block and the low-rank approximation of Cˆr
Cˆ(block)r = mean(Cˆr)1C×C (4.19)
Cˆ(lr)r = λvv
>, (4.20)
where λ is the largest eigenvalue of
Cˆr and v the corresponding eigenvector;













, which we de-
note with vpers and vlr respectively, using Eq (4.13);
• define the variance explained by persistent, rescaling-GxC and heterogeneity-GxC
as vpers, vlr − vpers, vset − vlr1 .
An alternative strategy to estimate these variances is to estimate the variance ex-
plained by persistent and rescaling-GxC effects directly from the MLE of Cr when
considering block and low-rank models for Cr. Empirically, we observed that two
approaches gave very similar results (data not shown).
4.1.4 Relationship to existing interaction tests
iSet extends existing multivariate LMMs and set-based interaction tests (see Table C.1
for a tabular comparison). While multivariate LMMs have been limited to analyses of
single variants, existing interaction set tests build on a univariate LMM and cannot be
applied to analyse datasets with complete designs. In the following, I provide a brief
overview of these methods.
1Note that the defined variances are well defined (i.e., non-negative) as vpers ≤ vlr ≤ vset.
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Multi-trait LMMs for interaction test. In studies with complete designs, it is
possible to use the multi-trait linear mixed model in Eq (2.79) to test for GxC in-
teractions by regarding trait measurements across the different contexts as multiple
phenotypes. In this setting, a specific-effect test (see Section 2.4.3) corresponds to a
test for interaction. For stratified designs considering a categorical context (i.e., two














where y ∈ RN is the phenotype vector for N individuals, F ∈ RN×K is the fixed
effect design matrix for K covariates, e ∈ RN a binary indicator that specifies the
context for each individual and g ∈ RN the genotype vector of the variant being
tested. Additionally, b ∈ RK , α, β and γ denote the fixed effects of the covariates, the
context variable, the variant being tested and the GxC interaction, respectively. Finally,
u ∼ N (0, σ2gR) is a random effect modelling genetic relatedness and ψ ∼ N (0, σ2nIN)
is the residual noise, where R ∈ RN×N denotes the realised relatedness matrix (RRM)
and σ2g and σ2n the relatedness and noise variance components. The test γ 6= 0 allows
assessing the presence of a GxC interaction.
Set-based interaction tests. One of the first set tests is the Turkey’s one degree-
of-freedom (dof) test (Chatterjee et al., 2006). Using the notation introduced above
and denoting with {g1, . . . gR} the genotype vectors for the R variants in the analysed


















with the assumption that the interaction effect for variant i is proportional to its
marginal effect (i.e., γi = θβi). The presence of GxC interactions can be assessed by
considering the one dof test θ 6= 0. For analysis of binary phenotypes, Jiao et al. (2013)
proposed an alternative strategy to re-weight the interaction effects of the variants in
the set based on the correlation between the set genotypes and the context variable.
An alternative strategy to aggregate GxC effects across multiple variants is to use
a random effect model. Different random-effect models for interaction set test have
been proposed (Tzeng et al., 2011; Lin et al., 2013; Lin et al., 2016; Zhao et al., 2015),
all of which build on closely related statistical models. In the following, I describe the
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Gene-Environment Set Association Test (GESAT) (Lin et al., 2013), a representative
interaction set test that we consider as a comparison partner (Section 4.4). The GESAT
model is similar to the model in Eq (4.22); however, the presence of interaction is
assessed by modelling γ as a random effect, γ ∼ N (0, τIR), and testing τ 6= 0. This
is done by using a score test, similar to Wu et al. (2011). Score tests are attractive,
as they do not require to explicitly fit the alternative model. When considering sets
with a large numbers of variants, the number of fixed effects in the null model is also
large, which may lead to overfitting. To overcome this issue, Lin et al. (2013) have
considered ridge regression to fit the null model (Hoerl and Kennard, 1970)2. The
score test statistics is
Q = (y − µˆ)>SS>(y − µˆ), (4.23)
where S = [g1  e, . . . , gR  e] and µˆ is the optimised mean under the null model (i.e.,
for γ = 0). It can be shown that Q follows a mixture of χ2 distributions with 1 dof (Wu








0 ∈ RN×N , (4.24)




F˜> and σˆ2n is the maximum likelihood estimate
of the noise variance under the null and F˜ = [F , e, g1, . . . , gR] ∈ RN×(K+R+1). P
values can be calculated from the score test statistics under the assumption that the
asymptotic distribution is valid, typically using the Davies method (Davies, 1980).
Computation of the eigenvalue decomposition of T has complexity O(N3). However,
if the number of variants is lower than the number of samples (R < N) the non-zero
eigenvalues of T can be computed as the eigenvalues of S>P0S, whose computation
and eigenvalue decomposition requires O(NR2) and O(R3) respectively. For details on
score-based methods I refer to Wu et al. (2011), Lee et al. (2012c) and Lippert et al.
(2014a).
Building on a multi-trait framework, iSet extends existing interaction set tests: (i)
it enables interaction set test in the analysis of data with either complete or stratified
designs, (ii) it explicitly model noise heterogeneity across the different contexts, (iii) it
allows for testing different classes of GxC effects, (iv) it enables estimation of variance
components. On the other hand, some of the methods mentioned here have features
that are not available in iSet. Specifically, the model is not designed for rare variant as-
2Ridge regression is a penalised maximum likelihood method. Specifically, ridge regression con-
sidered a quadratic penalisation on the fixed effects of the model. The extent of the penalisation is
selected by cross-validation.
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sociation tests and does not explicitly support case/control phenotypes and continuous
environments (Lin et al., 2016; Broadaway et al., 2015; Zhao et al., 2015).
4.2 Simulation study
First, we assessed statistical calibration and power of the proposed iSet method using
simulated data. We considered the synthetic cohort of 1,000 individuals simulated
from genotypes of European populations in the 1000 Genomes Project as described in
Section 3.2.1. We considered genetic variants with a minor allele frequency of at least
2%.
4.2.1 Phenotype simulation strategy
Similar to the simulation procedure described in Section 3.2.2, we generated trait mea-
surements in two contexts as the sum of the contribution from a randomly-selected
causal region of 30kb (S), polygenic background effect (G), effects from K = 10 unob-
served covariates (H) and iid noise (Ψ):
Y = S +G+H + Ψ. (4.25)
Genetic effects from the causal region were simulated to generate persistent, rescaling-
GxC or general-GxC effects (rescaling-GxC effects + heterogeneity-GxC effects).
• Persistent and rescaling-GxC effects. Sr causal variants were randomly
selected from the region. Denoting with G ∈ RN×Sr the standardised genotypes
of the selected causal variants, the local polygenic effect was simulated as
S = Gb [1, η] , where b iid∼ {−1,+1} , (4.26)
where b ∈ RSr is the effect size of the causal variants and η is the proportionality
factor of the effect sizes across the two contexts. Note that η can be positive
(positive rescaling), negative (negative rescaling) or zero (i.e. the polygenic effect
is specific to the first context). Additionally, η = 1 corresponds to the case of
persistent effects.
• General-GxC. When simulating general-GxC, we included scenarios with dif-
ferent causal variants between the two contexts. To do so, we independently
sampled sr causal variants in each of the two contexts, resulting in a total of
Sr = 2sr variants. In each context, the causal variants were selected such that all
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pairwise squared Pearson correlations were lower than 0.4. This was done by re-
jecting sampled configurations that did not satisfy this condition. Denoting with
G1 ∈ RN×sC and G2 ∈ RN×sC the standardised genotypes of the casual variants
in the two contexts and with b1 ∈ RsC and b2 ∈ RsC the respective vectors of




] [ b1 0sr×1
0sr×1 b2
]
, where b1, b2
iid∼ {−1,+1} . (4.27)
The extent of heterogeneity-GxC was controlled by additionally controlling the
correlation of the polygenetic effects between the two contexts. In particular,
given a certain target correlation range [ρm, ρM ], we only considered realisations
for which
ρm < corr(S:,1,S:,2) < ρM , (4.28)
by rejecting realisations that did not satisfy this condition.
The genetic contributions from the regions were scaled so that vr = var [vec(R)] =
2%. When considering the general-GxC case, to limit the extent of rescaling-GxC, we
rescaled each column of R to have variance 2%.
Similar to the simulation strategy described in Section 3.2.2, the effects from popu-
lation structure and unobserved covariates were generated as the sum of a shared and
an independent component across contexts.
G = G(s) +G(i) (4.29)



















whereM ∈ RN×K is the design matrix of the hidden confounders, R denotes the global










αG,γG,αH,γH ∼ Uniform(0, 1) (4.36)
Mi,j ∼ N (0, 1) i = 1, . . . , N, k = 1, . . . ,K. (4.37)
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Denoting with α the fraction of shared signal and with β the fraction of residual variance




















= (1− α)β(1− vbg − vr) (4.41)
var [vec(Ψ)] = (1− β)(1− vbg − vr) (4.42)
Unless specified otherwise, we considered the default values vr = 2%, vbg = 40%,
α = 0.6 and β = 0.5. When simulating scenarios with rescaling-GxC we varied the
number of causal variants (Sr) and proportionality factor of the effects in the two
contexts (η, which quantifies the extent of rescaling). When simulating general-GxC
(rescaling-GxC + heterogeneity-GxC) we varied the number of causal variants (Sr) and
the range of correlations between the genetic effects in the two contexts ([ρm, ρM ]),
thereby varying the extent of heterogeneity-GxC. A summary of the parameter values
used in simulations is provided in Table C.2.
4.2.2 Illustration case
To illustrate the ability of the proposed set tests to detect and characterise associ-
ated loci, we considered a sliding-window analysis using simulated data (Fig. 4.3).
Genetic effects for a quantitative trait in two contexts were generated from three non-
overlapping causal regions (each with size 30 kb) selected from a 5 Mb genomic portion
on chromosome 13. In particular, we simulated a region with persistent effects, a region
with rescaling-GxC effects and a region with heterogeneity-GxC effects (Fig. 4.3a-b).
The variance explained by of the region was set to 5%. We then applied mtSet, iSet
and iSet-het considering a sliding-window analysis in the 5 Mb region (30kb windows,
15kb step). The three tests accurately resolved the genetic architectures at the three
causal loci (Fig. 4.3d-e). Indeed, the association test (mtSet) detected genetic effects
in all three regions, the interaction test (iSet) revealed GxC interactions in the second
and the third regions while the test for heterogeneity-GxC (iSet-het) only detected
the third region. For comparison, we also considered a conventional multi-trait linear
mixed model (Korte et al., 2012) to test for association (mtLMM) and GxC interac-



















































































Figure 4.3: Illustration of iSet using simulated data. We simulated trait mea-
surements in two contexts with genetic effects from three distinct polygenic loci. (a)
Schematic representation of the architecture of the three simulated regions. (b) Simu-
lated effect sizes on the trait in two contexts. (c) Manhattan plots for results from a
single-variant LMM (Korte et al., 2012) to test for associations (mtLMM) or interac-
tions (mtLMM-int). Horizontal lines correspond to the α = 0.10 significance threshold
(Bonferroni adjusted). (d) Manhattan plots for results from set test methods, testing
for associations (mtSet), interaction effects (iSet) and heterogeneity-GxC effects (iSet-
het) in consecutive sets (30 kb regions; step size 15 kb). P values of set tests are bound
(> 10−6) by the number of null LLR samples used to estimate significance levels. (e)
The proportion of variance that could be attributed to persistent effects, rescaling-GxC
and heterogeneity-GxC, considering the same regions as in (c-d).
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4.2.3 Calibration of P values
We assessed the calibration of the P values obtained from iSet and iSet-het by simulat-
ing only persistent polygenetic effects (no interactions). This analysis was carried out
on 100,000 randomly selected 30kb regions. For each region, we generated phenotype
values across two contexts, simulating persistent effects from four causal variants and
tested for interaction (iSet) and heterogeneity-GxC (iSet-het). P values were estimated
using 30 parametric bootstraps for each region/test, resulting in a total of 3,000,000
null LLRs to estimate empirical P values. The QQ plots for iSet and iSet-het of the
obtained P values are shown in Fig. 4.4a.
Analogously, we assessed the calibration of iSet-het when simulating rescaling-GxC
effects. To do so, we pooled results from iSet-het across all the simulations with pure
rescaling-GxC that were considered in power simulations (see next section). The re-
sulting QQ plot is shown in figure Fig. C.1.
4.2.4 Power comparison
To assess power of iSet for alternative local genetic architectures, we simulated inter-
action effects in a 30kb region either considering rescaling-GxC effects or general-GxC
effects. We compared iSet to the single-variant interaction tests discussed in Section
2.4.3 (mtLMM-SV-int, Korte et al., 2012) using an implementation in LIMIX (see
Section 5.2.2, Lippert et al., 2014c). To obtain region-based P values, we used the min-
imum P value across all the variants in the region, following adjustment for multiple
testing. We considered two alternative strategies for this adjustment, i) a conservative
Bonferroni approach and ii) eigenMT (Davis et al., 2016), which estimates the number
of effect independent tests based on the local linkage disequilibrium (LD, see Section
2.2.2). Fig. C.2 shows a comparison between the number of variants and the number
of effective tests estimated from eigenMT, considering 10,000 30kb-sized regions used in
the power simulations (the same comparison is shown also for the other two genotype
data considered in this chapter). Note that existing set-based interaction tests cannot
be applied to complete designs and hence were not considered (see Section 4.1.4). To
obtain P values for iSet and iSet-het we considered 30 parametric bootstraps for each
region and computed empirical P values from the 30,000 null LLRs generated in each
simulated scenario. For each parameter setting, we considered 1,000 repeat experi-
ments. We used the Benjamini-Hochberg (BH) procedure to adjust for multiple testing
across repeat experiments for each method, and assessed different methods in terms of

























































Figure 4.4: Simulated data to assess power and calibration of iSet. (a) QQ plot
for the P values obtained by iSet and iSet-het when only persistent genetic effects were
simulated. (b) Comparison of the power for detecting genetic interactions on simulated
data with rescaling- GxC effects (without heterogeneity-GxC) and for increasing num-
bers of simulated causal variants. Considered were iSet and a single-variant interaction
test (mtLMM-int), using two alternative approaches to adjust for multiple testing of
single variants (Bonferroni or eigenMT). (c) Lower panel: power comparison as in (b),
varying the factor of proportionality of the variant effect sizes between contexts; top
panel: average fraction of genetic variance explainable by persistent, rescaling-GxC
and heterogeneity-GxC effects. (d) Analogous comparison as in (c) when simulating
heterogeneity-GxC effects and varying the correlation of the total genetic effect be-
tween contexts. Additionally, iSet-het was used to test for heterogeneity-GxC, which
was best powered for large simulated heterogeneity-GxC effects (i.e. low correlation
of context-specific genetic signals). White stars indicate default parameter values that
were kept constant when varying other parameters for simulated rescaling-GxC (Table
C.2).
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Scenarios with rescaling-GxC. Initially, we considered scenarios with only rescaling-
GxC. Varying the number of causal variants in the region (from 1 to 20; Fig. 4.4b),
we found that iSet was better powered than single-variant models when multiple causal
variants were simulated (Fig. 4.4b). We then varied the extent of rescaling-GxE ef-
fects, which can be controlled using the proportionality factor of the effect sizes between
contexts (η, see Section 4.2.1). Negative rescaling (η < 0, negative x-axis in Fig. 4.4c)
corresponds to opposite directions of the polygenic effects in the two contexts while
η = 0 corresponds to an effect that is specific to one of the two contexts. The limit
η → 1 corresponds to the setting with no rescaling, which is equivalent to a scenario of
persistent effects across contexts. As expected, all models were best powered for larger
rescaling constants and for effects with opposite directions (Fig. 4.4c).
Scenarios with heterogeneity-GxC. We then considered simulated scenarios with
both rescaling-GxC and heterogeneity-GxC effects and varied i) the extent of simulated
heterogeneity-GxC (Fig. 4.4d) and ii) the total number of causal variants (Fig. C.3).
To control the extent of heterogeneity-GxC in Fig. 4.4d, we monitored the correlation ρ
between the simulated genetic signals from the causal region across the two contexts (see
Section 4.2.1). Low to moderate genetic correlations correspond to larger heterogeneity-
GxC effects, whereas strongly correlated signals (ρ ≈ ±1) cannot be distinguished from
either negative rescaling-GxC effects (for ρ ≈ −1) or persistent genetic effects (for
ρ ≈ 1). We considered iSet-het to test for heterogeneity-GxC, which was best powered
in regimes of low to moderate correlation between genetic effects (power > 60% for
r2 < 0.16, Fig. 4.4d). Simulations with larger number of causal variants suggest that
iSet robustly detects heterogeneity-GxC Fig. C.3.
Comparison with a baseline test for heterogeneity-GxC. To study the accu-
racy of iSet-het to detect heterogeneity-GxC, we also compared iSet-het with a with a
baseline method for detection of heterogeneity-GxC. This method, which we denote as
uLMM-het, assigns a heterogeneity-GxC score to genetic regions based on the P values
from a univariate LMM and LD information. The scoring strategy is described in the
following.
• For regions that fail marginal significance in at least one context, uLMM-het as-
signs a heterogeneity-GxC score of 0. Marginal significance is assessed using a
region-based P value, obtained as the P value of the lead variant from a stan-
dard LMM after adjustment for multiple testing using Bonferroni. The intuition
behind this scoring rule is that the detection of a significant association in both
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contexts is a necessary condition to reveal heterogeneity-GxC effects.
• For regions with significant marginal associations in both contexts, uLMM-het
assigns a heterogeneity-GxC score of 1 − R2, where R2 is the squared Pearson
correlation between the per-context lead variants.
Intuitively, uLMM-het assigns a high heterogeneity-GxC score only to regions with
significant per-context lead variants that are in low LD. For iSet-het, we used the LLR
as a score for heterogeneity-GxC.
We used the two methods to score the 20,000 regions considered in the power
simulations (Fig. 4.4c and Fig. 4.4d), half of which harbours heterogeneity-GxC ef-
fects. Ranking was assessed using both the receiver-operating characteristic (ROC)
and precision-recall (PR) curves (Fig. C.4). For uLMM-het, we considered alter-
native significance thresholds on region-based P values (P < 0.5, 0.01, 0.01, 0.001).
This experiment confirmed that iSet-het is substantially more accurate for identify-
ing heterogeneity-GxC than this basic univariate approaches.
4.2.5 Variance decomposition
We also investigated the proportion of local genetic variance that can be explained by
a model with either persistent, rescaling-GxC or heterogeneity-GxC effects (see Section
4.1.3), when considering different simulated settings (Fig. 4.4c-d). A persistent effect
model could capture large proportions of the simulated genetic variance, even in the
presence of positively correlated GxC, but could not capture variance due to GxC
effects with negative rescaling. An LMM that models rescaling-GxC did account for
negative and positive rescaling and captured a substantial part of the heterogeneity-
GxC effects (Fig. 4.4d). Finally, variance contributions that were exclusively captured
by a heterogeneity-GxC model were largest for uncorrelated context-specific genetic
effects, the same regime where the corresponding test was best powered. We also
confirmed that the most general model (i.e., with a full rank trait covariance in the set
term) yields unbiased estimates of the total genetic variance in genomic regions, whereas
other models yielded biased estimates for some of simulated architectures (Fig. C.5).
4.3 Analysis of stimulus-specific eQTLs in monocytes
As a first application to real data, we considered a monocyte stimulus eQTL dataset (Fair-
fax et al., 2014). In the primary analysis, Fairfax et al. (2014) mapped cis and trans
eQTLs in purified monocytes from 432 healthy Europeans after exposure to interferon-γ
93
(IFN) for 24 hours and lipopolysaccharide for 2 hours (LPS-2h) or 24 hours (LPS-24h).
Mapping genetic effects in stimulated immune cell types is important to characterise
the genetic component of common disorders associated with a malfunctioning of im-
mune activity and inflammation, e.g. atherosclerosis, inflammatory bowel disease and
cancer (Fairfax et al., 2014). The study revealed master trans-eQTL regulators and
characterised the molecular mechanism underlying GWAS loci associated with inflam-
matory diseases. Here, we focus on the local (cis) genetic architecture of gene expres-
sion and how genetic effects change across different cellular contexts. To do so, we
performed a naive/stimulus pairwise analysis for each of the three stimulated states
(i.e. naive/IFN, naive/LPS-2h and naive/LPS-24h; see also Fig. 4.5a).
4.3.1 Data preprocessing
Gene expression levels in the naive state, and after exposure to IFN, LPS-24h and LPS-
2h were available for 414, 367, 322 and 261 individuals respectively. Normalisation,
correction for batch and probe filtering were performed by Fairfax et al as described in
the primary study. We discarded probes that did not have an associated ENSEMBL
ID, resulting in 12,661 probes for analysis (out of 15,421). We further limited analysis
to the 288 individuals for which gene expression levels were available in all the four
cellular contexts. To account for hidden covariates and confounding factors, we applied
PEER (Stegle et al., 2012) with default parameter values, fitting 30 hidden factors
across all samples (individuals and stimulus states). PEER residuals for each gene and
context were quantile-normalised to a unit variance normal distribution and used for
all subsequent analysis.
4.3.2 Mapping of associations and interactions
For each of the 12,661 probes, we used iSet to test for pairwise interaction effects, consid-
ering the naive monocyte state and each stimulus condition in turn, performing a single
test using proximal (putatively cis acting) variants in a 100 kb region centred on the
transcription start site. We tested for cis associations (mtSet), GxC interactions (iSet)
and heterogeneity-GxC (iSet-het). For comparison, we applied single-variant tests in
the same regions, testing for association (mtLMM) and GxC interaction (mtLMM-
int). For single-variant tests, we estimated gene-level significance using the P value of
the lead cis variant adjusted within cis regions using eigenMT, Brown et al., 2016.
Empirical P values for mtSet, iSet and iSet-het were estimated from 30 permutation-
s/parametric bootstraps per-gene and stimulus, combining all null LLRs across genes
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bAssociation test Interaction test Het-GxC test
Contexts mtLMM mtSet mtLMM-int iSet iSet-het
IFN / naive 5,126 5,858 1,135 1,402 399
LPS-2h / naive 4,957 5,715 1,474 1,862 475
LPS-24h / naive 5,040 5,820 1,122 1,391 407



























Figure 4.5: Analysis of stimulus-specific eQTLs in monocytes. (a) Number
of probes with at least one significant cis association (Association test) or genotype-
stimulus interaction (Interaction test) for alternative methods and stimulus contexts.
Considered were the proposed set tests (mtSet, iSet, iSet-het) as well as single-variant
multi-trait LMMs (mtLMM, mtLMM-int), testing for genetic effects in cis (100kb re-
gion centred on the transcription start site; FDR < 5%). Additionally, iSet-het was
used to test for heterogeneity-GxC effects. Individual rows correspond to different
stimulus contexts with "All" denoting the total number of significant effects across
all pairwise analyses. (b) Venn diagram of significant effects detected by alternative
methods and tests (across all pairwise analyses). (c) Bivariate plot of the variance at-
tributed to persistent genetic effects versus genotype-stimulus interactions for all probes
and stimuli. Significant interactions are shown in red. Density plots along the axes
show the marginal distributions of persistent genetic variance (top) and variance due
to interaction effects (right), either considering all (black) or the subset of probe/stim-
ulus pairs with significant interactions (red). (d) Average proportions of cis genetic
variance attributed to persistent effects, rescaling effects and heterogeneity-GxC, con-
sidering probes/stimuli with significant cis effects (5% FDR, mtSet) and stratified by
increasing fractions of the total cis genetic variance. Shown on top of each bar is the
number of instances in each variance bin. The top panel shows density of genes as a
function of the total cis genetic variance.
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(resulting in 379,830 null LLRs per stimulus and statistical test, see Section 4.1.2).
Results from all methods were adjusted for multiple testing across genes using the BH
procedure applied to each naive/stimulus analysis separately. We defined significant
associations, interactions and heterogeneity-GxC effects at genome-wide FDR < 5%
(Fig. 4.5a).
Although many of the genes with significant associations from single-variant and set-
based tests were consistent (Fig. 4.5b), set tests offered increased power for detecting
both associations and interactions (24.8% power increase for interactions; 4,655 versus
3,731 probes and stimuli with an interaction; FDR < 5%, Fig. 4.5a, Fig. C.6).
Additionally, iSet-het yielded 1,282 genes with heterogeneity-GxC effects (Fig. 4.5a-
b). This suggests that GxC effects are frequently associated with different regulatory
architectures between contexts, which is consistent with previous reports (Fairfax et al.,
2014).
Although on average the proportion of variance explained by GxC tended to be
smaller than for persistent effects (median 4.0% for GxC versus median 10.4% for
persistent effects, for genes with significant GxC, Fig. 4.5c), GxC was the dominant
genetic source of variation for 11.7% of the significant cis eQTLs (Fig. 4.5d; defined
as explaining 50% or more of the cis genetic variance). Consistent with previous
reports (Gagneur et al., 2013; GTEx Consortium, 2015), we observed that genes with
large relative GxC effects were associated with weak overall cis effects, whereas large-
effect eQTLs tended to be persistent across the jointly analysed contexts (Fig. 4.5d).
4.3.3 Mechanistic underpinning of heterogeneity eQTLs
Heterogeneity eQTLs correspond to weakly correlated polygenic signal across
contexts. We expect that heterogeneity eQTLs are associated to i) marginally signif-
icant genetic effects in both the analysed contexts and ii) weakly correlated polygenic
signals. To test this hypothesis we applied a univariate set test (stSet, see Section
3.1.1) to each cellular context independently, considering the same cis genetic regions.
For each gene and naive/stimulus pair,
1. the strength of the marginal associations was quantified as the -log10 of the max-
imum stSet P value across the jointly analysed contexts (after adjustment for
multiple testing across genes using BH);
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2. the correlation between polygenic signals was estimated as the correlation between
the cis Best Linear Unbiased Predictors (BLUP) from stSet3 across the jointly
analysed contexts.
Fig. 4.6 shows a scatter plot across all genes and probe/stimulus pairs of these two
quantities. Heterogeneity eQTLs are coloured in red. The results show very clearly that
heterogeneity eQLTs correspond to instances where marginal associations are strong
and polygenic signals are weakly correlated across contexts, which confirms our hy-
pothesis.
Figure 4.6: Heterogeneity eQTLs correspond to significant marginal associa-
tions and weakly correlated polygenic signals. Scatter plot across all probe/stim-
ulus pairs of the maximum adjusted P value between the naive state the corresponding
stimulated state versus the correlation of the BLUP across the two contexts. Het-
erogeneity eQTLs are highlighted in red. The figure clearly shows that heterogeneity
eQTLs are association to strong marginal associations with weakly correlated polygenic
signals between the two contexts.











(y − F bˆ),
where ·ˆ denotes the restricted MLE of the corresponding parameter. See also description in Section
2.3.6.
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Heterogeneity eQTLs are associated with complex genetic architectures.
Next, we assessed whether classes of genes with significant associations, interactions
and heterogeneity-GxC effects were associated with different complexities of the ge-
netic architecture, i.e. different numbers of independent associations. To estimate
the number of independent genetic effects (up to three), we applied a single-variant
step-wise selection LMM (Segura et al., 2012) to each gene and context independently.
Briefly, we considered iterative analyses in the region of interest, where in each step the
lead variant from the previous step is added in the model as an additional fixed effect
covariate. For each context, region-based P values were adjusted for multiple testing
across genes using the BH procedure for each of the three steps. We assessed marginal
significance and counted the number of signals at FDR<0.05. This analysis yielded
12,371, 1,646 and 123 instances (across all genes and contexts) with one, two or three
associations respectively.
Fig. 4.7 shows the cumulative fraction of different classes of probe/stimulus pairs
(all genes and those with association, interaction and heterogeneity-GxC) with the av-
erage numbers of independent associations across the jointly analysed contexts. As
expected, genes with significant heterogeneity-GxC were more likely to harbour multi-
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Figure 4.7: Cumulative fraction of gene/stimulus pairs with increasing num-
bers of distinct univariate eQTLs for different gene sets. Shown are the frac-
tions for all probe/stimulus pairs (All), probe/stimulus pairs with significant cis asso-
ciations (mtSet), probe/stimulus pairs with significant GxC (iSet) and instances with
significant heterogeneity GxC (iSet-het) with the average numbers of distinct univariate
eQTLs from a step-wise selection across the corresponding naive/stimulated state.
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Breakdown of heterogeneity eQTLs into different classes. We then used a
simple method based on the summary statistics from the step-wise analysis and LD
information to define different classes of context-specificity and annotate heterogeneity
eQTLs.
For each gene/stimulus pair, cases with significant marginal associations in both
contexts and context-specific lead variants in low LD (R2 < 0.20) were associated to a
change in the lead variant (Fig. 4.8a). For cases with significant marginal associations
in both contexts and a shared lead eQTL (lead variants R2 > 0.80), we annotated
context-specific secondary effects when either i) the secondary effect was significant in
only one of the two contexts or ii) the context-specific lead variants of the secondary
signal were in low LD (R2 < 0.20). We find 1,218 gene/stimulus pairs associated with
a shift in the lead variant and 3,874 gene/stimulus pairs associated with shared effects,
with 700 cases having context-specific secondary eQTLs.
Overlaying heterogeneity eQTLs with these different classes, we attributed 42%
of the heterogeneity-GxC effects (542 out of 1,282) to context-specific lead variants
(Fig. 4.8a-b). For an additional 13% of the heterogeneity eQTLs (165 out of 1,282)
we found context-specific secondary effects (Fig. 4.8a,c). Interestingly, the remaining
574 heterogeneity eQTLs (45%) could not be annotated using the considered single-
variant approach. For 46% of the heterogeneity-GxC cases without clear single-variant
interpretation (266 out of 574), the lead variants from the single-variant LMM were
marginally significant but in weak linkage (0.2 < R2 < 0.8, see example in Fig. 4.8d).
These were also cases where it is hard to assess the presence of independent genetic
signals using exclusively single-variant methods. The annotation of heterogeneity-GxC
eQTLs may also be hampered by the lower power of the univariate approach in com-
parison with iSet, which integrates across multiple variants and contexts (Flutre et al.,
2013). Indeed, we find that for another 30% of the instances without annotation (176
out of 574) the single-variant method did not detect a significant association in at least
one of two jointly analysed contexts (Fig. C.7).
4.3.4 Note on opposite effects
Finally, we tested whether polygenic signals with opposite effects across contexts are
associated with heterogeneity-GxC. We classified the 3,874 instances with significant
marginal associations in both contexts and a shared lead eQTL (lead variants R2 >
0.80) into same-direction and opposite-direction eQTLs. The classification was based on
the sign of the correlation of the genetic effects across contexts, defined as sign (β1β2corr (g1, g2))
where g1 and g2 are the genotypes of the lead-variants and β1 and β2 their effect sizes
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Figure 4.8: Characterisation of genes with significant heterogeneity GxC for
stimulus eQTLs in monocytes. (a) Breakdown of 1,282 probe/stimulus pairs with
significant heterogeneity GxC into different classes using a single-variant step-wise
LMM. (b-d) Manhattan plots for representative genes with significant heterogeneity
GxC. The gene body is shown as grey box. (b) Manhattan plot (left) and r2 statistics
for variants in both contexts (right) for the gene SLC1A4. Dark circles indicate distinct
lead variants in both contexts (R2<0.2). (c) Manhattan plot from the second step of
the step-wise selection analysis for the gene PROK2. The start symbol indicates the
shared lead variant in both contexts. The single- variant analysis reveals a secondary
association signal that is specific to the naive state. (d) Analogous plot as in c for the
gene NSUN2, which could not be interpreted using single- variant analyses.
respectively. These criteria led to the identification of 53 opposite-direction eQTLs
and 3,821 same-direction eQTLs across all naive/stimulus analysis. Notably, iSet-het
detected significant heterogeneity-GxC for 11 of the opposite-direction QTLs, a 3.6
fold enrichment (P < 10−3, one-sided Fisher’s exact test) compared to eQTLs with
consistent effect directions between contexts (261 gene/stimulus pairs with significant
heterogeneity-GxC out of 3,821 eQTLs with consistent direction). There is a concern
that the heterogeneity-GxC tests are not independent as a consequence of the fact that
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the naive state is considered in all pairwise analyses. To address this we repeated the en-
richment analyses for each naive/stimulus pair independently. Results are summarised
in Table C.3. For naive/IFN, naive/LPS2 and naive/LPS24 we find a fold enrichment
of 5.2 (P < 0.05), 1.11 (P = 0.56) and 7.2 (P < 10−3). Taken together, these results
suggest that changes in the configuration of causal variants may underly a substan-
tial fraction of seemingly opposite-direction cis eQTLs, a result that is consistent with
recent findings (GTEx Consortium, 2015). Interestingly, among the genes that were
identified as opposite-effect eQTLs in the primary analysis of the same data (Fairfax
et al., 2014) we found three cases with strong heterogeneity-GxC signal (OAS1, LMNA
and PTK2B ; see Fig. C.8).
4.4 Extension to analysis of stratified designs
Thus far, we have focused on settings with repeat measurements, where the same trait
is observed in all individuals and contexts. I here discuss applications of iSet to studies
where each individual is phenotyped in only one context. This scenario occurs when































Figure 4.9: Alternative study designs supported by iSet. iSet supports efficient
interaction set tests both for datasets with complete designs (where each individual
is phenotyped in all analysed contexts, (a), and stratification analyses (where each
individual is phenotyped in only one of the analysed contexts, (b).
After deriving the model in Section 4.4.1, I discuss validation in simulations in
Section 4.4.2. Finally, in Section 4.4.3 I discuss application to a gene-by-sex interaction




Let us consider a dataset with N unrelated individuals in C = 2 contexts. If trait
observations are available in all individuals and contexts we can consider the model
vec (Y ) ∼ N
(
vec (FB) ,Cr ⊗GG> +Cn ⊗ I
)
(4.43)
where Y is the N×C phenotype matrix, F ∈ RN×K the design matrix of K fixed effect
covariates, B ∈ RK×C their effect sizes and G the N×R standardised genotype matrix
for R variants and Cr and Cn are C×C covariance matrices. Note that in Eq (4.43) we
did not consider a relatedness component. Similar to the mtSet-PC model (see Section
3.1.4), population structure can be accounted for by introducing the first principal
components of the RRM as fixed effect covariates. This assumption is necessary to
derive an efficient inference scheme for stratification analyses.
Let us consider the case where the first N1 < N individuals have been phenotyped
in one of the contexts while the remaining N2 = N −N1 have been phenotyped in the
other context. It is convenient to introduce the extended N × N context covariance
matrices C˜r and C˜n for the set and noise component respectively as
C˜r n1,n2 = Cr e(n1),e(n2) (4.44)
C˜n n1,n2 = Cn e(n1),e(n2) , (4.45)
where e : n ∈ [1, N ] −→ e(n) ∈ {1, 2} is an indicator function that returns the context






∈ RN×2K . (4.46)
Denoting with y ∈ RN the vector of the observed trait measurements, marginalising
out the unobserved trait measurements in the model in Eq (4.43) results in
y ∼ N
(
Xb, C˜r GG> + C˜n  I
)
, (4.47)
where we set b = vec (B). This model has two important properties:
1. The first covariance term can be written as a low-rank covariance







 (11×2 ⊗G) (4.48)
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where ei = e(i) i = 1, . . . N , and
rank(C˜r GG>) = rank(Cr) ·R, (4.49)
assuming rank(Cr)R < N .
2. The likelihood does not depend on the off-diagonal elements of C˜n4 and hence
without loss of generality, we can consider a diagonal matrix for the noise covari-
ance.



















with σ21 and σ22 denoting the context-specific noise variances. Note that in the model
in Eq (4.50) the total covariance is the sum of a low-rank and a diagonal matrix. This
allows us us to reduce the naive O(N3) complexity to O(NR2 + NK2 + R3 + K3) as
shown in Section A.6.
Single-variant models for stratification analysis. For comparison, we considered













where g ∈ RN denotes the genotype vector of the variant to be tested, e is a binary
indicator specifying in which context the phenotype has been observed, α is the fixed
effect of the context variable, β the fixed effect of the genetic variant and γ the fixed
effects of their interaction. The test for interaction corresponds to testing for γ 6= 0.
Following Korte et al. (2012) and Furlotte and Eskin (2015), the total covariance matrix
4This can be easily understood from the fact that in a stratified design there are no repeat trait
measurements of the same individuals across contexts so that the residuals correlation across contexts
cannot be estimated.
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is estimated under the no-association model while for single-variant testing only the
total variance is updated (see also Section 2.4.4).
4.4.2 Simulations
To study the performance of iSet when considering interaction analyses of stratified pop-
ulations, we carried out simulation experiments analogous to those considered for fully
observed designs (Section 4.4). We generated a synthetic cohort of 2,000 Europeans
using the strategy described in Section 3.2.1 (dataset simPopStruct). The context in
which each phenotype was observed was independently sampled from a Bernoulli dis-
tribution with rate 50%. Population structure was accounted for including the first
ten principal components of the RRM as fixed effect covariates. We did not consider
tests for heterogeneity-GxC, as differential tagging of causal variants could potentially
result in spurious heterogeneity-GxC signals, and hence additional controls would be
required.
We compared iSet to the single-variant interaction test for incomplete designs intro-
duced in the previous section and the gene-environment set association test described
in Section 4.1.4 (GESAT, Lin et al., 2013). The latter approach is representative for a
family of very similar set tests that can only be applied to test for interaction effects
in stratified populations. GESAT was run using the function GESAT of the pack-
age iSKAT version 1.2. Both iSet and GESAT were applied on identically processed
standardised variants. Results are shown in Fig. 4.10.
We again confirmed statistical calibration of iSet and found similar power benefits
as for complete designs. Notably, iSet was consistently better powered than GESAT,
most likely because GESAT does not explicitly model correlations of the local genetic
effect between contexts (see Section 4.1.4). Surprisingly, the single-variant interaction
test performed slightly better than iSet and GESAT in the range of positive correlations
when general-GxC was simulated (Fig. 4.10d).
4.4.3 Application to gene-by-sex interaction analysis in lipid traits
Next, we applied iSet to a genome-wide analysis of genotype-sex interactions in the
same four lipid-related traits we considered in Section 3.3.1 (fasting HDL and LDL
cholesterol levels, triglycerides and C-reactive protein). Note that while in Section 3.3.1,
we considered a multi-trait analysis across the four traits, here we perform a gene-sex
interaction analysis independently for each of these trait. The data were preprocessed
as described in Section 3.3.1. Similar to the multi-trait analysis, we tested consecutive
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Figure 4.10: Simulated data to assess power and calibration of iSet for analy-
ses of stratified designs. (a) QQ plot for the P values obtained when applying iSet
and GESAT to synthetic datasets where only persistent genetic effects were simulated.
(b-d) Power comparison of iSet and alternative methods using simulated data where
each individual is phenotyped in one of two contexts. Shown are power comparisons for
alternative methods, analogous to Fig. 4.4. (b) Power to detect genetic interactions
when simulating rescaling-GxC for increasing numbers of causal variants. (c) Power
comparison when varying the factor of proportionality of the variant effect sizes be-
tween contexts. (d) Power comparison when varying the correlation of the simulated
genetic effects. We considered iSet, a single-variant interaction test (mtLMM-int, [10])
as well as the interaction sequence kernel association test (GESAT, Lin et al., 2013), a
set test designed for stratified populations. For single-variant models, two alternative
adjustments for multiple testing were considered (Bonferroni, eigenMT).
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100kb regions for genotype-sex interactions with a step size of 50kb. We considered both
the association set test (mtSet) and the interaction set test (iSet), which we compared
to a single-variant interaction test (mtLMM-int), GESAT and a univariate set test
without stratification by sex (stSet). In order to correct for population structure we
considered the first ten principal components of the RRM as fixed effect covariates. For
each window we considered 100 permutations for mtSet and stSet and 100 parametric
bootstraps for iSet. The obtained null LLRs were combined across windows and traits
for each method to obtain empirical P values. Significance of the considered statistical
tests was assessed at FWER=10%. Manhattan plots and QQ plots for all methods are













Figure 4.11: QQ-plot of P values from genotype-sex interaction tests for C-
reactive protein levels considering different methods. QQ-plot of P values
from genotype-sex interaction tests for C-reactive protein levels in individuals from the
Northern Finland Birth Cohort Study considering iSet, a single-variant interaction test
(mtLMM-int) and the interaction sequence kernel association test (GESAT).
iSet retrieved one genome-wide significant interaction effect (C-reactive protein,
chr1:40,450,000; P = 1.47 · 10−6; FWER < 10%), whereas alternative set tests and
single-variant models did not yield any significant effect (Fig. 4.11, Fig. C.9 and
Fig. C.10). There may be a concern that the reduced power of a single-variant inter-
action test is due to poor tagging of genetic signals from the sparse genotype in the
NFBC1966 cohort. To explore this, we imputed genotype data in the region using the
1000 Genomes Project phase 3 reference panel in a 5Mb region centred in the associ-
ation found by iSet. After aligning the dataset to the reference panel, we ran shapeit
v2.r727 (Delaneau et al., 2014) with the recommended parameters to estimate haplo-
types. We then used impute2 v2.3.2 (Howie et al., 2012) with the recommended param-
eters to impute untyped genotypes. Notably, the single-variant approach mtLMM-int
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did not identify significant associations on imputed data (Fig. C.11).
The interaction found by iSet on chromosome 1 is within 400 kb from a replicated
locus identified in a large meta-analysis (66,185 individuals, P < 6·10−11 Dehghan et al.,
2011). This study also reported a marginally significant interaction effect with sex at
the same locus (P < 5 · 10−3). This replication is encouraging, however further work is
required to assess whether the polygenic locus identified by iSet and the GWAS variant
underlie the same causal variant. Finally, a local single-variant analysis, separately for
female and male individuals, provided evidence that this interaction most likely reflects
a male-specific genetic effect (Fig. C.12).
iSet revealed a second suggestive interaction with sex for LDL cholesterol levels
(chr3:121,850,000, Fig. C.9). Although this effect failed genome-wide significance
(FWER<20%, iSet), iSet again provided stronger statistical evidence than other ap-
proaches (PiSet = 3.7 · 10−6, PGESAT = 4.8 · 10−6, PmtLMM-int = 3.2 · 10−5). Among
the genes at this locus is ADCY5, which has been linked to blood glucose levels in
large meta-analysis (Dupuis et al., 2010; Saxena et al., 2010) and hence is a plausible
candidate to affect LDL via glucose regulation (Otero et al., 2002).
Finally, we note that stratification of quantitative traits by context can also be
used to increase power for detecting associations rather than interactions, which is
similar to previous strategies applied in the context of single-variant analyses of quan-
titative (Kim et al., 2014) and categorical traits (Gauderman et al., 2013; Morris et
al., 2010). Using this approach, we identified three additional associations when us-
ing mtSet on sex-stratified individuals, which were missed by standard set tests and
other methods (Fig. C.9). These include the same locus with a sex-specific effect on
C-reactive protein (P = 1.42 · 10−7 using mtSet, P = 1.89 · 10−3 using a standard set
test) and an association for HDL cholesterol levels and triglycerides, loci that harbour
two replicated associations (Sabatti et al., 2009; Kraja et al., 2011).
The interaction and association loci discussed here are highlighted in the Manhattan
plots in Fig. C.9. A tabular summary is provided in Table C.4.
4.5 Summary and discussion
In this chapter, I have presented iSet, a method based on linear mixed-models to test for
gene- context interactions using variant sets. On simulated data we have shown that
iSet offers power advantages compared to previous methods. Additionally, we have
shown that set-based models are effective for disentangling the genetic architecture of
interaction effects, differentiating between consistent changes in genetic effects between
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contexts and changes in the configuration of causal variants. The underlying test for
heterogeneity-GxC we propose is related to co-localization tests (Wallace, 2013; Wallace
et al., 2012; Fortune et al., 2015), however with an opposite objective.
In an application to a stimulus eQTL study, we have shown that approximately 25%
of the gene-stimulus interactions are associated with significant heterogeneity-GxC.
This suggests that complex changes in the genetic architecture between cellular contexts
are relatively frequent. Additionally, we have observed that genes with opposite effects
are enriched for heterogeneity-GxC. This finding points to a possible bias, whereby
opposite effects identified using single-variant models may in part be due to context-
specific causal variants that are tagged by a common lead variant.
The proposed iSet model is not free of limitations. First, scalable inference in our
model requires low-rank assumptions, meaning that the number of variants in the anal-
ysed region is small compared to the number of individuals. Similar to mtSet, there
may be trade-offs between the size of variant sets and the number of samples, in partic-
ular for densely imputed or sequenced cohorts. The inference scheme we have derived
is efficient if phenotypes are either observed in all contexts and individuals or, alterna-
tively, if a cohort has been stratified using a context variable. Intermediate designs can
also be handled but currently require the use of separate imputation schemes (Dahl et
al., 2016). It is also worth noting that the test for heterogeneity-GxC (iSet-het) will be
most accurate if all individuals are phenotyped in each context. Although in principle
the model can also be used in stratified designs, there may be concerns that heterogene-
ity results from technical factors, for example due to differences in genotyping accuracy
or variant allele frequencies in the corresponding sub populations.
Finally, although iSet is general, we here have focused on the pairwise analysis
of alternative contexts. By jointly analysing multiple, related context and traits, it
would be possible to obtain a more comprehensive picture by discerning the regulatory
architectures within regions. Extensions of iSet in this direction are an area of future
work.
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5 | Flexible LInear MIXed models
Although a substantial number of different genetic analyses can be cast within the
linear mixed model (LMM) framework, most efficient software implementations are
designed for solving a narrow set of tasks. One reason for this is a trade-off between
flexibility and computational efficiency, whereby efficient LMM implementations are
specialised to exploit algebraic properties that are specific to the considered model.
The design of software that enables flexible modelling while retaining computational
efficiency whenever possible, is challenging. In this chapter, I discuss LIMIX, a frame-
work for LInear MIXed models that aims at overcoming these challenges. LIMIX builds
on a flexible inference framework that allows designing Gaussian models with compos-
ite covariance matrices, encoded as functions of model parameters. Building on this
core structure, higher-level modules facilitate different single-trait and multi-trait ge-
netic analyses, including variance decomposition, single-variant tests, set-based tests
and genomic prediction models. All the models in this thesis, including those that we
considered for comparison, are implemented and available in LIMIX (with the exception
of the iSKAT model). The development of LIMIX was motivated by several applied
projects I have contributed to during my PhD. In these projects, I have designed, im-
plemented and validated customised genetic models to address specific analysis needs.
LIMIX has been used to perform different genetic analyses (Dubin et al., 2015a; Sasaki
et al., 2015; Kawakatsu et al., 2016; Horton et al., 2016; Sudmant et al., 2015; Märtens
et al., 2016; Baud et al., 2017; Schor et al., 2017; Cannavò et al., 2016; Chen et al.,
2016).
In Section 5.1, I discuss the core flexible framework for parameter inference. In
Section 5.2, I describe two high-level modules for specific genetic analyses: a module
for variance component analysis and a module for single-variant association testing for
the analysis of multiple traits. To demonstrate the utility of this software suite, in
Section 5.3, I describe two analyses from collaborative projects. Finally, in Section 5.4
I discuss some of the advantages and pitfalls of flexible modelling.
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5.1 A flexible inference framework for linear mixed models
A large range of genetic models for quantitative traits can be cast as
y ∼ N (Xβ, Kθ) , (5.1)
where y is the phenotype vector for N samples, X is the N × K design matrix of
K covariates, β is the vector of their effects and Kθ is the covariance function of the
Gaussian model, which specifies the covariances between observations as a function of
the model parameters θ (see also Section D.1). Given an arbitrary covariance function
Kθ, model parameters are typically estimated by maximising the restricted maximum
likelihood (Eq (A.7))
L = const− 1
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Importantly, parameter inference in LIMIX is conducted by providing computa-
tional efficiency if possible. This is achieved by
• exploiting the structure of Kθ,
• caching expensive computations during gradient-based parameter inference.
In the following, I discuss some of the implementation details of this inference frame-
work.
I wrote most of the source code underlying the inference framework, with contri-
butions from Danilo Horta and Barbara Rakitsch. In particular, Danilo Horta imple-
mented an automatised caching strategy (which I do not discuss here) and worked on
the testing and the deployment of the software.
5.1.1 Basic classes for inference
Within the LIMIX framework, the log (restricted) marginal likelihood (LML) is opti-
mised using a gradient-based method, which requires repeated evaluations of the LML
and its gradients (see Eqs A.7-A.8). Basic building blocks of these computations are
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implemented in different classes, which are responsible for computing and caching these
operations. The three basic classes for inference are:
• the mean term, which stores X, y and βθ and is responsible for computing and
caching all operations between these quantities;
• the covariance term, which is concerned with all the computations specific to
the covarianceKθ, including Cholesky decomposition, matrix inverse, eigenvalue
decomposition, log determinant (logdet) and gradients of the logdet (i.e. the trace
term in Eq A.8);
• the Gaussian process (GP, see Section D.1 for a brief description of Gaussian
processes), which governs the mean and the covariance terms. The GP evaluates
the LML and its gradients and is responsible for computing all the operations
that would involve cross talk between the mean term and the covariance term.
Note that the evaluation of the LML and its gradients requires the computation of
the inverse, the logdet and the gradients of the logdet of Aθ = X>K−1θ X (see Eqs
A.7-A.8). As all these methods are already defined within the covariance term, it is
convenient to introduce a derived covariance class, which we denote with Areml, that
takes care of all computations involving Aθ. Areml is defined in the initialisation of








y ⇠ N (X ,K✓)
Figure 5.1: Representation of the basic classes for inference in the LIMIX
framework. The figure illustrates the basic inference classes in the LIMIX framework
and their dependencies. The mean term takes care of the computations between y, X
and βθ, while the covariance term is responsible for all the computations concerning
the covarianceKθ. The Areml term is a derived covariance class, which takes care of all
the computations involving Aθ in Eqs (A.7-A.8). Using the building blocks provided
by the other classes, the GP allows for evaluating the LMM and its gradients and
interfaces with the optimiser.
There are two main advantages of considering such a hierarchical structure for
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inference. First, we can define derived classes of covariance terms and mean terms
so that some of their methods can be adapted to specific cases, thereby enabling us
to achieve faster computation (if possible, see Section 5.1.5). Second, we can define
derived covariance classes that combine two or more covariance terms1, for example,
as discussed in Section 5.1.2, we define the sum and the Hadamart combinator class.
Using this strategy, computations from low-level elements can be used by higher-level
elements, resulting in a hierarchical structure that promotes reusability of the code and
flexibility.
Gradient-based optimisation of the LML is performed considering the low-memory
Broyden-Fletcher-Goldfarb-Shanno algorithm (L-BFGS) (Liu and Nocedal, 1989; Zhu
et al., 1997), as implemented in the fmin_l_bfgs_b optimisation method in the SciPy
python library (Jones et al., 2001). Specifically, the optimiser interfaces with the GP,
which can evaluate the LML and its gradients. The GP communicates the updated
parameter values to the mean term and the (composite) covariance term, which in
turn propagates these updates to lower-level elements. After optimisation, standard
errors of the model parameters can be also retrieved (see Section D.3 for details).
A representation of the basic classes for inference and how they interact is given in
Fig. 5.1.
5.1.2 Covariance models
A covariance matrix is defined as a real-valued positive semidefinite matrix. Specifically,
a symmetric matrix A ∈ RN×N is positive semidefinite if and only if x>Ax ≥ 0
∀x ∈ RN . The set of covariance matrices is closed under basic operations, such as
matrix addition and Hadamart product. By exploiting this property, LIMIX provides
the user with the possibility to combine basic covariance models to define more complex
ones.
Basic covariance models. Basic covariance models include a fixed covariance (a pre-
defined covariance matrix with a scaling parameter), a low-rank covariance, a freeform
covariance (i.e. a general semi-definite positive matrix), a diagonal covariance, a squared
exponential covariance and others. Details on the parametrisation of the different co-
variance terms implemented in LIMIX are provided in Section D.2. For a comprehensive
review on covariance models, see Rasmussen (2006).
1While the same concept is applicable to mean terms, I do not discuss mean combinators here.
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Combining covariance models. LetK1θ1 andK2θ2 denote two N ×N covariance
matrices with parameters θ1 and θ2, respectively. The sum and the Hadamart product
of the two covariance terms
K
(sum)
θ = K1θ1 +K2θ2 (5.5)
K
(Had)
θ = K1θ1 K2θ2 , (5.6)

































The LIMIX framework exploits these properties proposing a modelling framework
where covariance models can be combined flexibly.
5.1.3 Kronecker-structured covariance models
Let us consider the covariance of the matrix-variate mixed model in Section 2.4
Cg ⊗Rg︸ ︷︷ ︸
relatedness component
+ Cn ⊗ IN︸ ︷︷ ︸
noise component
. (5.9)
Denoting with P the number of analysed traits and with N the number of individuals,
Cg ∈ RP×P andCn ∈ RP×P are the trait covariance matrices of the relatedness and the
noise classes respectively, while Rg ∈ RN×N denotes the realised relatedness matrix.
Note that only Cg and Cn are estimated using restricted maximum likelihood, while
Rg ∈ RN×N is estimated from the genotype data. Within the LIMIX inference frame-
work, the covariance in (5.9) is defined as a composite covariance term that combines
parametrized covariance models Cg and Cn.
Let us now consider the covariance of the mtSet/iSet model in Eq (3.3)
Cg ⊗GG>︸ ︷︷ ︸
low-rank set component
+ Cg ⊗Rg︸ ︷︷ ︸
relatedness component




where an additional (low-rank) Kronecker product is considered. In Eq (5.10), we
introduced the trait set covariance Cr ∈ RP×P and the genotype matrix G ∈ RN×R
of the R variants in the considered set. Within LIMIX, the covariance in (5.10) is also
defined as a composite covariance term that combines LIMIX covariance functions Cr,
Cg and Cn. As many of computations are common to the two covariance models, the
three-term covariance class reuses most methods implemented in two-term covariance
class in the LIMIX framework.
One advantage of the framework is that the user can specify arbitrary parametrized
covariance functions for Cr, Cg and Cn. As as consequence, the models in iSet can be
easily obtained using the covariance combinator in Eq (5.10) and setting (i) a freeform
covariance for Cg, (ii) a freeform covariance for Cn, (iii) either a block, a rank-one or
a freeform model for Cr (which correspond to the persistent, the rescaling-GxC and
the general-GxC models in Section 4.1.1, respectively). Note that the framework also
allows for more complex covariance models. For example, in analyses of time-series
phenotypes, a squared exponential kernel (see Section D.2) could be used to model
trait-to-trait covariances of the genetic component across time points.
Covariance matrices that are sum of multiple Kronecker terms can also be defined
within LIMIX.
5.1.4 An example of complex covariance model to study social effects
In the previous sections, I discussed a framework that allows for combining multiple
covariance functions. In this section, I showcase how this framework can help define
complex LMMs for genetic analyses. In particular, I here discuss a statistical model I
built in collaboration with Amelie Baud, a postdoc in Oliver Stegle’s group, to study
genetic effects from social partners (social genetic effect). Full details on the model and
the genetic analysis can be found in Baud et al. (2017). Note that similar models have
been considered for the study of social effects in previous studies (Bijma, 2014).
In social effect LMMs, the genetic contribution to the phenotype is modelled as the
sum of a direct and a social component (Bijma, 2014). For each individual, the direct
genetic component is defined as the additive effect of its own genes, while the social
genetic component is defined as the additive effect of the genes of its social partners.
As an illustrative example, let us consider an experimental design with 2N animals in
N cages, with each cage containing two animals. Additionally, let G ∈ RN×S denote
the standardised genotype matrix for S variants and let us introduce the N ×N cage
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design matrix Z as
Zij =
1 if i and j are cagemates and i 6= j0 otherwise (5.11)


















Here, Cg is a 2 × 2 covariance matrix modelling the covariance between the effects
of the genes of one individual (focal individual) and the effects of the genes of its




















Within the LIMIX framework, this covariance model can be defined from an arbitrary
covariance function Cg and constant matrices R and Z.
Following the same rationale, we introduced an environmental component with
direct and indirect environmental effects2 (see also Bijma, 2014). The total covariance
of the model is
K(ds)(Cg;R,Z)︸ ︷︷ ︸
genetic component
+ K(ds)(Cn; I,Z)︸ ︷︷ ︸
environmental component
, (5.16)
where Cn is a 2× 2 covariance matrix that models the covariance between direct and
indirect environmental effects. Importantly, the implementation of such a complex
covariance model is straightforward within the LIMIX framework, as it only requires
the definition of the derived covariance model in Eq (5.15), which builds on an existing
(and arbitrary) LIMIX covariance term (Cg in Eq (5.15)).
2Direct environmental effects correspond to iid noise. Indirect environmental effects correspond to
effects that are mediated by the social partner.
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5.1.5 Exploiting covariance structures
Naive inference in Gaussian models is bound to the O(N3) complexity of some of the
computations to evaluate the LML and its gradients. These computations include
the product of the inverse of Kθ by a matrix, the product of the gradients of Kθ
by a matrix, the logdet of Kθ and the gradients of the logdet. Importantly, as we
have seen in the previous chapters, some of these operations can be more efficiently
computed for specific structures of the total covariance Kθ. For example, if Kθ is
the sum of a low-rank matrix of rank R and a diagonal matrix, its determinant can
be computed in O(NR2 + R3) using the matrix determinant lemma (Harville, 1998).
Similarly, the operation K−1θ W , where W is an N ×M matrix, can be computed in
O(NKR+NR2 +KR2 +R3) using the Woodbury identity (Woodbury, 1950).
Within this inference framework, all the methods whose computational complexity
depends on the structure of the covariance matrix are defined within the covariance
term. As a consequence of this design consideration, efficient inference comes automat-
ically when the total covariance allows (and provides) efficient implementations of these
methods (i.e. the product of the inverse ofKθ by a matrix, the product of the gradients
ofKθ by a matrix, the logdet ofKθ and the gradients of the logdet). This strategy has
been used to implement the iSet model for stratification analysis (see Section 4.4.1), for
which the sole implementation of a specialised covariance term and its efficient methods
(see Section A.6) enables inference with linear complexity in the number of individuals,
O(N). For some special models we have achieved further speedups by implementing
specialised GP classes. This approach has been used for implementations of mtSet,
mtSet-PC and mtSet-LowRankBg.
5.1.6 Other flexible inference frameworks
The idea of building composite covariance terms based on simpler building blocks is
not exclusive to LIMIX. For example, GPy (GPy, since 2012) and PyGP (https:
//github.com/PMBio/pygp) also propose a flexible framework based on GPs, where
covariance functions can be combined to define complex GP regression models. How-
ever, none of these implementations focuses on analysis needs in genetics. Specifically,
these frameworks do not provide efficient implementations for Kronecker-structured co-
variance matrices, do not enable computation of standard errors and omit fixed effects.
In the context of genetics, softwares such as AsREML (Gilmour et al., 2009) and
Wombat (Meyer, 2007) are widely popular in the animal breeding community. These
software tools, especially AsREML, enable genetic analyses considering a large class of
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linear mixed models. However, these methods are not open-source and do not imple-
ment recent mixed-models implementations to achieve fast computation in analyses of
multiple variants and/or traits (Listgarten et al., 2013; Lippert et al., 2014a; Zhou and
Stephens, 2014; Casale et al., 2015) (see also the comparison in Zhou and Stephens,
2014, Table 1).
5.2 Modules for genetic analyses
In the previous section, I discussed the basic framework for parameter inference. Here,
I describe higher-level modules that implement recurrent analyses in genetic studies.
Specifically, I discuss modules for variance decomposition and association testing across
multiple traits. The material presented in this section is joint work with Christoph
Lippert. I have developed all the code required for the variance decomposition module.
Christoph implemented the code for fixed effect testing.
5.2.1 The variance decomposition module
Denoting with N the number of samples and with P the number of phenotypes, the







Ui + Ψ, (5.17)
where the N × P phenotype matrix Y is modelled as the sum of J fixed effect terms,
I random effect terms and residual noise.
Fixed effects. Each of the fixed effect terms has a trait design matrix Aj ∈ RMj×P ,
an individual design matrix Fj ∈ RN×Kj and a fixed effect matrix Bj ∈ RKj×Mj .
Here, Kj is the number of covariates for term j and Mj is the number of independent
effects that each of the Kj covariates has across the analysed traits. While the trait
and the individual design matrices are known (i.e. they are specified by the user), the
fixed effect matrices are estimated by restricted maximum likelihood. Importantly, the
trait design Aj specifies the cross-trait architecture of the Mj independent effects. For
example, the scenario in which each covariate in term j has the same effect on all the
traits corresponds to Aj = 11×P (Mj = 1). Alternatively, the scenario where each
covariate has a different effect on each trait corresponds to Aj = IP (Mj = P ). A
more complex example in which the covariates have the same effects on all traits with
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the exception of trait p corresponds to
Aj =
1 · · · 1 0 1 · · · 10 · · · 0 1︸︷︷︸
p-th column
0 · · · 0
 ∈ R2×P . (5.18)
Random effects. Each of the random effects Ui follows a matrix-variate normal
distribution with row covariance matrix Ri ∈ RN×N and column covariance matrix
Ci ∈ RP×P
Ui ∼ MVN (0, Ri, Ci) . (5.19)
While the row covariance matrices are known 3, the trait covariance matrices are es-
timated by restricted maximum likelihood. Notably, user can specify the covariance
model of the column covariance matrices for the different random effects. Finally, the
residual noise is also matrix-variate normally distributed and covaries across traits while
it is independent across individuals Ψ ∼ MVN (0, IN , Cn).
Parameter inference. The model in Eq (5.17) can be equivalently written as









(Ci ⊗Ri) +Cn ⊗ IN
 , (5.20)
which is a special case of Eq (5.1). Parameter inference is performed using the frame-
work described in Section 5.1.
Predictions The model can be used to predict contributions from individual terms
(either fixed or random) for test individuals (out-of-sample individuals). Denoting with
N? the number of out-of-sample individuals and with F ?j ∈ RN
?×Kj the design matrix
for the N? individuals, the predictions from fixed effect j are
Y ?j = F
?
j BˆjAj , (5.21)
where Bˆj is the restricted maximum likelihood estimator (MLE) of Bj . Additionally,
denoting withR?i ∈ RN
?×N the cross-covariance between the originalN individuals and
3Row covariance matrices are normalised so that 1
NP−1 tr (PRi) = 1, i = 1, . . . , I so that the
diagonal elements of the corresponding covariance can be interpreted as variance explained (Kostem
and Eskin, 2013).
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the N? out-of-sample individuals (see also Section 2.3.6) the predictions from random
effect i are














where Cˆi and Cˆn are the restricted MLE of Ci and Cn, respectively.
5.2.2 Flexible fixed effect tests in multi-trait mixed models
The multivariate model used for single-variant testing has a fixed effect term for co-
variates, a fixed effect for the genetic variant being tested, a random effect to account
for confounding and a noise term
Y = F (cov)B(cov)A(cov) + gb>A+U + Ψ, with (5.23)
U ∼ MVN (0, R, Cg) , Ψ ∼ MVN (0, I, Cn) .
Here, F (cov) ∈ RN×K , A(cov) ∈ RM(cov)×P and B(cov) ∈ RK×M(cov) denote respectively
the individual design matrix, the trait design matrix and the effect size matrix for K
covariates, respectively. Additionally, g denote the genotype vector of the variant being
tested, A ∈ RM×P the trait design matrix of the genotype (M is the number of the
independent effects on the traits, see also previous section), b ∈ RM the effect size vector
of the M effects, R the realised relatedness matrix, Cg the trait polygenic covariance
and Cn the trait noise covariance. Following Korte et al. (2012) and Furlotte and Eskin
(2015), the trait matrices Cg and Cn are estimated under the no-association model
(b = 0) using the variance decomposition module (employing the efficient inference
scheme described in Section A.2). By default, A(cov) = IP and Cg and Cn are freeform
covariance terms.
The single-variant test is perfomed by comparing the alternative hypothesis H1 :
A = A1 versus the null hypothesis H0 : A = A0 using a log-likelihood ratio test.
Importanly, LIMIX enables the user to specify both A1 and A0, thereby offering more
flexibility than previous implementations (Korte et al., 2012; Zhou and Stephens, 2014;
Furlotte and Eskin, 2015). The standard multivariate tests proposed in Korte et al.
(2012) (see Section 2.4.3) can be obtained as special cases by choosing A0 and A1
appropriately (Table 5.1). However, LIMIX allows assessing more specific hypothesis
on the trait design of the variant effect, as I show in the application case in the next
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section.
Test Alternative hypothesis Null hypothesis
Any effect test A = IP A = 0
Common effect test A = 1>P A = 0







Table 5.1: Standard multivariate association tests and corresponding trait
design in the null and in the alternative hypothesis. Multivariate tests proposed
in Korte et al. (2012) and corresponding choices of the trait design model in the null
and in the alternative model. Here, Id and I∼d are P -dimensional indicator vectors
such that (Ip)i = δip and I∼p = 1D − Ip.
5.3 Vignettes
In this section, I describe two analyses from collaborative projects as vignettes of ap-
plication, mainly focusing on the analysis challenges.
5.3.1 A genetic study of transcription initiation in Drosophila
This first application case concerns a genetic study of transcription initiation, pro-
filed using Cap Analysis of Gene Expression (CAGE) in Drosophila melanogaster at
three different stages of development. This analysis is part of a project in collabora-
tion with Eileen Furlong’s group in EMBL Heidelberg (Germany) and was published
in Schor et al. (2017). CAGE measurements were available across three distinct stages
of Drosophila development. The aim of this part of the analysis was to map QTLs for
transcription initiation in a joint analysis across developmental stages.
The analysis of these data is challenging, as transcription initiation is a high-
dimensional molecular trait consisting of hundreds of univariate measurements. More-
over, development adds another phenotypic dimension to the data. To approach these
challenges, we first performed a conventional dimensionality reduction using PCA and
then considered PC-based phenotypes for joint QTL mapping across developmental
stages. The flexibility of the fixed-effect testing module implemented in LIMIX (see
Section 5.2.2) was essential to define statistical tests for the specific study design (see
below). The statistical pipeline for QTL mapping presented herein, was designed and
validated by me in collaboration with Jacob Degner.
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Background. A transcription start site (TSS) is a genomic location where transcrip-
tion is initiated (Zvelebil and Baum, 2007). CAGE is a molecular profiling assay that
enables the characterisation of transcription initiation on a genome-wide scale (Shiraki
et al., 2003). CAGE isolates the sequence fragment at the 5’ end of RNA molecules,
which is the first part of the gene being transcribed. Mapping these short sequences to
a reference genome enables the characterisation of the TSS distribution. Recent studies
have shown that while many genes have a unique and well-defined TSS, for others, the
distribution of TSS can span regions of up to thousands of bases (Lenhard et al., 2012;
Carninci et al., 2006; Ni et al., 2010). While genetic effects on RNA expression levels
have been largely studied, the extent to which genetic variation affects transcription
initiation remains unknown. To investigate this, Eileen Furlong’s group profiled tran-
scription initiation in 81 genotyped lines of Drosophila melanogaster at 2-4h, 6-8h and
10-12h after egg laying using CAGE.
Phenotype definition. Transcription initiation regions (TIR) were defined as the
1kb regions centred around the highest CAGE peaks. In total, 13,508 TIR were identi-
fied. Denoting with N (= 81) the number of individuals and with D (= 3) the number
of development stages, each TIR corresponds to N ×D×1, 000 count measures (where
1,000 is the number of base pairs in a TIR). Even considering a single-stage analysis,
joint modelling of the count data in a TRI would entail a joint QTL mapping of 1,000
univariate traits. To reduce the dimensionality of the problem, we projected the TSS
distribution onto the three leading principal components, i.e. we performed dimension-
ality reduction in the base pair space. Specifically, we performed PCA on square-rooted
counts across all lines and developmental stages. For each TIR, we also defined a mean-
based phenotype as the sum of the read counts in the TIR. To adjust for batch effects
and other hidden covariates, we applied PEER (Stegle et al., 2012) independently for
each TIR and developmental stage to each of the KPC = 3 PC-based phenotypes and
the mean-based phenotype considering 10 unknown factors. The residuals from PEER
were quantile-normalised to a normal distribution to ensure that model assumptions
were fulfilled.
Molecular QTL mapping. For each TIR, we considered all bi-allelic variants with
MAF > 5% that are within 100 kb from the centres of TIR regions and considered
three different analyses:
1. Single-stage analysis of mean expression. For each TIR and developmental
stage, we considered the univariate linear mixed model described in Section 2.29.
121
We used the RRM to model genetic relatedness between lines.
2. Multi-stage analysis of mean expression. For each TIR, we considered the
multi-trait linear mixed model in Eq (5.23) jointly modelling mean expression
levels across the three developmental stages. We considered both a common
effect test across all developmental stages and a specific effect test for each stage
(see Section 5.2.2).
3. Multi-stage analysis of PC-based phenotypes. For each TIR, we considered
the multi-trait linear mixed model in Eq (5.23) jointly modelling theKPC = 3 PC-
based phenotypes across the D = 3 developmental stages, resulting in a total of
9 phenotypes. Denoting with Yi ∈ RN×D the matrix of PC i phenotypes, where
rows are samples and columns are developmental stages, the total phenotype
matrix is Y = [Y1,Y2,Y3] ∈ RN×KD. Tests for common and specific effects across
stages require the increased flexibility made available by the LIMIX framework.
In this setting, a common effect is an effect that is heterogeneous across the KPC
PCs but constant (for each PC) across the D developmental stages. In the same
vein, a specific effect at stage d is an effect that is different at stage d (for each
PC) with respect to the other developmental stages. These two tests correspond
to
common effect test : H1 : A = IK ⊗ 1D×1 vs H0 : A = 0





vs H0 : A = IK ⊗ 1D,1
where Id and I∼d are D-dimensional indicator vectors such that (Id)i = δid and
I∼d = 1D − Id.
To account for multiple testing we used a two-step procedure (see discussion in Sec-
tion 2.2.2). First, we calculated a TIR-level P value for each TIR considering 10,000
permutations of the genotype data across lines. Second, the TIR-level P values were
corrected for multiple testing across TIRs using the Benjamini-Hochberg (BH) proce-
dure. For the single-stage analysis, the BH correction was performed both across TIRs
and developmental stages.
Results. Joint modelling of mean-based phenotypes across multiple stages increased
power compared to the single-stage analysis (Fig. 5.2A-B). Additionally, the multi-
stage PC-based analysis almost doubled the number of significant TIRs with respect to
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the mean-based analysis, identifying 4,526 TIRs with a significant QTL (FDR < 1%,
Fig. 5.2A-B). Note that this set of QTLs includes variants that only affect the expres-
sion level (see Fig. 5.2C), variants that only affects the shape of the TSS distribution
(see Fig. 5.2D) and variants that affect both. Interestingly, the model did not retrieve
any TIR with significant stage-specific effects.
5.3.2 Dissecting the genetic and the epigenetic component of gene
expression
The analysis described in this section is a component of the BluePrint Whole Package
10 (BP-WP10, Chen et al. (2016)). BP-WP10 generated high-resolution transcrip-
tional, genetic and epigenetic profiles in three immune cell types. These data offer
a unique opportunity to study the interplay of genetic and epigenetic factors in the
regulation of gene expression. The aim of the analysis presented herein is to assess
the extent to which associations between epigenetic changes and gene expression are
driven by underlying local genetic variation. The robust identification of these associ-
ations requires correction for different levels of sample heterogeneity, including sample
processing, polygenic effects and underlying local genetic variation. To do so, we de-
signed different LMMs with multiple variance components using LIMIX. The analysis
presented here was done in collaboration with Nicole Soranzo’s group at the Sanger
Institute. I have designed the set of statistical models and analysed the data.
Data The BluePrint Whole Package 10 (BP-WP10) project has generated high-
resolution transcriptional, genetic and epigenetic profiles in three immune cell types
from 200 healthy Europeans, including CD14+ monocytes, CD16+ neutrophils and
naive CD4+ T cells. For brevity, I here consider only CD14+ monocytes. The dataset
consists of the following molecular layers:
• whole genome sequencing data: 5,237,919 common variants at MAF > 4%;
• M-values for 440,905 CpG sites profiled with the 450K array;
• ChIP data for H3K27ac/H3K4me1 histone marks4: 64,843/39,815 peaks;
• RNA-seq: 16,577 genes.
4H3K4me1 indicates the mono-methylation of the K4 lysine of histone H3 while H3K27ac indicates
the acetylation of the K4 lysine of histone H3. H3K4me1 has been associated to regions with active
and poised enhancers while H3K27ac is specific to active enhancers (Hon et al., 2009; Creyghton et al.,
2010).
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Figure 5.2: Results from the QTL mapping of transcription initiation in
Drosophila using multi-trait mixed models.
Figure by Jacob Degner and Ignacio Shor. Used with permission.
(a) Fraction of significant TIRs with a QTL considering alternative association tests as
a function of the FDR cut-off. Association tests include single-stage association anal-
ysis for mean expression, common effect test on mean expression and common effect
test on PC-based phenotypes. (b) Overlap of genes having significant QTL (FDR<1%)
considering the three association tests. (c) Example of QTL that affects the expression
level without affecting the shape of the TSS distribution. The top panel shows the raw
CAGE signal for the different developmental stages pulled across all lines. The mid
panel shows a heatmap of the raw CAGE signal at 6-8h for each line, where individuals
are ordered based on the genotype at the lead variant. The third panel shows the mean
CAGE signal stratifying by the genotype of the lead QTL. (d) Analogous represen-
tation as in (c) for a QTL that affects the shape of the distribution of transcription
initiation.
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To account for hidden covariates and confounding factors, we applied PEER (Stegle
et al., 2012) to both the expression and the epigenetic data. In the analyses described
in the following, we considered the set of 158 individuals for which all molecular layers
had passed all quality control steps. Details on the different molecular assays and the
preprocessing of the data can be found in Section D.4.1.
Mapping of cis epiQTL. To identify epigenetic associations with gene expression
that are explainable in terms of local genetic effects, we tested for association between
gene expression and epigenetic features within 1Mb from the gene-body either with or
without accounting for local genetic variation.
• cis epiQTL mapping.
For each gene, we considered the following LMM
y ∼ N
1µ+ eβ, σ2gKg︸ ︷︷ ︸
relatedness component





Denoting with N the number of individuals, here y ∈ RN is the normalised5
gene-expression vector, 1µ ∈ RN an intercept term, e ∈ RN the epigenotype
vector of the feature being tested andKg ∈ RN×N the RRM. Additionally, Kh ∈
RN×N denotes the expression heterogeneity (EH) covariance and was introduced
to account for confounding due to hidden sample heterogeneity. Specifically, the
EH covariance is defined as Kh = ZZT ∈ RN×N , where Z denotes the N × G
gene expression matrix for N individuals and all G genes. The underlying idea
of this strategy is that genome-wide expression heterogeneity is likely to capture
technical confounding. This is a common strategy in QTL mapping (Kang et al.,
2008a; Fusi et al., 2012). Importantly, we find that a variance component model
not accounting for this contribution gave inflated variance component estimates
for epigenetic features (Section D.4.2). When testing for association, we used a
conservative approach and quantile-normalised epigenetic features to a normal
distribution. For computational efficiency, the association testing was performed
by fixing the relative contribution of the relatedness and the EH component to
the total phenotypic variance. Specifically, we first used the null model (Eq (5.24)
with β = 0) to estimate σ2g and σ2h by restricted maximum likelihood. Then we
considered the univariate LMM in Section 2.29 and we set the covariance matrix
5quantile-normalised to a unit variance normal distribution
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where σˆ2g and σˆ2h are the restricted MLE of σ
2
g and σ2h respectively under the null
model.
• Accounting for cis-genetic effects. To account for local genetic effects, we first
corrected epigenetic features as described in the following. For each epigenetic
mark, we considered the linear mixed model
e ∼ N (1µ+ eβ, σ2g100kbRg100kb + σ2eI) , (5.26)
where Rg100kb denotes a local RRM built from genetic variants within 100kb
from the epigenetic mark. The effect from local genetic variants was estimated
using the best linear unbiased predictor (see Section 2.3.6) and the residuals
were used as an estimate of the non-genetic component of the epigenetic marks
(cisG-corrected features).
For each gene, we then considered the following LMM
y ∼ N
1µ+ e?β, σ2genoKgeno︸ ︷︷ ︸
cis genetic comp.
+ σ2gKg︸ ︷︷ ︸
relatedness component






where e? denotes the cisG-corrected epigenetic vector and Kgeno denotes the
local RRM built considering all variants in 1Mb from the gene-body. This ad-
ditional random effect accounts for cis genetic variation within the entire 1Mb
region considered in the mapping. We used the same strategy as above for the
association testing. CisG-corrected epigenetic features were quantile-normalised
to a Gaussian distribution prior to the association testing.
For multiple hypothesis correction, we performed a two-step procedure (as in Battle
et al., 2014, see also discussion in Section 2.2.2). We first obtained a gene-level P-value
as the minimum nominal P-value (Bonferroni-corrected to account for multiple testing
across cis features) and then used the BH procedure to correct for multiple testing
across genes. We called genes with significant epigenetic association at FDR < 5%.
Results Accounting for cis-genetic variation reduced the number of genes with a
significant epigenetic association from 5,813 to 2,861 (see Fig. 5.3a-c). The biological
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interpretation of the results is ongoing work and will be omitted for brevity.
Figure 5.3: Results from the analysis in the BluePrint data. (a) Scatter plot
of the gene-level P values obtained from the epiQTL mapping either accounting (y-
axis) or not (x-axis) for cis-genetic variation. (b) Fraction of genes with significant
epigenetic associations (FDR<5%) before and after accounting for cis-genetic variation.
(c) Manhattan plot for gene TMEM176A obtained from the EWAS analysis on gene
expression without (top panel) and with (bottom panel) accounting for cis-genetic
variation. (d) Analogous plot as in (c) for gene MSR1.
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5.4 Summary and discussion
The generation of cohorts with increasingly deep phenotype data posits the need for
analysis tools that allow for adapting genetic models to variable study designs. Indeed,
the analysis of such datasets typically requires iterative changes to the model, starting
from a simple univariate approach, followed by more complex multivariate models. In
this chapter, I presented LIMIX, a flexible mixed-model framework to address such
analysis needs. Notably, LIMIX unifies a wide range of tasks in a single framework,
including variance decomposition, single-variant and set-based association testing, and
genomic predictions for the analysis of single and multiple traits. Technically, LIMIX
builds on a general inference framework for Gaussian models, in which model parame-
ters are estimated by maximising the restricted marginal likelihood. A key component
of this inference framework is the covariance term, as it defines the set of model pa-
rameters and is a major determinant of the computational complexity of the model.
Additionally, existing covariance models can be combined using basic operations; a
strategy that facilitates implementation of new models and that promotes flexibility
and re-usability of the code.
In addition to this inference framework, LIMIX provides higher-level modules that
implement standard genetic analyses. I have described a module for flexible variance
decomposition and a module for multi-trait GWAS that is more general than previous
implementations. I have illustrated the utility of these modules in two applied projects.
In the first application case, I described a genetic analysis of transcription initiation
in Drosophila melanogaster during development. Using the multi-trait GWAS module
in LIMIX, we defined a set of non-standard multivariate tests that consider common
and development-specific genetic effects on transcription initiation. The flexibility of
the LIMIX GWAS module was essential to adapt the statistical tests to the specific
design. In the second application case, I discussed an integrative analysis of genetic,
epigenetic and expression profiles. This analysis required the fitting of multiple LMMs
accounting for different sources of confounding, which were implemented in a coherent
fashion using the variance decomposition module in LIMIX.
Although flexible tools in genetics can help the analysis of complex datasets, flex-
ibility comes at the cost of the increased complexity of the software. Indeed, in order
for the user to leverage the flexibility of the framework and make optimal modelling
choices, she or he will be required to have a good understanding of the modelling frame-
work and some of its implementation details, a compromise that might be suboptimal
for many users. One possible solution is to utilise a flexible framework as the foundation
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for different predefined workflows. This strategy would enable (i) the development of
new methods (by extending the core inference framework and by designing new high-
level modules), (ii) the flexible design of genetic models (by using higher-level modules
such as the variance decomposition) and (iii) the use of predefined workflows.
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6 | Concluding remarks
The success of the first genome-wide association studies, which uncovered common
variants with moderate effect sizes for traits such as type 2 diabetes (Scott et al., 2007)
and coronary artery disease (Burton et al., 2007), fuelled the hope that GWAS could
be applied to characterise the genetic component of virtually any trait of interest (Viss-
cher et al., 2012). However, as increasing numbers of traits have been surveyed using
genetic association analyses, it has become increasingly clear that these expectations
were too optimistic and that the genotype-to-phenotype map is more complex than ini-
tially hypothesised. Many traits of interest are complex and can be regulated by tens or
even hundreds of genetic loci with each locus having a small individual effect (Wood et
al., 2014; Ripke et al., 2014). Moreover, genetic variants commonly entail pleiotropic
effects across several related phenotypes and diseases (Fortune et al., 2015; Pickrell
et al., 2016) and interactions of genetic effects with environmental factors and other
contexts are common (Andreassi, 2009; Winkler et al., 2015). Additionally, many dis-
covered variants lie in non-coding regions of the genome, hampering the interpretation
of the molecular mechanisms that underlie such associations. Genetic studies of gene
expression levels and other molecular traits have helped identify the regulated gene for
a fraction of such intergenic GWAS loci. However, as the effects of genetic variants can
arise in specific tissue types or under specific stimuli (GTEx Consortium, 2015; Fairfax
et al., 2014), these genetic studies need to be conducted in disease-relevant cellular
states.
One avenue to tackle these challenges is to increase statistical power by consider-
ing ever-increasing sample sizes (Visscher et al., 2012). This strategy is employed in
large meta- and mega-analyses, where several studies exceed sample sizes of 100,000
individuals (Gormley et al., 2016; Sudlow et al., 2015). A complementary direction
of investigation is to consider joint analyses across multiple traits, molecular layers
and contexts. These integrative analyses can help characterise pleiotropy (Fortune
et al., 2015), assess colocalisation of genetic effects on gene expression and complex
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traits (Wallace et al., 2012) and study context-specificity (Flutre et al., 2013). As
increasingly deep phenotype data are being generated, there is the need for new inte-
grative methods for tying together different traits and genetic effects in flexible ways,
while retaining computational efficiency in large cohorts.
This thesis has contributed new statistical methods for integrative analysis. In
Chapter 3, I presented mtSet, a mixed-model approach that enables association test-
ing of variant-sets with multiple traits. This approach can leverage the availability
of multiple related phenotypes in the same individuals, while modelling effects from
sets of variants at the same locus and accounting for confounding. In applications
to a number of experimental settings, we find that joint modelling of multiple traits
and variants offers power advantages compared to methods that aggregate either across
traits or variants in isolation. Importantly, mtSet uses an efficient algorithm implemen-
tation, allowing for applications to large cohorts. Building on this inference scheme,
in Chapter 4, I derived a new strategy to test for interactions between a set of genetic
variants and categorical contexts (iSet). iSet accounts for polygenic effects and allows
for characterising context-specificity at specific loci. In an application to a monocyte
eQTL dataset, the proposed approach is better powered than a single-variant interac-
tion test, suggesting that gene expression is often regulated by multiple causal variants.
Moreover, our results reveal that changes of configuration of causal variants between
contexts are common. I also extended the iSet method to enable interaction testing in
GWAS cohorts when using context variables to stratify individuals into distinct sub-
groups. Finally, in Chapter 5, I presented LIMIX, a mixed-model software suite that
enables different types of genetic analyses. LIMIX provides the user with the flexi-
bility to design customised genetic models, facilitating integrative analyses in specific
data designs. To illustrate the use of this modelling framework, I have presented two
vignettes. In the first vignette, I showcased the use of flexible fixed effect testing to
investigate context-specific genetic effects in a joint analysis of multiple contexts and
traits. The second use case illustrates flexible variance component modelling, which I
used to account for different types of confounding in association testing. In addition
to methodological contributions, the application of the proposed methods to different
data has also yielded new insights into the genetic architecture of traits. Perhaps most
notably, these results highlight that even low-level molecular traits, such as gene ex-
pression, have surprisingly complex cis genetic architectures, with multiple associated
variants and complex changes between different cellular contexts.
There are a number of use cases for the methods developed in this thesis that could
be explored in the future. The proposed association set test offers the potential for
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the discovery of new quantitative trait loci using set-based analyses of up to tens of
related phenotypes. Examples of interesting applications include joint genetic analyses
of multiple metabolite measurements, groups of phenotypes that are predictive for
disease susceptibility, measures of stress, anxiety and other behavioural traits in animal
models, and genetic molecular analyses of small gene networks or correlated epigenetic
factors. Importantly, as mtSet can account for different types of genetic relatedness,
it can be applied to either large human cohorts of unrelated individuals, such as UK
Biobank (Sudlow et al., 2015) and NFBC (Sabatti et al., 2009), or medium-sized cohorts
of related individuals, such as the human cohorts considered in Sidore et al. (2015) and
Panoutsopoulou et al. (2014) and the model organism datasets considered in Baud et
al. (2014) and Atwell et al. (2010).
The proposed interaction set test will enable region-based gene-context (GxC) in-
teraction analyses in the two most common designs of GxC studies: complete designs,
where every individual has been phenotyped in all contexts, and stratified designs,
where each phenotype has been measured in only one of a number of contexts. Ex-
amples of analyses with a complete design include GxC studies of gene expression and
other molecular traits across cell types, tissues or development, analyses of global phe-
notypes in model organisms across different environments or stimuli (e.g., see designs
in Sasaki et al. (2015) and Bloom et al. (2013)), and genetic analyses of traits over
time in longitudinal studies. Conversely, the possibility to consider stratified designs
will enable GxC interaction analyses in large human cohorts by stratifying individuals
by sex, age bins and other context variables.
The flexible LIMIX software tool will enable the design of ad hoc genetic models
to address specific analysis needs. Applications of LIMIX have concerned variance
component analysis of multiple molecular layers in human primary cells (Chen et al.,
2016), gene-environment (GxE) interaction study of methylation and flowering time in
Arabidopsis (Dubin et al., 2015b; Sasaki et al., 2015), genetic analysis of transcription
initiation (Schor et al., 2017), multivariate expression locus mapping in Drosophila
during development (Cannavò et al., 2016), studies of social genetic effects (Baud
et al., 2017) and predictions of growth traits in yeast (Märtens et al., 2016). The
availability of robust software implementations of these methods will enable new ge-
netic analyses in ambitious study designs to gain insights into the complexities of the
genotype-phenotype map.
I will conclude with an outlook on future research by discussing some extensions and
follow-up analyses linked to the work in this thesis. First, while I here have focused on
sliding-window experiments, different strategies to define variant-sets can be adopted
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to test for specific hypotheses and increase statistical power. For example, sets can be
defined by using genome annotations such as gene positions or ENCODE elements. The
most common analysis types that implements this principle are gene-based set tests.
This strategy offers the advantage that the obtained results can be directly interpreted
and increases power by reducing the number of tested hypothesis and leveraging LD.
Analyses of variant-sets could also be applied to study the local genetic architecture
at specific loci, for example, by testing for residual effects from multiple low-frequency
alleles after conditioning on the main genetic signals. Such analyses could be easily
implemented within mtSet by modelling the main effect as fixed and considering a set
relatedness matrix built from only low-frequency variants. Additionally, it would be
important to explore the optimal design of variant-sets by comparing alternative ways
of weighting the variants in the set component, for example, to account for uneven LD
tagging (Speed et al., 2012), to prioritise low-frequency variants (Wu et al., 2011) or
to introduce prior biological knowledge (MacLeod et al., 2016).
As efficient multi-trait implementations are currently limited to analyses of tens
of traits, one important line of research is the development of new models for the
genetic analysis of high-dimensional phenotypes, such as high throughput molecular
measurements and images of cells, faces and organs. Such challenge can be tackled us-
ing different analysis strategies. For example, one approach is to design dimensionality
reduction methods that can extract heritable latent variables by leveraging genotype
information. Alternatively, one can extend current multi-trait implementations so that
they can be directly applied to analyse hundreds of traits, which entails different sta-
tistical challenges. First, it will be important to devise analysis strategies to deal with
missing phenotype observations. Promising avenues are approximate inference methods
such as variational Bayes (Dahl et al., 2016) and efficient inference schemes available for
Gaussian models with structured covariances (Wilson et al., 2014). Another statistical
challenge is the robust estimation of large trait-to-trait covariance matrices. Inference
of large covariances is an active area of research in statistics and principles of low-rank
approximations, regularisation (Dahl et al., 2013) and bootstrap-based estimation could
also be applied.
An important extension of the models presented in this thesis, which require access
to genotype and phenotype population datasets, is to enable the analysis of summary
statistic data from previous GWAS and molecular studies. Methods based on summary
statistics are appealing as these data are more easily accessible, without the privacy
concerns that limit access to genetic data (Pasaniuc and Price, 2016). For example, a
probabilistic model on the variant effect statistics can be obtained from a generative
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model on phenotype by using the relationship between trait observations and the esti-
mated effect sizes (see also Chen et al., 2015). This approach could be used to extend
the iSet model to consider applications on summary statistics from GTeX, enabling
analyses of eQTL signal heterogeneity across multiple tissues.
While I here have focused on the study of genetic interactions with simple environ-
ments, specifically categorical contexts, the development of methods to study interac-
tions with continuous and multidimensional environments is an important area of future
work. For example, principles of variable warping (Fusi et al., 2014b) can be used to
learn non-linear functions of environmental factors and determine on which scale con-
tinuous environments interact with genetic variants. Another interesting direction is to
apply variance component models to study the heterogeneity of genetic signals across
multiple correlated environmental exposures. These advanced GxE models will enable
us to leverage the rich information on lifestyle covariates and other environments avail-
able in large cohorts such as UK Biobank, with the potential for revealing new insights
on how environment mediates the genetic architecture of traits.
Finally, although several of the developed methods are available through open soft-
ware (https://github.com/limix/limix) with accessible public interface documen-
tation (http://limix.readthedocs.io) and interactive notebooks (https://github.
com/limix/limix-tutorials), more work is needed to provide workflows for users to
reuse and adapt. For example, in order to broaden the user community of the LIMIX
software suite, it will be important to release command-line interface tools for an in-




A.1 Restricted maximum likelihood
Denoting with the N the number of samples and with y ∈ RN the outcome vector, let
us consider the Gaussian model
y ∼ N (Xβ,K) (A.1)
where X is the N × F design matrix of K fixed effects, β their effect sizes, Kθ the
covariance function of the Gaussian model and θ its parameters. The logarithm of
the restricted marginal likelihood of the Gaussian model can be expressed as (Harville,
1974; LaMotte, 2007)




log detKθ − log detAθ (A.2)
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An equivalent form that we will use in the following is
























































A.2 Implementation of LMMs with two-Konecker covari-
ance matrices











where the N × P phenotype matrix Y is modelled as the sum of J fixed effect terms,
a random effect to correct for confounding and residual noise. Each of the fixed effect
terms has a trait design matrix Aj ∈ RMj×P , an individual design matrix Fj ∈ RN×Kj
and a fixed effect matrix Bj ∈ RKj×Mj . The terms U ∈ RN×P and Ψ ∈ RN×P follow
matrix-variate normal distributions
U ∼ MVN (0, Rg, Cg) , Ψ ∼ MVN (0, IN , Cn) , (A.11)
where Rg is a constant N×N covariance. Note that this model generalises the matrix-
variate mixed model introduced in Section 2.4 and it is a particular case of the variance
decomposition model considered in LIMIX (see Eq (5.17)). In restricted maximum
likelihood the model parameters are defined by the covariance and, in this case, are the
parameters of Cg and Cn. In the following, to simplify notation, we do not explicitly
indicate the dependency on the model parameters.
Using the properties of the vec operator and Kronecker product introduced in Sec-
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tion 2.4.1 the model can be written as






vec (B)j , Cg ⊗Rg +Cn ⊗ IN
 . (A.12)
This model is a special case of Eq (A.1) with
y = vec (Y ) (A.13)
X =
[













In Section 2.4 we derived that the inverse of the covariance can be rewritten as (see
Eq (2.82))
K−1 = LTDL (A.17)



















L = Lc ⊗Lr (A.22)
D =
(
SC?g ⊗ SRg + INP
)−1
. (A.23)
In the following, we will see how the restricted log marginal likelihood and its gradients
can be computed efficiently exploiting the particular structure of the covariance.
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Restricted log marginal Likelihood
Using Eq (A.17), the restricted log marginal likelihood in (A.7) can be written as
Lθ = −1
2
log |K| − 1
2



















where we have introduced












whose computation has complexity O(N2P +NP 2);
• the transformed fixed effect design
X˜ = (Lc ⊗Lr)X =
[
A˜T1 ⊗ F˜1 . . . A˜TJ ⊗ F˜J
]
. (A.27)
Here we have introduced A˜j = AjL>c and F˜j = LrFj . Computation of A˜j has
complexity O(P 2Mj) and computation of F˜j has complexity O(N2Kj).
Note that Lr (the row rotation matrix, see Section 2.4.4) is constant, i.e. does not
change during parameter optimisation. As consequence all row rotations need to be
performed only once prior to model fitting. These operations are highlighted in blue.
Eqs (A.4-A.5) can be written as

















All terms in Eq (A.25) can be derived with complexity O(K3 +NPK).
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Gradients
Note that the term K−1 ∂K∂θiK























be a Kronecker product that we denoted with C˜ ⊗ S˜. Note that S˜ is either SRg or I
depending on whether θi is a parameter of Cg or Cn respectively.
All terms in (A.8) can be computed efficiently as follows.






































which has complexity O(P 3 +NP ).
















which has complexity O(NPK + P 2NK +NPK2 +K3).




















which has complexity O(NP +NP 2).
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which has complexity O(NP +NP 2).












which has complexity O(NP ).
A.3 Implementation of mtSet gradients
The efficient implementation of the marginal likelihood are given in Section 3.1.3. Here
we discuss the efficient calculation of the gradients. The derivative of the log likelihood














vec (Y )T K−1
∂K
∂θi
K−1vec (Y ) , (A.40)
where
K = EE> ⊗GG> +Cg ⊗Rg +Cn ⊗ IN . (A.41)
Here, G ∈ RN×R denotes the standardised genotype matrix for R variants in the set,
E ∈ RP×C is defined such that EE> is the trait covariance of the set component
(C < P ), Cg ∈ RP×P is the trait covariance of the relatedness component, Cn ∈ RP×P
is the trait covariance of the noise component and Rg ∈ RN×N is the RRM (see also
Section 3.1.3). In the following, we will use the result in Eq (3.26):
K−1 = L>DL−L>DWΛ−1W>DL
to derive the efficient computation of the gradients.
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E˜T + E˜ ∂˜E∂θi
>
⊗WrW Tr if θi is an entry of E
∂˜(Cg)
∂θi
⊗ Sr if θi is a param of Cg
∂˜(Cn)
∂θi
⊗ I if θi is a param of Cn
, (A.45)











First, we compute the column covariance matrix of ∂˜K∂θi , which can be done in O(P
2C),
O(P 3) and O(P 3) respectively for random effect, error and noise parameters. Calcu-
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lating ∂̂K∂θi requires more care: we first compute the dot product between D and W ,
which requires us to explicitly calculate W , taking O(NPRC) time and O(NPRC)
space. The resulting matrix consists of NP rows and RC columns.
In the next step, we multiply each column of DW:,i with ∂˜K∂θi from the right side



































E˜T + E˜ ∂˜E∂θi
>))











if θi is a parameter of Cn.
This leads to an overall runtime complexity of O(RC ·(NPC+NCR)), O(RC ·(NP +
NP 2)) and O(RCNP 2) for region, random effect and region parameters.
We use the same trick to compute the multiplication between W T and D ∂˜K∂θiDW
efficiently, leading to a complexity of O(RC(NPC + NCR)). Finally, computing the
trace term has an additional runtime of O(NP + C2R2).
Evaluating the derivative of the squared form The derivative of the squared
form can be rewritten as








D −DWΛ−1W TD) ∂˜K
∂θi
(














−DWΛ−1vec (Y¯ )) .








, which can be done
in O(C2R2) after having precomputed the inverse. Exploiting that W has Kronecker
structure andD is a diagonal matrix, reduces the runtime for multiplying the resulting
matrix with DW from the left from O(NP + NPRC) to O(NPC + RNC + NP ).




and multiply it with
∂˜K
∂θi
from the left, having an additional runtime of O(NPR + NP 2), O(NP + NP 2)
and O(NP 2) for the region, the random effect and the noise term respectively. Finally
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we have to multiply two vectors of size N × P , which can be done in O(NP ) time. A
tabular overview of the individual computations and how often these need to be carried
out can be found in Table ??.
A.4 Implementation of mtSet-PC
Denoting with with Y the N × P phenotype matrix for N samples and P traits,
with F ∈ RN×K the sample design matrix of the fixed effect, with G ∈ RN×R the
standardised genotype matrix for the R variants in the set, with Cr ∈ RP×P the
trait covariance matrix of the set component and with Cn the residual trait covariance
matrix, the model considered by mtSet-PC is
vec (Y ) ∼ N
(
(I ⊗ F ) vec (B) , Cr ⊗GG> +Cn ⊗ IN
)
, (A.49)
where analogous to mtSet, we set Cr = EET where E ∈ RP×C and C < P (i.e. Cr
is low-rank). In mtSet-PC, population structure is modelled as fixed effects using the
first principal components instead than using a random effect term as in the full mtSet.
Again, this is a special form of the model in Eq (A.1) with
y = vec (Y ) (A.50)
X = (IP ⊗ F ) ∈ RNP×K (A.51)
K = Cr ⊗GGT︸ ︷︷ ︸
low rank
+Cn ⊗ IN , (A.52)
Let us consider the log restricted marginal likelihood in (A.3):




log detK − log detA (A.53)
−1
2




A = X>K−1X (A.55)
β = A−1X>K−1vec (Y ) . (A.56)
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The covariance matrix can be rewritten as





























where we used the notation M = UMS
1/2
M XM
1 for the singular value decomposition






)T × (A.62)INP − (UE? ⊗UG) (S−1E? ⊗ S−1G + IRC)−1︸ ︷︷ ︸
D












I −W TDW )L (A.64)
Calculating the SVD of E? and G? takes respectively O(PC2) and O(NR2) oper-
ations. All computations that has to be performed only once during optimisation are
marked in blue.
Evaluating the log-likelihood The log-likelihood of the model is
Lθ = const.− 1
2








log detA︸ ︷︷ ︸
reml term
(A.65)
The log-determinant term can be computed as follows by applying the matrix de-
1M ∈ Rn1,n2 , U ∈ Rn1,n1 ,S ∈ Rn1,n2 ,X ∈ Rn2,n2
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terminant lemma
log detK = log det
(
(UE? ⊗UG) (SE? ⊗ SG) (UE? ⊗UG)T + INP
)
(A.66)
+N log detSn (A.67)
= log det
(
S−1E? ⊗ S−1G + I
)
+R log detSE? + C log detSG (A.68)
+N log detSn. (A.69)
A and β can be computed respectively as
A = XTK−1X (A.70)
= (LX)TLX − (WLX)TD(WLX) (A.71)
= (Lc ⊗ F )T (Lc ⊗ F )− (WcLc ⊗WrF )TD(WcLc ⊗WrF ) (A.72)
and
β = A−1XTK−1vec (Y ) = (A.73)
= A−1
(





F TY LTc Lc
)− (WLX)TDvec (WrY LTcW Tc )) (A.75)
Finally, the quadratic term can be rewritten as
vec (Z)T K−1vec (Z) = (Lvec (Z))T (Lvec (Z))−
(WLvec (Z))TD(WLvec (Z)) (A.76)
where
Lvec (Z) = vec
(
Y LTc − FBLTc
)
(A.77)









The log-likelihood can be evaluated in O(NN2PC + NNPCR + NNPCP + NPR +
NNPCP +NP +NP
2) where we only report all quantities depending on N , which are
bottleneck for huge sample sizes, and denote in blue all the quantities that have to be
computed only once during optimization.
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K−1vec (Z)︸ ︷︷ ︸
squared form 1
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= LT
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WcC˜W Tc︸ ︷︷ ︸
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where we used that ∂K∂θi =
∂C
∂θi
⊗R where C and R are Cr and Rr if θi is a region term
parameter or Cn and IN if θi is a noise term parameter.








































































Lvec (Y )) (A.86)
Several of the matrix products in (A.82, A.85, A.86) have already been computed
for estimating the log-likelihood. The additional terms can be computed efficiently by



























Notice that the computation of RY or RV can also be done in linear time in N . In
the non-trivial case where R = GGT we can rewrite RY = G(GTY ) which takes
O(NRP ).






























where again many of the matrix products have already been computed while the new
















































= trC˜ trR− diag(D)Tdiag(C¯ ⊗ Sr) (A.98)
A gradient evaluation takes O(NRNPC +NRP +N +NNPC +NP +NP 2) oper-
ations, where we just report terms that depend on N as they are bottleneck for large
sample size and we report in blue terms that have to computed only once.
A.5 Implementation of mtSet-LowRankBg
Here we consider a low-rank approximation to the background covariance, which leads
to a model with two low-rank variance components and a full-rank noise term. Let
NNT be a K rank approximation to the RRM Rg. The log-likelihood of the model is
L = const.− 1
2








K = EET ⊗GGT +Cg ⊗NNT +Cn ⊗ IN (A.100)
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The covariance matrix of the model can be rewritten as
































































?TE? ⊗GTG E?TC?g 1/2 ⊗GTN
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Evaluating the log-likelihood The squared form can be computed as
vec (Y )T K−1vec (Y ) = vec (Y )T LT
(
I −W TΛ−1W )Lvec (Y ) (A.105)
= (Lvec (Y ))TLvec (Y )− (WLvec (Y ))TΛ−1WLvec (Y )(A.106)
where








While logdet term can be efficiently calculated as
log detK = N log detSn + log det Λ (A.108)
Reporting only terms that depend onN , a likelihood evaluation takes O(NR2+NRK+
NK2 + NKP + NRP + NP + NP 2) where we reported the operations that need to
be computed just once in blue.



































I −W TΛ−1W )L
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E?T C˜E? ⊗GTRG E?T C˜C?g 1/2 ⊗GTRN
C?g






and we used that ∂K∂θi can be written as
∂C
∂θi
⊗R where C and R are Cr and Rr if θi
is a region term parameter or Cn and IN if θi is a noise term parameter.
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The quadratic form term can then be computed as
vec (Y )T K−1
∂K
∂θi





Lvec (Y ) (A.114)
































































Λ−1ij (W (C˜ ⊗R)W T )ij . (A.120)
Reporting only terms that depend on N , a gradient calculation takes O(NR2 +
NK2 + NRK + NKP + NRP + N + NP + NP 2) where operations that need to be
computed just ones are marked in blue.
A.6 Implementation of iSet for stratification analysis










where y ∈ RN is the vector of the observed trait measurements, D is a diagonal matrix








 (11×2 ⊗G) , (A.122)
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where e ∈ {1, 2}N is a context indicator and G ∈ RN×R is the standardised genotype




log |K| − 1
2








































K = WW T +D (A.125)
A = X>K−1X (A.126)

















K−1 = D−1 −D−1WH−1W TD−1, (A.130)
H = I +W TD−1W (A.131)
As shown in more detail in the next paragraph, evaluation of a LML and its gradients
has complexity O(NR2 +NK2 +R3 +K3).
Computational complexity of all terms We denote with · · · the blocks which








• K−1y = D−1 −D−1WH−1W TD−1y
O(N +NR)
• K−1X = D−1 −D−1WH−1W TD−1X
O(NK +NRK)












































































−∑ijH−1ij ( D−1W T ∂D∂θi D−1W
)
ij
O(NR+N +NR2 +R3 +R2)
156
157
B | Supplementary Results for: Ef-
ficient set tests for joint anal-
ysis of correlated traits
B.1 Supplementary tables
Dataset Method pi a d
NFBC mtSet 0.06 0.55 2.67
mtSet-PC 0.06 0.50 3.12
stSet (crp3dec) 0.65 0.50 0.94
stSet (FS_KOL_L) 0.64 0.50 0.89
stSet (FS_KOL_H) 0.65 0.50 0.89
stSet (FS_TRIGL) 0.65 0.50 0.94
Rat dataset mtSet 0.22 0.59 2.08
mtSet-PC 0.19 0.55 2.33
stSet (basos) 0.91 0.50 0.59
stSet (eos) 0.93 0.35 1.14
stSet (lucs) 0.92 0.50 0.74
stSet (lymphs) 0.92 0.35 1.04
stSet (monos) 0.93 0.59 0.55
stSet (neuts) 0.93 0.35 1.14
Table B.1: Estimated parameters of the parametric LLR distribution. The
P values for the proposed set test are obtained from a log-likelihood ratio (LLR) test
statistics, assuming 1aLLR ∼ piχ20 + (1 − pi)χ2d. The mixture (pi), the scale (a) and
the degree-of-freedom (d) parameters are estimated by fitting the parametric form to
the distribution of LLRs obtained through permutations (see Section 3.1.2 for more
details). We here report the estimated values of pi, a and d for mtSet, mtSet-PC




A−1 O(N3 + P 3)
Cholesky
chol(I +W TDW ) D∧W O(NPCR)
W T∧(DW ) O(NPRC2 +NR2C2)
chol(I +W TDW ) O(C3R3)
Log Likelihood
log detK log detA O(NP )
log det Λ O(CR)
y˜TDy˜ − y¯TΛ−1y¯ y˜ = Lvec (Y ) O(N2P +NP 2)
y¯ = W TDvec (Y ) O(NP +NPC +NRC)





T O(N2R+ P 2C) region
O(N3 + P 3) rand effect
O(N3 + P 3) noise
∂̂K
∂θi
= W TD ∂˜K∂θiDW
∂˜K
∂θi ∧(DW ) O(NRPC





W T∧(D ∂˜K∂θiDW ) O(NPRC
2 +NR2C2)
**computed only once
**computed only once per-region
Table B.2: Tabular summary of the complexity of individual computational
steps in the mtSet inference.
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h2r 0.001 0.002 0.004 0.006 0.008 0.010 - -
Sr 1 2 5 8 12 20 - -
pir 0.00 0.125 0.375 0.50 0.75 1.00 - -
α 0.0 0.125 0.375 0.50 0.75 1.00 - -
h2g 0.00 0.10 0.20 0.40 0.60 0.80 - -
λ 0.00 0.10 0.20 0.40 0.60 0.80 - -
window size (in kb) 1 5 10 20 30 50 100 200
Table B.4: Parameter ranges for simulated datasets. To assess the power of
different methods, we considered a range of alternative simulations, varying key pa-
rameters that determine the genetic architecture of the traits. We altered the variance
explained by the region (h2r), the number of causal variants from the region (Sr), the
percentage of shared causal variants (pir), the percentage of background and residual
signal that is shared across traits (α), the variance explained by genetic background
(h2g), the percentage of residual variance explained by hidden confounders (λ) and the
window size. Each of those parameters was varied while keeping the other values at

















































































































































































































































































































































































































































































































































































































































































































Simulated term Variance explained
reg shared pirh2r
reg ind (1− pir)h2r
pop struct shared αh2g
pop struct ind (1− α)h2g
noise conf shared λα(1− h2g − h2r)
noise conf ind λ(1− α)(1− h2g − h2r)
noise iid (1− λ)(1− α)(1− h2g − h2r)
Table B.5: Average variance across traits explained by each term in the sim-
ulation framework. The table shows how the variance explained by each of the
simulated terms is related to the simulation parameters. The simulation parameters
are the variance explained by the causal region (h2r), the number of causal variants in
the region (Sr), the percentage of shared causal variants (pir), the variance explained by
relatedness effects (h2g), the fraction of residual variance that is not iid across samples
(λ), and the fraction of relatedness and residual signal that is shared across traits (α).
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Method Dataset Significance Level True Windows Test Windows Train Windows
mtSet 1000G α =5.00e-02 4.25e-02 5.41e-02 4.89e-02
1000G α =5.00e-03 4.26e-03 5.62e-03 5.08e-03
1000G α =5.00e-04 4.33e-04 5.73e-04 4.94e-04
1000G α =5.00e-05 5.37e-05 4.81e-05 5.39e-05
mtSet-PC 1000G α =5.00e-02 5.41e-02 4.83e-02 4.95e-02
1000G α =5.00e-03 6.49e-03 4.82e-03 5.08e-03
1000G α =5.00e-04 7.41e-04 4.13e-04 5.05e-04
1000G α =5.00e-05 1.09e-04 3.47e-05 4.68e-05
mtSet simPopStructure α =5.00e-02 4.70e-02 4.75e-02 4.92e-02
simPopStructure α =5.00e-03 4.87e-03 4.45e-03 5.00e-03
simPopStructure α =5.00e-04 4.53e-04 3.92e-04 4.77e-04
simPopStructure α =5.00e-05 4.92e-05 2.91e-05 4.01e-05
mtSet-PC simPopStructure α =5.00e-02 5.09e-02 4.86e-02 5.06e-02
simPopStructure α =5.00e-03 5.14e-03 4.40e-03 4.91e-03
simPopStructure α = 5.00e-04 5.17e-04 3.95e-04 4.66e-04
simPopStructure α =5.00e-05 4.03e-05 2.46e-05 4.23e-05
mtSet simUnrelated α =5.00e-02 4.57e-02 4.55e-02 4.79e-02
simUnrelated α =5.00e-03 4.56e-03 4.63e-03 4.96e-03
simUnrelated α =5.00e-04 4.06e-04 4.43e-04 4.72e-04
simUnrelated α =5.00e-05 5.37e-05 3.13e-05 5.06e-05
mtSet-PC simUnrelated α =5.00e-02 5.27e-02 4.89e-02 5.01e-02
simUnrelated α =5.00e-03 5.32e-03 4.89e-03 4.99e-03
simUnrelated α =5.00e-04 5.03e-04 4.62e-04 4.62e-04
simUnrelated α =5.00e-05 6.72e-05 2.69e-05 4.54e-05
mtSet simRelated α =5.00e-02 4.39e-02 4.72e-02 5.02e-02
simRelated α =5.00e-03 4.14e-03 4.32e-03 4.94e-03
simRelated α =5.00e-04 4.22e-04 4.06e-04 4.48e-04
simRelated α =5.00e-05 2.24e-05 4.48e-05 3.11e-05
mtSet-PC simRelated α =5.00e-02 1.40e-01 4.82e-02 5.00e-02
simRelated α =5.00e-03 2.86e-02 4.98e-03 5.19e-03
simRelated α =5.00e-04 5.57e-03 4.78e-04 5.22e-04
simRelated α =5.00e-05 9.77e-04 4.70e-05 4.45e-05
Table B.6: Type-1 error estimates on simulated data. Shown are the type-1 error
estimates for increasingly stringent α level thresholds α ∈ {0.05, 0.005, 0.005, 0.0005}
on four alternative simulated datasets (see also Fig. B.3). Train windows denote
regions that have been used (based on permutations) to fit the parametric model of null
distribution. True windows denote genomic regions that have not been used to train the
null model (independent test validation). Finally, test windows denote regions where
the genotype and phenotype relationship have been shuﬄed. These are equivalent to
train windows, but using a different set of permutations. mtSet and mtSet-PC perform
equally well when no structure or population structure is present, while the calibration
of mtSet-PC detoriates when the individuals are related.
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CRP LDL HDL TRIGL
Heritability Estimates
single-trait 0.11±0.04 0.37±0.02 0.36±0.02 0.15±0.04
multi-trait 0.11±0.04 0.36±0.02 0.36±0.02 0.16±0.03
Genetic Covariance Matrix
CRP 0.11±0.05 -0.03±0.03 0.06±0.03 -0.10±0.04
LDL -0.03±0.03 0.36±0.05 -0.05±0.04 0.06±0.04
HDL 0.06±0.03 -0.05±0.04 0.36±0.05 -0.11±0.04
TRIGL -0.10±0.04 0.06±0.04 -0.11±0.04 0.16±0.05
Noise Covariance Matrix
CRP 0.89±0.05 0.13±0.03 -0.24±0.04 0.36±0.04
LDL 0.13±0.03 0.63±0.05 -0.07±0.04 0.28±0.04
HDL -0.24±0.04 -0.07±0.04 0.64±0.05 -0.25±0.04
TRIGL 0.36±0.04 0.28±0.04 -0.25±0.04 0.84±0.05
Phenotypic Covariance Matrix
CRP 1.00±0.00 0.10±0.01 -0.18±0.01 0.26±0.01
LDL 0.10±0.01 1.00±0.00 -0.12±0.01 0.34±0.01
HDL -0.18±0.01 -0.12±0.01 1.00±0.00 -0.35±0.01
TRIGL 0.26±0.01 0.34±0.01 -0.35±0.01 1.00±0.00
Table B.7: Estimates of trait heritability and covariances for 4 lipid-related
traits from the NFBC dataset.
Heritability estimates: Single-trait heritability estimates are obtained indepen-
dently for each trait. Multi-trait estimates correspond to the marginal estimates ob-
tained form the genetic and noise trait covariance matrix from the null model fit of
mtSet. As expected, these marginal estimates are consistent.
Genetic covariance matrix: Trait-trait covariances of the relatedness component
from the null model fit of mtSet.
Noise covariance matrix: Trait-trait covariances of the noise component of the null
model fit of mtSet.
Phenotype covariance: Empirical covariance matrix of the raw phenotypes. All
estimates are obtained from a maximum likelihood fit of mtSet; standard errors are
denoted by ±.
164
CRP LDL HDL TRIG pos1 CRP LDL HDL TRIG
1 55250000 2.0E212 1.8E212 3.6E)01 3.8E214 3.6E)01 3.5E)01 ) ) ) ) ) )
1 55300000 1.3E214 2.2E214 3.6E)01 1.6E215 3.6E)01 3.5E)01 ) ) ) ) ) )
1 55450000 2.8E)06 5.2E)06 3.6E)01 3.8E208 3.6E)01 2.1E)01 ) ) ) ) ) )
1 55500000 2.8E208 1.1E208 2.9E)01 2.8E210 3.6E)01 2.7E)01 ) ) ) ) ) )
1 62850000 1.4E207 9.4E208 3.6E)01 3.0E)05 2.7E)02 7.4E)04 ) ) ) ) ) )
1 109600000 1.6E213 3.1E214 4.0E)02 1.1E)13 5.0E)02 1.1E)01 109620053 6.4E216 1.2E)01 2.9E215 7.3E)02 1.0E+00
1 109650000 2.2E213 6.2E)06 1.6E)01 1.2E)13 9.0E)02 2.3E)01 ) ) ) ) ) )
1 157850000 2.4E211 4.8E212 2.0E213 2.4E)02 3.6E)01 8.5E)02 157908973 4.8E214 5.3E216 9.3E)01 8.6E)02 5.0E)01
1 157900000 2.7E223 1.7E225 3.0E225 1.5E)01 2.0E)01 3.5E)01 157914612 7.0E213 3.0E214 5.7E)01 8.1E)01 9.6E)01
1 157950000 8.4E225 3.0E227 5.0E227 3.6E)01 1.8E)01 3.5E)01 157919563 6.5E216 4.9E218 9.5E)01 4.6E)02 4.1E)01
1 158000000 1.3E214 6.6E216 3.0E216 3.6E)01 3.6E)01 3.5E)01 157945440 3.6E221 1.3E222 7.1E)01 2.8E)01 8.9E)01
1 ) ) ) ) ) ) ) 157966663 1.5E208 5.8E209 1.5E)01 6.0E)02 7.1E)01
2 21000000 2.3E)07 6.3E209 2.7E)01 4.6E)09 4.6E)04 1.8E)03 21047434 1.1E208 1.2E)01 6.8E)07 4.0E)06 8.8E)06
2 21050000 5.0E208 9.0E210 2.4E)01 1.4E)08 5.5E)05 1.1E)04 21059688 1.1E208 1.0E)01 5.4E)07 4.7E)06 1.2E)05
2 21100000 4.2E209 6.3E211 3.6E)01 1.0E)10 1.4E)04 1.9E)04 21085700 1.3E)07 4.1E)01 1.8E209 3.0E)02 7.6E)03
2 21150000 8.1E209 3.0E209 3.6E)01 1.8E)11 4.6E)02 3.5E)01 21091049 2.5E208 1.6E)01 6.5E)06 2.4E)06 3.8E)06
2 21200000 1.8E207 1.0E207 3.6E)01 5.1E)10 3.8E)02 3.5E)01 21165046 5.1E208 7.3E)01 5.3E210 1.3E)01 1.1E)01
2 27550000 1.8E)06 1.6E207 3.6E)01 2.4E)02 3.6E)01 1.8E208 27584444 2.1E208 2.9E)02 1.1E)01 1.7E)01 3.5E210
2 27600000 7.1E)07 5.7E208 7.7E)02 1.0E)02 3.6E)01 6.3E209 27594741 2.3E)07 7.5E)02 2.6E)01 3.5E)01 6.2E209
8 9200000 6.9E208 4.8E209 2.1E)03 6.9E)03 1.3E)03 3.0E)01 9215142 1.6E209 6.0E)04 2.4E)03 2.8E)05 9.2E)01
8 9250000 1.1E207 9.5E209 4.5E)03 1.1E)02 1.3E)03 3.5E)01 9222556 3.8E210 1.5E)03 6.9E)04 1.5E)05 5.3E)01
8 19850000 6.1E208 5.0E208 2.1E)01 3.6E)01 1.3E)04 8.4E)07 19875201 7.8E210 2.9E)01 9.0E)01 2.9E)06 4.6E209
8 19900000 5.5E212 2.5E212 3.6E)01 3.6E)01 3.0E)07 8.0E209 ) ) ) ) ) )
8 19950000 7.7E212 8.7E212 2.5E)01 3.6E)01 2.2E208 7.1E209 ) ) ) ) ) )
11 61300000 7.0E)07 1.8E208 2.9E)01 8.7E)07 5.4E)03 9.6E)03 61314379 2.2E208 8.1E)01 3.3E)06 2.8E)02 1.4E)02
11 61350000 2.8E)07 2.6E209 3.6E)01 4.8E)06 2.4E)02 6.2E)02 61326406 1.7E208 7.9E)01 2.4E)06 5.0E)02 1.2E)02
11 61400000 1.1E207 1.7E209 3.6E)01 2.3E)06 3.4E)03 5.1E)02 ) ) ) ) ) )
11 116100000 7.7E)07 6.2E)07 3.6E)01 2.3E)02 6.0E)03 4.6E208 ) ) ) ) ) )
11 116150000 2.4E208 2.8E208 3.6E)01 5.7E)02 2.7E)03 8.7E210 ) ) ) ) ) )
12 119850000 4.9E210 2.7E211 4.9E212 3.6E)01 3.6E)01 1.5E)01 119873345 5.1E212 1.3E213 9.4E)01 1.8E)01 8.9E)01
12 119900000 6.1E211 2.6E212 1.1E212 3.6E)01 1.9E)01 2.0E)01 119888107 3.0E211 7.2E213 9.3E)01 1.4E)01 7.9E)01
12 119950000 3.6E208 4.1E)01 2.1E208 3.6E)01 3.6E)01 3.5E)01 119915608 6.8E210 2.2E210 3.7E)01 4.7E)01 3.1E)01
12 ) ) ) ) ) ) ) 119919810 7.9E210 1.8E210 5.1E)01 4.1E)01 3.5E)01
12 ) ) ) ) ) ) ) 119923227 7.1E209 5.1E209 3.1E)01 5.7E)01 1.9E)01
15 56450000 1.1E212 1.4E214 3.6E)01 9.1E)02 1.6E209 4.4E)02 56468097 1.4E209 4.8E)01 3.5E)02 1.0E)07 2.3E)01
15 56500000 4.4E224 7.6E226 1.2E)01 2.8E)01 6.7E215 7.8E)04 56470658 8.2E216 6.7E)01 3.4E)01 6.6E213 4.0E)02
15 56550000 1.7E212 1.2E212 1.8E)01 3.6E)01 4.1E)07 4.3E)03 56478046 1.0E209 5.4E)01 5.7E)01 1.8E)08 9.0E)02
15 ) ) ) ) ) ) ) 56524633 8.4E209 6.1E)02 4.7E)01 1.4E)03 4.6E)05
15 ) ) ) ) ) ) ) 56529710 4.6E209 6.3E)02 2.1E)01 5.7E)04 6.4E)05
16 55500000 1.0E208 3.1E209 2.2E)01 3.6E)01 1.9E210 3.5E)01 55542640 7.0E209 7.0E)01 7.9E)01 7.2E210 9.5E)01
16 55550000 1.9E233 3.6E236 4.8E)02 1.8E)01 5.5E235 3.2E)01 55550825 8.7E236 2.7E)01 7.2E)02 4.4E236 2.1E)01
16 55600000 1.7E233 2.8E236 8.3E)02 2.1E)01 4.6E235 3.5E)01 55562980 1.8E224 1.4E)01 1.8E)01 3.6E226 7.1E)02
16 ) ) ) ) ) ) ) 55564091 1.4E219 2.7E)01 8.0E)01 5.8E219 5.9E)01
16 66550000 2.1E)06 3.8E208 3.6E)01 3.2E)01 7.8E)08 3.2E)01 ) ) ) ) ) )
19 11050000 2.0E209 4.6E210 2.6E)02 5.4E)12 2.7E)01 2.5E)01 ) ) ) ) ) )
19 11100000 6.1E208 1.7E208 1.4E)01 2.9E)10 3.6E)01 1.4E)01 ) ) ) ) ) )
19 49850000 1.9E208 1.2E208 8.8E)03 6.4E)06 1.6E)01 3.5E)01 50087106 1.0E208 2.2E)01 5.1E209 1.5E)02 1.4E)03
19 49900000 1.1E210 7.6E212 9.2E)04 6.7E)10 1.2E)01 1.2E)02 50087459 4.7E212 9.9E)06 1.1E)05 4.0E)02 1.2E)04
19 49950000 1.8E209 5.7E211 3.7E)02 4.2E)10 3.6E)01 1.2E)02 ) ) ) ) ) )
19 50050000 3.4E219 1.7E221 7.1E)08 1.5E)16 1.4E)01 1.9E)03 ) ) ) ) ) )
19 50100000 2.1E232 8.3E236 4.1E212 1.0E)25 1.5E)01 8.2E)05 ) ) ) ) ) )




















Table B.8: Tabular summary of QTLs identified by different set tests and
single-variant LMMs on the NFBC dataset. The table shows all significant
associations (α < 0.01, Bonferroni adjusted) found by different set test (left) and single-
variant LMMs (right) grouped by locus. Significant associations (α < 0.01, Bonferroni
adjusted) are boldified. The numbers in square brackets after the gene names indicate
whether the locus was identified in Teslovich et al. (2010), [1], in Zhou and Stephens
(2014), [2], or both, [1,2].
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Region mtSet*(100*kb) mtSet*(60*kb) mtSet*(300*kb)
chrom pos pv chrom pos pv chrom pos pv
PCSK9[1]* 1 55250000 1.95E&12 1 55260000 1.01E&11 1 55200000 7.88E&13
1 55300000 1.30E&14 1 55290000 5.04E&09 1 55350000 1.77E&17
1 55500000 2.84E&08 1 55320000 2.64E&08 1 55500000 3.44E&09
1 55500000 5.60E&08
ANGPTL3[1] 1 62850000 1.44E&07 1 62940000 7.91EK04 1 62850000 1.21EK06
SORT1[1],*CELSR2[2] 1 109600000 1.59E&13 1 109590000 1.28E&11 1 109500000 1.81E&12
1 109650000 2.23E&13 1 109620000 2.75E&15 1 109650000 7.85E&13
1 109650000 1.29E&14
CRP[2] 1 157850000 2.44E&11 1 157860000 4.27E&11 1 157800000 2.20E&25
1 157900000 2.71E&23 1 157890000 1.76E&21 1 157950000 1.46E&23
1 157950000 8.44E&25 1 157920000 4.26E&25 1 158100000 5.06E&11
1 158000000 1.25E&14 1 157950000 1.07E&28
1 157980000 7.61E&17
1 158010000 2.44E&09
APOB[1,2] 2 21050000 5.00E&08 2 21030000 3.33E&08 2 21000000 2.94E&10
2 21100000 4.19E&09 2 21060000 1.19E&08 2 21150000 1.14E&11
2 21150000 8.09E&09 2 21090000 1.27E&07
2 21200000 1.77E&07 2 21120000 1.58E&09
2 21150000 2.36E&09
2 21180000 4.12E&08
PPP1R3B[1,2] 8 9200000 6.87E&08 8 9210000 4.98E&09 8 9150000 7.34E&08
8 9250000 1.09E&07 8 9240000 7.47E&09 8 9300000 4.81E&07
LPL[1,2] 8 19850000 6.12E&08 8 19860000 8.58E&09 8 19800000 4.54E&09
8 19900000 5.55E&12 8 19890000 6.56E&10 8 19950000 1.97E&09
8 19950000 7.71E&12 8 19920000 7.65E&15
FADS[1,2] 11 61400000 1.12E&07 11 61350000 6.09E&08 11 61350000 4.98E&07
APOA1KC3KA4KA5[1] 11 116150000 2.42E&08 11 116130000 1.93E&09 11 116250000 8.97EK07
11 116160000 8.27E&09
HNF1A[1,2] 12 119850000 4.93E&10 12 119850000 4.04E&10 12 119850000 1.40E&11
12 119900000 6.05E&11 12 119880000 4.35E&11 12 120000000 5.07E&10
12 119950000 3.61E&08 12 119910000 2.92E&11
12 119940000 1.77E&09
LIPC[1,2] 15 56450000 1.10E&12 15 56460000 2.22E&14 15 56400000 5.56E&28
15 56500000 4.35E&24 15 56490000 1.44E&26 15 56550000 9.26E&27
15 56550000 1.71E&12 15 56520000 5.40E&13
15 56550000 2.35E&09
CETP[1,2] 16 55500000 1.02E&08 16 55530000 1.51E&33 16 55350000 2.02E&07
16 55550000 1.94E&33 16 55560000 1.64E&38 16 55500000 2.37E&32
16 55600000 1.70E&33 16 55590000 3.43E&29 16 55650000 1.58E&31
LDLR[1,2] 19 11050000 1.97E&09 19 11070000 6.31E&11 19 10950000 8.15E&10
19 11100000 6.06E&08 19 11100000 5.47E&08 19 11100000 2.02E&08
19 49850000 1.90E&08 19 49920000 3.33E&10 19 49800000 8.48E&11
APOEKC1KC2[1,2] 19 49900000 1.05E&10 19 49950000 4.65E&10 19 49950000 6.04E&26
19 49950000 1.82E&09 19 50070000 1.84E&19 19 50100000 3.36E&32
19 50050000 3.39E&19 19 50100000 3.49E&36 19 50250000 4.88E&16
19 50100000 2.11E&32 19 50130000 7.73E&23
19 50150000 1.37E&20
Table B.9: Tabular summary of QTLs identified by mtSet with varying win-
dow size on the NFBC dataset. The table shows all significant associations
(α < 0.01, Bonferroni adjusted) found by mtSet when considering different window
sizes. Specifically, we considered window sizes of 60kb, 100kb and 300kb. The results
are overall robust, with only the PCSK9 locus missed by both the 60kb and the 300kb
analysis, and the APOA1-C3-A4-A5 locus missed by the 300kb analysis.
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basos eos lucs monos neuts
Heritability Estimates
single-trait 0.29±0.03 0.44±0.03 0.33±0.03 0.59±0.02 0.46±0.03
multi-trait 0.31±0.03 0.44±0.03 0.33±0.03 0.60±0.02 0.46±0.03
Genetic Covariance Matrix
basos 0.31±0.05 0.14±0.04 0.22±0.04 0.34±0.05 0.21±0.04
eos 0.14±0.04 0.49±0.07 0.04±0.04 0.14±0.05 0.20±0.05
lucs 0.22±0.04 0.04±0.04 0.34±0.05 0.39±0.05 0.22±0.04
monos 0.34±0.05 0.14±0.05 0.39±0.05 0.66±0.07 0.26±0.05
neuts 0.21±0.04 0.20±0.05 0.22±0.04 0.26±0.05 0.48±0.06
Noise Covariance Matrix
basos 0.68±0.03 0.18±0.03 0.21±0.03 0.31±0.03 0.27±0.03
eos 0.18±0.03 0.64±0.04 0.17±0.03 0.19±0.02 0.19±0.03
lucs 0.21±0.03 0.17±0.03 0.70±0.03 0.27±0.02 0.30±0.03
monos 0.31±0.03 0.19±0.02 0.27±0.02 0.45±0.03 0.26±0.02
neuts 0.27±0.03 0.19±0.03 0.30±0.03 0.26±0.02 0.56±0.03
Phenotypic Covariance Matrix
basos 1.00±0.00 0.28±0.03 0.42±0.02 0.62±0.02 0.48±0.02
eos 0.28±0.03 1.00±0.00 0.20±0.03 0.30±0.03 0.33±0.03
lucs 0.42±0.02 0.20±0.03 1.00±0.00 0.60±0.02 0.51±0.02
monos 0.62±0.02 0.30±0.03 0.60±0.02 1.00±0.00 0.50±0.02
neuts 0.48±0.02 0.33±0.03 0.51±0.02 0.50±0.02 1.00±0.00
Table B.10: Estimates of trait heritability and covariances for 6 phenotypes
related to basal haematology on the rat dataset.
Heritability estimates: Single-trait heritability estimates are obtained indepen-
dently for each trait. Multi-trait estimates correspond to the marginal estimates ob-
tained form the genetic and noise trait covariance matrix from the null model fit of
mtSet. As expected, these marginal estimates are consistent.
Genetic covariance matrix: Trait-trait covariances of the relatedness component
from the null model fit of mtSet.
Noise covariance matrix: Trait-trait covariances of the noise component of the null
model fit of mtSet.
Phenotype covariance: Empirical covariance matrix of the raw phenotypes. All
estimates are obtained from a maximum likelihood fit of mtSet; standard errors are
denoted by ±.
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basos eos lucs lymphs monos neuts
1 chrom1:273500000 9.76E407 9.27E'02 7.18E'02 1.12E'02 8.15E'02 1.71E'05 7.46E'02
2 chrom1:274000000 4.65E407 9.27E'02 7.18E'02 2.02E'02 8.15E'02 8.45E'06 7.46E'02
3 chrom8:128500000 4.99E407 9.27E'02 7.18E'02 8.12E'02 8.15E'02 7.63E'06 7.46E'02
4 chrom8:129000000 1.56E407 9.27E'02 7.18E'02 8.12E'02 8.15E'02 8.17E'06 7.46E'02
5 chrom8:129500000 1.11E407 9.27E'02 7.18E'02 8.12E'02 8.15E'02 9.34E'06 7.46E'02
6 chrom8:130000000 3.23E407 9.27E'02 7.18E'02 8.12E'02 8.15E'02 1.31E'05 7.46E'02
7 chrom8:130500000 1.17E408 9.27E'02 7.18E'02 8.12E'02 8.15E'02 3.29E'07 7.46E'02
8 chrom8:131000000 2.17E409 9.27E'02 7.18E'02 8.12E'02 8.15E'02 5.15E408 7.46E'02
9 chrom8:131500000 1.27E409 9.27E'02 7.18E'02 8.12E'02 8.15E'02 2.78E408 7.46E'02
10 chrom8:132000000 1.21E409 9.27E'02 7.18E'02 8.12E'02 8.15E'02 3.71E408 7.46E'02
11 chrom8:132500000 1.06E409 9.27E'02 7.18E'02 8.12E'02 8.15E'02 4.68E408 7.46E'02
12 chrom9:500000 7.99E410 9.27E'02 7.18E'02 8.12E'02 8.84E413 7.19E'02 7.46E'02
13 chrom9:1000000 2.05E410 3.99E'03 7.18E'02 1.88E'03 1.67E414 7.19E'02 7.46E'02
14 chrom9:1500000 6.55E411 1.83E'03 7.18E'02 1.17E'03 1.04E414 7.19E'02 7.46E'02
15 chrom9:2000000 6.20E410 7.99E'03 7.18E'02 1.13E'02 1.22E411 7.19E'02 7.46E'02
16 chrom9:2500000 3.38E409 1.05E'02 7.18E'02 8.12E'02 3.85E411 7.19E'02 7.46E'02
17 chrom9:3000000 8.66E408 9.27E'02 7.18E'02 8.12E'02 9.70E409 7.19E'02 7.46E'02
stSetCandidate@Windows mtSet
(a) Set tests
basos eos lucs lymphs monos neuts
3 chrom8:131701894 1.03E411 2.24E&02 6.63E&01 2.99E&02 3.27E&02 3.79E411 6.41E&01
12 chrom9:902862 7.66E414 9.84E&03 5.96E&01 1.55E&04 5.62E414 3.14E&01 8.13E&01
13 chrom9:1177156 6.70E414 1.38E&02 5.48E&01 1.93E&04 8.75E414 3.56E&01 9.23E&01
stLMM4SVmtLMM4SVLeadASNP
(b) Single variant tests
start%QTL end%QTL length%QTL
3 128089062 132222468 4.13Mb
12 865652 2619519 1.75Mb
13 865652 2619519 1.75Mb
(c) QTL length in single-variant tests
Table B.11: Tabular summary of QTLs identified by different set test and
single-variant LMMs on the rat dataset. The table shows significant associations
(α < 0.01, Bonferroni adjusted) found by different set test and single-variant LMMs
in the analysis of the rat data. Only significant associations (α < 0.01, Bonferroni
adjusted) are in bold. (a) shows the results from all regions identified using set tests.
(b) shows the lead variants from the regions identified by single-variant tests. (c) shows
the length of QTL intervals identified by the multi-trait single-variant models, which
were calculated as the genomic distance between the most extreme significant variants
at the same locus.
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B.2 Supplementary figures




























































Figure B.1: Parametric Fit of the Null Distribution on the 1,000 Genomes
dataset for mtSet. The null distribution is fit by a mixture pi of χ20 and aχ2d test
statistics using five genome-wide permutations. Although, we use only the top 10%
of null test statistics for fitting the free parameters pi, a, d, we found empirically that
our fit works well for the complete range of the test statistics. Shown are the results
for five different repetitions of four simulated phenotypes when only background effects
are present.
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Figure B.2: Comparison mtSet-PC and mtSet-LowRankBg. Compared are like-
lihood ratio test statistics for mtSet-PC and mtSet-LowRankBG. For large cohorts, we
find good concordance between both models. This shows that accounting for PCs as
(REML) fixed effects or random effects yields similar results.
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Figure B.3: Characterization of the confounding structure in the four sim-
ulated datasets that were used to assess statistical calibration. Shown are
the empirical relatedness matrices as well as the scatter plots of the first two principal
components. (a) Empirical genotype data of 1,000 individuals from 14 populations
that are part of the 1000 genomes project (1000G). (b-d) Synthetic datasets based on
genotypes from 1,000 Genomes Projects of European ancestry. In brief, each individ-
ual is assigned to n ancestors, randomly inheriting blocks of SNPs from its ancestors.
By placing alternative restrictions on the ancestors (number of ancestors, ancestors are
drawn from the same or different populations), datasets with different confounding pop-
ulation structure are obtained: (b) simPopStructure (kinship matrix is low-rank), (c)





Figure B.4: Computational cost for variable numbers of traits. Shown is the
extrapolated CPU time (h) to test associations on chromosome 20, considering a total
of 3,975 windows (tests), on a simulated cohort with 1,000 individuals for increasing
numbers of traits. Compared are mtSet and the approximate mtSet-PC model. Naive
denotes the runtime for a standard LMM package, which scales cubical in the number
of traits times the number of individuals. Runtime estimates were obtained from a

























mtSet mtSet-PC stLMM mtLMM
Figure B.5: Statistical calibration of mtSet, mtSet-PC, stLMM-SV and
mtLMM-SV on simulated datasets with different confounding structure.
Shown are QQ-plots for simulated data when only background effects (no causal vari-
ants) were simulated when considering alternative degrees of population structure and
relatedness (see Fig. ??). Compared are a single trait singe SNP LMM (stLMM-SV),
a multi-trait single-SNP LMM (mtLMM-SV) as well as mtSet and the PC-based ap-
proximation (mtSet-PC).
From left to right: mtSet, mtSet-PC, stLMM-SV and mtLMM-SV.
From top to bottom: 1000 Genomes (real genotypes), simPopStructure, simUnre-
lated, simRelated. Whereas the calibration of mtSet, stLMM-SV and mtLMM-SV were
not affected by the type of confounding, mtSet-PC was not able to account for complex




Figure B.6: Scalability of mtSet as a function of the number of variants in
the set component. Shown is computational time to fit a single window using mtSet
(a) and mtSet-PC (b) (randomly drawn from chrom 20, 1,000 Genomes dataset), con-
sidering a Intel(R) Xeon(R) CPU E5-2670 0 @ 2.60GHz, for windows with increasing
numbers of variants. Runtimes are reported for windows of varying size (1kb-200kb)
using simulated data generated using the default parameter settings (see also Table
B.4).
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Figure B.7: Power comparison of alternative methods on simulated data from
1000 genomes project genotypes. Shown is power at 10% family-wise error rate
for mtSet, stSet, mtSet-PC, mtLMM-SV and stLMM-SV varying different simulation
parameters. Specifically, we altered the proportions of variance explained by the region
(h2r), the numbers of causal variants in the region (Sr), the percentages of shared causal
variants (pir), the proportions of variance explained by genetic background (h2g), the
percentage of residual variance explained by hidden confounders (λ), and the percentage
of background and residual signal that is shared across traits (α) (see also Table B.4).
174
(a) (b) (c)
Figure B.9: QQ-plots for blood lipid levels on the NFBC dataset. All
methods show good calibration. Genomic control is λ(mtLMM-SV) = 0.979,
λ(stLMM-SV[CRP]) = 0.995, λ(stLMM-SV[LDL]) = 0.996, λ(stLMM-SV[HDL]) =
1.001 and λ(stLMM-SV[TRIGL]) = 0.978 for the single-variant methods, λ(mtSet) =
1.001 and λ(mtSetPC) = 0.989 for the set methods.
Figure B.8: Distribution of the number of variants within testing regions as
well as the squared intra-SNP correlation coefficient, both as a function of
the considered window size. Left column: Dependency between window sizes and
number of SNPs. Right column: Dependency between window sizes and SNP-SNP
squared correlation within windows. From top to bottom: Rat datasets, NFBC
data, 10000 Genomes (chromosome 20). The computational cost of mtSet depends on
the number of (unique) SNPs in a window. In the experiments, we considered 100kb
windows for NFBC, 1mb windows for rat and 30kb windows for the 1,000 genomes
data.
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Figure B.10: Histogram of p-values obtained from set tests applied to four
blood lipid levels on the NFBC dataset. Top row: multi-trait set tests (mtSet,
mtSet-PC) applied to all four traits jointly.
Bottom two rows: single-trait set test (stSet) applies to individual traits. The
peaks in the histograms is common to all set tests and is a result of the constrained
optimization of the marginal likelihood: in these instances the set component variance
parameter is zero, the bound of the optimization. The location of the peak is a function
of the mixture coefficients of the parametric null distribution fit.
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(a) stLMM-SV: minimum p-value




Figure B.11: Manhattan plots for blood lipid levels on the NFBC dataset.
We report the minimal p-values over all phenotypes (CRP, LDL, HDL and TRIGL)
for the single-trait methods stLMM-SV (a) and stSet (b). The manhattan plots for
mtLMM-SV, mtSet and mtSet-PC are shown in (c,d) and (e). The model mtSet-PC
recovers all associations that are found by its competitors (stLMM-SV,mtLMM-SV and
stSet) and two additional associations: the first one is on chromosome 1 (shared with
mtSet) and the second one on chromosome 16 .
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(a) stLMM-SV(basos) (b) stSet(basos)
(c) stLMM-SV(eos) (d) stSet(eos)
(e) stLMM-SV(lucs) (f) stSet(lucs)
(g) stLMM-SV(lymphs) (h) stSet(lymphs)
(i) stLMM-SV(monos) (j) stSet(monos)
(k) stLMM-SV(neuts) (l) stSet(neuts)
(m) mtLMM-SV (n) mtSet
Figure B.12: Manhattan plots for quantitative traits related to basal haema-
tology on rat. (a, c, e, g, i, k) show manhattan plots for basophils (basos), eosinophils
(eos), large unstained cells (luc), lymphocytes (lymphs), monocytes (monos) and neu-
trophils (neuts) obtained using stSet-SV while (b, d, f, h, j, l) show manhattan plots
for the same traits from stSet. Finally, (m) and (n) show manhattan plots for multi-
trait mixed model (mtLMM-SV) and mtSet respectively. Notice that the horizontal
line in manhattan plots for stSet contains all regions for which the log-likelihood ratio
is ≈ 0 and it is a consequence of the LLR test statistics, which follows approximately
a mixture of chi squared.
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(a) Multi-Trait Set Test - without the relatedness component (mtSet-noBg).
(b) Multi-Trait Set Test - top 30 principal components (mtSet-PC).
(c) Multi-Trait Set Test - including the relatedness component (mtSet).
Figure B.13: Manhattan plots for alternative set tests applied to six phe-
notypes related to basal haematology on the rat dataset. a, manhattan plot
obtained when omitting the relatedness component (mtSet-noBg). b, equivalent man-
hattan plot when using mtSet-PC to correct for population structure. c, corresponding
results when including the relatedness component (mtSet). Only the full model that




C | Supplementary results for: Test-











































































































































































































































Table C.1: Comparison table of iSet and related models for interaction test-
ing.
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Effect Function of parameters Variance explained
Region effect vr 2%
Shared relatedness effects αvbg 24%
Independent relatedness effects (1− α)vbg 16%
Shared effects from hidden factors αβ(1− vr − vbg) 17.4%
Independent effects from hidden factors (1− α)β(1− vr − vbg) 11.6%
IID noise (1− β)(1− vr − vbg) 29%
(a) Variance explained by the different contributions
Parameter
Number of causal variants 1 2 4 8 12 20 - - - -
Proportionality factor
(extent of rescaling-GxC) -0.5 -0.3 -0.2 -0.1 0 0.1 0.2 0.3 0.5 0.7








heter-GxC) -1, -.8 -.8, -.6 -.6, -.4 -.4, -0.2 -.2, 0 0, .2 .2, .4 .4, .6 6, .8 .8, 1
(c) Parameter values for general-GxC simulations
Table C.2: Simulation settings. Simulated Phenotype data were generated as sum
of an effect from the variants of the genetic region, an effect from relatedness / popu-
lation structure, an effect from K = 10 unmeasured hidden confounders and iid noise.
We fixed the variance explained by the region (vr = 2%), the fraction of shared back-
ground signal (α = 0.6), the fraction of residual variance that is explained by the the
hidden factors (β=0.5) while varying the number of causal variants and the extents of
rescaling-GxC and heterogeneity-GxC. (a) The contributions to phenotypic variance
of all simulated effects. (b,c) The values of parameters considered respectively for
simulations of rescaling-GxC and heterogeneity-GxC effects. Each of the parameters






















































(7.3%) 3.6 8.9 10
-4
(d) All
Table C.3: Enrichment of heterogeneity-QTLs in opposite direction QTLs
Breakdown of probe / stimulus pairs with shared lead variants, stratified by concor-
dance of the effect direction (opposite-direction versus same-direction eQTLs) and
significance of the heterogeneity-GxC test (heter vs No heter) in naïve/IFN (a),









































































































































































































Table C.4: Tabular summary of interaction and association loci in blood lipid
profiles from NFBC1966. Tabular summary of the interaction and association loci
discussed in the Section 4.4.3.
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C.2 Supplementary figures
Figure C.1: Statistical calibration of iSet-het when only rescaling-GxC ef-
fects are simulated. Shown is the QQ plot for the P values obtained from the
heterogeneity-GxC interaction test (iSet-het) when simulating rescaling-GxC (without
heterogeneity-GxC). P values are pooled across all simulations in Fig. 4.4c (where
exclusively rescaling-GxC effects were simulated).
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(a) 1000G
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(b) Stimulus eQTL dataset
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Figure C.2: Distribution of the number of variants, number of effective tests
estimated by eigenMT and average squared correlation within the testing
regions in the different datasets. From left to right: distribution of the number
of variants across the analysed regions; distribution of the number of effective tests as
estimated by eigenMT; distribution of the average pair-wise squared Pearson correlation
(R2) across all variants in each region; scatter plot of the number of effective tests
versus the number of variants. Shown in colour is the within-region average correlation
(R2) across all pairs of variants. From top to bottom: (a) 10,000 30kb regions from
the simulated data (1,000 individuals) based on 1000 Genomes individuals, (b) 100kb
cis regions (centred on the TSS) considered in the cis stimulus eQTL analysis (288









Figure C.3: Power of iSet and iSet-het when simulating heterogeneity-GxC
effects and increasing numbers of causal variants. Shown is the power of iSet
and a single-variant interaction test (mtLMM-int) to detect GxC interactions when
simulating heterogeneity-GxC and increasing the number of causal variants. We also
report power of iSet-het to detect heterogeneity-GxC.
ba
Figure C.4: Comparison of iSet-het and single-variant strategies for dis-
criminating rescaling from heterogeneity-GxC. Receiver operating curve (a)
and precision-recall curve (b) when using different approaches to discriminate
heterogeneity-GxC. Considered was the iSet test to score the extent of heterogeneity
(iSet-het) and a baseline approach based on single-trait single-variant LMMs. Briefly,
the considered score is 1− r2 (where r is the Pearson correlation between lead variants
identified in each context) for regions with significant associations in both contexts
(P-value thresholds 0.5, 0.01, 1e-3, 1e-4). Regions that were not marginally significant
in either one of the two contexts were assigned a score of zero. In a ROC curve the
true positive rate is plotted against the false positive rate threshold. In a PR curve
precision of the model (which is the fraction of retrieved cases that are positive) is



























































































































































































































Figure C.5: Assessment of genetic variance estimates from iSet using differ-
ent covariance models. Shown are the estimates of the genetic variance explained
by the set component across different simulated settings when considering alternative
covariance models. In particular, shown are the variance component estimates when
alternatively considering a full-rank covariance (full, general case), a rank-one covari-
ance (rank1, only rescaling-GxE) and a block covariance matrix (block, which models
only persistent genetic effects). Both designs with fully observed cohorts (complete -
1,000 individuals and 2 contexts for a total of 2,000 trait measurements) and strat-
ified samples (stratified - 2,000 individuals and 2 contexts for a total of 2,000 trait
measurements) are considered. Only the full-rank iSet model yields variance compo-
nent estimates that are calibrated across all simulated scenarios. In particular, we
considered scenarios with either rescaling-GxC effects (where we varied the number of
causal SNPs and the proportionality factor of the effect sizes across the two contexts)
or heterogeneity-GxC (where we vary the number of SNPs). For each simulated sce-
nario we considered 1,000 simulated regions and altered the variance explained by the
region (we consider the values 2%, 5% and 10%). Grey horizontal lines denote the true
simulated local genetic variance.
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Figure C.6: Comparison of single-variant methods and set tests on the mono-
cyte stimulus eQTL data. Shown are the scatter plots of the -log10P values from
single-variant LMMs and set tests for association tests (mtLMM vs mtSet) and inter-
action tests (mtLMM-int vs iSet) for different stimulus contexts (IFN / naive, LPS-2h
/ naive, LPS-24h / naive). Region-based P values for single-variant models are mini-
mum P-value across variants in the region, adjusted for the effective number of tests
(estimated using eigenMT). Venn diagrams on the top of individual panels show the













% Uninterpretable heterogeneity eQTLsusing single-variant approach
Interpretable heterogeneity eQTLs
using single-variant approach
Figure C.7: Comparison of adjusted P values obtained using either a univari-
ate set set or a univariate single-variant test. Scatter plot of the adjusted P values
across pairs of contexts (independent analysis), comparing set tests and single-variant
tests for different stimulus pairs. Heterogeneity-GxC cases without clear single-variant
interpretation (highlighted in red) tend to be more significant when using set tests, sug-






PTK2B (chrom 8)a b cPhet = 1.31e-05 Phet = 8.15e-05 Phet = 9.15e-04
Figure C.8: Examples of opposite-effect eQTLs with significant heterogeneity-
GxC effects. Shown is the z-score statistics at cis variants for OAS (a), LMNA (b) and
PTK2B (b) across the contexts showing opposite effects. While the three examples are
identified as opposite effects when using single-variant methods (Fairfax et al., 2014),
iSet identifies significant heterogeneity-GxC, indicating changes in the configuration of
causal variants. Lead variants in individual contexts are annotated using circles and






























Figure C.9: Manhattan plots when applying alternative methods to lipid
levels in NFBC1966. Shown are Manhattan plots for C-reactive protein (crp3dec,
a), LDL cholesterol (FS_KOL_L, b), HDL cholesterol (FS_KOL_H, c), and triglyc-
erides (FS_TRIG, d) obtained from univariate set tests ignoring sex-specific differences
(stSet), an association test that accounts for differences in genetic effect across strata
(mtSet), iSet, GESAT and single-variant interaction test (mtLMM-int). Red arrows
indicate the interaction effects that are discussed in the Section 4.4.3. Blue arrows
indicated associations that can only be detected when modelling differences in effect




















































Figure C.10: QQ plots when applying alternative methods to lipid levels in
NFBC1966. Shown are the QQ plots for C-reactive protein (crp3dec), LDL choles-
terol (FS_KOL_L), HDL cholesterol (FS_KOL_H), and triglycerides (FS_TRIG)
obtained using a univariate association set tests ignoring sex (stSet, a), an associa-
tion test modelling sex-specific genetic effects (mtSet, b), iSet (c), GESAT (d) and
single-variant interaction test (mtLMM-int).
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Figure C.11: Manhattan plot in the interaction locus for C-reactive protein
using single-variant interaction tests on imputed variants. Shown is the Man-
hattan plot for C-reactive protein obtained from single-variant interaction tests applied
to common variants (MAF> 0.5%) on imputed data. The vertical grey lines indicate
the 100kb region with significant genotype-sex interaction (FWER=10%) when using
iSet. Non-imputed typed variants are highlighted in red, showing that for this locus
imputation strategies did not increase the power of single-variant methods.
males females
b rs4660378
AAAG GG AAAG GG
rs4660378a b
Figure C.12: The interaction for C-Reactive protein on chromosome 1 is
a male-specific effect. (a) Local Manhattan plot (1Mb around significant region)
for single-variant association tests, either considering males (black) or females (pink).
For comparison, we also show P-values from the iSet (red), mtSet (green) and stSet
(grey). (b) C-Reactive protein level stratified by different alleles of rs4660378 (lead
SNP identified in the analysis using male individuals only). rho corresponds to the
Spearman correlation coefficient and the corresponding P value of the correlation test,
both for male and female individuals.
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D | Supplementary material for: Flex-
ible LINear MIXed models
D.1 Covariance functions and Gaussian processes
As we have seen in Chapter 5, the LIMIX inference framework builds on the concept of
Gaussian process and covariance function. As described below, the Gaussian process
can be seen as an extension of the linear mixed model (LMM). While I here introduce
the Gaussian process and the covariance function in an intuitive manner, for an in-depth
discussion I refer the interested reader to Rasmussen (2006).
Covariance function. Let F denote the input feature space. A function κ : (x, x′) ∈
F2 → R is a covariance function if and only if ∀N and ∀x ∈ FN the matrix Kx =
[κ(xi, xj)] ∈ RN×N is positive-semidefinte. Covariance functions are also known as
kernels.
Gaussian process. A Gaussian process (GP) is a distribution over functions char-
acterised by a mean function and a covariance function. Let F denote the input feature
space. A function f : F→ R follows a GP distribution with mean function m : F→ R
and covariance function κ : (x, x′) ∈ F2 → R if and only if f(x) ∼ N (m(x) , Kx )
∀N and ∀x ∈ FN , where f(x) = [f(xi)] ∈ RN , m(x) = [m(xi)] ∈ RN and Kx =
[κ(xi, xj)] ∈ RN×N . Intuitively, the Gaussian process, its mean function and its covari-
ance function are infinite-dimensional generalisation of a multivariate Gaussian distri-
bution, its mean vector and its covariance matrix, respectively.
Relationship with LMMs. Let N denote the number of samples, Q the number of
input variables, y ∈ RN the outcome vector and Z ∈ RN×Q the design matrix of the
input variables. In this example, the input feature space is F = RQ. Let us introduce
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a function of the input feature φθ : RQ ∈→ RQ that depends on some parameters θ.
Notice that neither the explicit form of φθ nor the dimension of Q are known. Denoting









 b+ψ, ψ ∼ N (0 , σ2eIN ) , (D.1)











> φθ (z1) . . . φθ (zN )> φθ (zN )
+ σ2eIN
 . (D.2)
The last equation shows that the non-linear relationship between the output variables
and the original input variables only depends on the the dot product in the transformed
space. This dot product can be defined using a covariance function κθ as follows
κθ(zi,:, zj,:) = φθ (zi,:)
> φθ (zj,:) , (D.3)
where θ are the parameters of the covariance function. In sum, covariance functions
can be used to define non-linear relationships between the output and the input vari-
ables (Schölkopf and Smola, 2002).
D.2 Basic covariance models
Fixed-form covariance When the covariance structure between samples is known,
only a positive scale parameter ea needs to be inferred. The covariance function and






where θ = {a} and K0 is a fixed covariance matrix.
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Freeform covariance A freeform covariance is the most general form of covariance
matrix. To represent a general covariance and ensure that it is positive semidefinite,
we use the Cholesky parametrisation. Briefly, indicating with d the dimension of the
covariance and with θ ∈ R 12d(d+1) the non-zero entries of a d×d lower triangular matrix














Lowrank covariance A lowrank covariance is a general covariance matrix having
rank r < d. Indicating with θ ∈ Rrd the elements of a d × r matrix Xθ, the lowrank














Diagonal covariance A diagonal covariance matrix and its gradients are




0, . . . , j-th element︷︸︸︷eaj , . . . , 0
 , (D.11)
where θ = {a0, . . . , ad}.
Covariance functions Indicating with N the number of individuals, let X be the
N × D input matrix for d features. As we have seen in Section D.1, a covariance
function C describes the covariance between sample i and sample j in terms of the D
features
Kij = C (xi,xj) , (D.12)
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Indicating with I the Fisher information matrix for a gaussian likelihood function for














The covariance matrix between parameters Σ is the inverse of the Fisher information,





D.4 Supplementary information for the analysis in BluePrint
WP10
D.4.1 Molecular assays and data preprocessing
Blood collection and cell isolation were perfumed at the University of Cambridge (UoC).
The produced monocyte population had purity 95%. As described in more detail
below, the subsequent molecular assays, quality control (QC) steps and data processing
were performed in different research institutes, including the Wellcome Trust Sanger
Institute (WTSI), the Max Planck Institute for Molecular Genetics (MPIMG), the
University College London (UCL), the Nijmegen Centre for Molecular Life Sciences
(NCMLS) and the European Bioinformatics Institute (EBI). I have not taken part to
the collection and the preprocessing of the data. The analyses I performed are described
in Section 5.3.2, for which I considered the set of 158 individuals for which all five
molecular layers (genotype, DNA methylation, H3K4me1, H3K27ac and expression)
had passed all QC steps.
WGS data. DNA extraction was performed at the UoC. Sequencing (100bp pair-
ended; HiSeq 2000/2500, Illumina; 7.05x coverage), alignment to reference genome
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(using BWA, Li and Durbin, 2009), variant calling (SAMtools / bcftools, Li, 2011) and
QC steps were performed at the WTSI. In the analyses discussed in the next sections
we considered a set of 5,237,919 common variants (MAF > 4%).
RNA-sequencing. Library preparation and sequencing (100 bp single end (SE); V3
chemistry, HiSeq 2000, Illumina) were performed at MPIMG. Pre-alignment QC steps,
alignment (with STAR, Dobin et al., 2013) and gene-level quantification (DESeq2, Love
et al., 2014) was performed at WTSI. Only the 16,577 genes with at least 10 read counts
in at least 50% of the samples were considered for further analysis.
Methylation data. Data generation with 450K array and data processing were car-
ried out at the UCL. CpG probes (i) with median P value ≥ 0.01 in at least one sample,
(ii) with bead count ≤ 3 in at least three samples, (iii) mapping to sex chromosomes
or to multiple locations, (iv) with common SNP (MAF ≥ 0.05) within 2 bp from the
CpG site were excluded. This led to a set of 440,905 CpG sites that we considered for
further analysis. Methylation of CpG sites was expressed using M-values, defined as
the log2 ratio of the intensities of methylated and unmethylated probes.
Histone modification. Chromatin immunoprecipitation (ChIP) assay for H3K27ac/H3K4me1
histone marks and sequencing were performed in different sequencing centres using dif-
ferent protocols. Monocytes 1-49/1-48 are were processed at teh NCMLS (Illumina
HiSeq 2000 at 43bp SE reads) while monocytes 50-162/49-172 at the WTSI (Illumina
HiSeq 2000 at 50bp SE reads). Alignment to reference genome (BWA, Li and Durbin,
2009), QC steps, peak calling (using MACS2, FDR ≤ 1%) and peak intensity quantifi-
cation were performed at the EBI. For each histone modification marker the reference
peak set was obtained by (i) considering the union of significant peaks across all indi-
viduals and cell-types and (ii) merging overlapping peaks. This procedure led to the
identification of 64,843 and 39,815 large peaks (≥ 100kb) for H3K27ac and H3K4me1
histone modifications, respectively. Peak intensities were expressed as log2 of the total
number of read counts within the peak per million base pairs and were normalised with
respect to the total number of reads in the library.
Data were corrected for batch effects and technical confounding using ComBat (Leek
et al., 2012).
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D.4.2 Accounting for sample heterogeneity
To assess whether the correction using PEER was sufficient to eliminate this potential
confounding, we proceeded as described in the following. Let N denote the number
of individuals, y ∈ RN the normalised gene-expression vector, Kg ∈ RN×N the global
RRM and Kcis ∈ RN×N a local RRM based on the genetic variants in the cis region




, σ2cisKcis︸ ︷︷ ︸
cis component





where 1µ ∈ RN is an intercept term. As discussed in Section 2.3.4, this model can
be used to estimate the proportion of phenotypic variance explained jointly by all cis
variants. We used the same approach to estimate the variance explained by cis CpG
sites, cis H3K27ac peaks and cis H3K4me1 peaks by using a local relatedness ma-
trices based on the corresponding cis epigenetic features. Epigenetic features were
quantile-normalised to a unit variance normal distribution before computing the local
(epigenetic) relatedness matrices. Denoting with Z denotes the N ×G gene expression
matrix for N individuals and all G genes, let us consider the expression heterogeneity
(EH) covariance as Kh = ZZT ∈ RN×N . Under the assumption that genome-wide
expression heterogeneity can be used as a tag for technical confounding, a common
strategy in eQTL mapping (Kang et al., 2008a; Fusi et al., 2012), we introduced Kh
in the model and re-estimated the cis variance components for the genetic and the
three epigenetic layers. We found that the model accounting for EH yielded substan-
tially lower epigenome variance estimates, whereas the cis genetic variances were robust
(Fig. D.1). We thereby decided to account for EH in all subsequent analyses.
D.4.3 Supplementary Figures
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Figure D.1: Comparison of variance component estimates either accounting
or not for expression heterogeneity. Compared are the estimated proportion of
variance explained by cis genetics, cis methylation and cis histone marks when either
considering a model that accounts for expression heterogeneity (y-axis) or standard
linear mixed model (x-axis). While genetic estimates were robust, epigenetic variance
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